<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia - Jones, C - 2018 | Cochrane Library</title> <meta content="Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia - Jones, C - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008712.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia - Jones, C - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008712.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008712.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia" name="citation_title"/> <meta content="Christopher Jones" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="c.a.jones@bham.ac.uk" name="citation_author_email"/> <meta content="David Hacker" name="citation_author"/> <meta content="Birmingham and Solihull Mental Health Foundation NHS Trust" name="citation_author_institution"/> <meta content="Alan Meaden" name="citation_author"/> <meta content="Birmingham and Solihull Mental Health Foundation NHS Trust" name="citation_author_institution"/> <meta content="Irene Cormac" name="citation_author"/> <meta content="Rampton Hospital" name="citation_author_institution"/> <meta content="Claire B Irving" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Jun Xia" name="citation_author"/> <meta content="The University of Nottingham Ningbo" name="citation_author_institution"/> <meta content="Sai Zhao" name="citation_author"/> <meta content="The Ingenuity Centre, The University of Nottingham" name="citation_author_institution"/> <meta content="Chunhu Shi" name="citation_author"/> <meta content="University of Manchester, Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Jue Chen" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD008712.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/11/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008712.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008712.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008712.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cognitive Behavioral Therapy [*methods]; Combined Modality Therapy [methods]; Patient Readmission [statistics &amp; numerical data]; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Schizophrenia [mortality, *therapy]; Schizophrenic Psychology; Social Behavior" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008712.pub3&amp;doi=10.1002/14651858.CD008712.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="xcg9958b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008712\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008712\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","ms","de","zh_HANT","fa","th","ja","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008712.pub3",title:"Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia",firstPublishedDate:"Nov 15, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008712.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008712.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008712.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008712.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008712.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008712.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008712.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008712.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008712.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008712.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12115 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008712.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0339"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0119"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-sec-0320"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/appendices#CD008712-sec-0356"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/table_n/CD008712StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/table_n/CD008712StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Christopher Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0003">David Hacker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0004">Alan Meaden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0005">Irene Cormac</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0006">Claire B Irving</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0007">Jun Xia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0008">Sai Zhao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0009">Chunhu Shi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information#CD008712-cr-0010">Jue Chen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information/en#CD008712-sec-0436">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 November 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008712.pub3">https://doi.org/10.1002/14651858.CD008712.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008712-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008712-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008712-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008712-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/th#CD008712-abs-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008712-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008712-abs-0001" lang="en"> <section id="CD008712-sec-0001"> <h3 class="title" id="CD008712-sec-0001">Background</h3> <p>Cognitive behavioural therapy (CBT) is a psychosocial treatment that aims to help individuals re‐evaluate their appraisals of their experiences that can affect their level of distress and problematic behaviour. CBT is now recommended by the National Institute for Health and Care Excellence (NICE) as an add‐on treatment for people with a diagnosis of schizophrenia. Other psychosocial therapies that are often less expensive are also available as an add‐on treatment for people with schizophrenia. This review is also part of a family of Cochrane Reviews on CBT for people with schizophrenia. </p> </section> <section id="CD008712-sec-0002"> <h3 class="title" id="CD008712-sec-0002">Objectives</h3> <p>To assess the effects of CBT compared with other psychosocial therapies as add‐on treatments for people with schizophrenia. </p> </section> <section id="CD008712-sec-0003"> <h3 class="title" id="CD008712-sec-0003">Search methods</h3> <p>We searched the Cochrane Schizophrenia Group's Study Based Register of Trials (latest 6 March, 2017). This register is compiled by systematic searches of major resources (including AMED, BIOSIS CINAHL, Embase, MEDLINE, PsycINFO, PubMed, and registries of clinical trials) and their monthly updates, handsearches, grey literature, and conference proceedings, with no language, date, document type, or publication status limitations for inclusion of records into the register. </p> </section> <section id="CD008712-sec-0004"> <h3 class="title" id="CD008712-sec-0004">Selection criteria</h3> <p>We selected randomised controlled trials (RCTs) involving people with schizophrenia who were randomly allocated to receive, in addition to their standard care, either CBT or any other psychosocial therapy. Outcomes of interest included relapse, global state, mental state, adverse events, social functioning, quality of life and satisfaction with treatment. We included trials meeting our inclusion criteria and reporting useable data. </p> </section> <section id="CD008712-sec-0005"> <h3 class="title" id="CD008712-sec-0005">Data collection and analysis</h3> <p>We reliably screened references and selected trials. Review authors, working independently, assessed trials for methodological quality and extracted data from included studies. We analysed dichotomous data on an intention‐to‐treat basis and continuous data with 60% completion rate. Where possible, for binary data we calculated risk ratio (RR), for continuous data we calculated mean difference (MD), all with 95% confidence intervals (CIs). We used a fixed‐effect model for analyses unless there was unexplained high heterogeneity. We assessed risk of bias for the included studies and used the GRADE approach to produce a 'Summary of findings' table for our main outcomes of interest. </p> </section> <section id="CD008712-sec-0006"> <h3 class="title" id="CD008712-sec-0006">Main results</h3> <p>The review now includes 36 trials with 3542 participants, comparing CBT with a range of other psychosocial therapies that we classified as either active (A) (n = 14) or non active (NA) (n = 14). Trials were often small and at high or unclear risk of bias. When CBT was compared with other psychosocial therapies, no difference in long‐term relapse was observed (RR 1.05, 95% CI 0.85 to 1.29; participants = 375; studies = 5, <i>low‐quality evidence</i> ). Clinically important change in global state data were not available but data for rehospitalisation were reported. Results showed no clear difference in long term rehospitalisation (RR 0.96, 95% CI 0.82 to 1.14; participants = 943; studies = 8, <i>low‐quality evidence</i> ) nor in long term mental state (RR 0.82, 95% CI 0.67 to 1.01; participants = 249; studies = 4, <i>low‐quality evidence</i> ). No long‐term differences were observed for death (RR 1.57, 95% CI 0.62 to 3.98; participants = 627; studies = 6, <i>low‐quality evidence</i> ). Only average endpoint scale scores were available for social functioning and quality of life. Social functioning scores were similar between groups (long term Social Functioning Scale (SFS): MD 8.80, 95% CI ‐4.07 to 21.67; participants = 65; studies = 1, <i>very low‐quality evidence</i> ), and quality of life scores were also similar (medium term Modular System for Quality of Life (MSQOL): MD ‐4.50, 95% CI ‐15.66 to 6.66; participants = 64; studies = 1, <i>very low‐quality evidence</i> ). There was a modest but clear difference favouring CBT for satisfaction with treatment ‐ measured as leaving the study early (RR 0.86, 95% CI 0.75 to 0.99; participants = 2392; studies = 26, <i>low quality evidence</i>). </p> </section> <section id="CD008712-sec-0007"> <h3 class="title" id="CD008712-sec-0007">Authors' conclusions</h3> <p>Evidence based on data from randomised controlled trials indicates there is no clear and convincing advantage for cognitive behavioural therapy over other ‐ and sometimes much less sophisticated and expensive ‐ psychosocial therapies for people with schizophrenia. It should be noted that although much research has been carried out in this area, the quality of evidence available is mainly low or of very low quality. Good quality research is needed before firm conclusions can be made. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008712-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008712-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD008712-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD008712-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008712-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD008712-abs-0013">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008712-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD008712-abs-0004">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD008712-abs-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008712-abs-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008712-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008712-abs-0003" lang="en"> <h3>Is Cognitive behavioural therapy as effective as other psychosocial treatments for people with schizophrenia </h3> <p><b>Background</b> </p> <p>People with serious mental illnesses such as schizophrenia can experience severe disturbances in their thought processes, which may lead to delusions (beliefs that are not based on reality) and hallucinations (seeing and hearing things that are not really there). The standard care for people with schizophrenia is antipsychotic medication, but these medications are not always successful on their own and additional treatments such as psychosocial therapies (including cognitive behavioural therapy (CBT)) are recommended for people with schizophrenia. CBT aims to help people re‐evaluate their views of their symptoms. This process is thought to help reduce distress and change behaviours. It is often used to help people with illnesses such as anxiety and depression. However, CBT is expensive and the evidence for its effectiveness is not clear, particularly for people with schizophrenia. </p> <p><b>Searches</b> </p> <p>The Information Specialist of Cochrane Schizophrenia searched their specialised register for trials that allocated people with schizophrenia to receive either CBT or another type of psychosocial treatment, up to March 2017. These searches found 4117 records. The review authors inspected and screened these records. </p> <p><b>Main results</b> </p> <p>Thirty‐six randomised controlled trials, randomising in total 3542 people with schizophrenia could be included. The quality of evidence from these trials is very low to low. For important outcomes such as relapse, rehospitalisation, mental state, death, social functioning, quality of life no real differences were found between CBT compared with other psychosocial treatments. The number of participants leaving the study early was used as an indirect measure for satisfaction with treatment. Slightly more people allocated to other psychosocial treatments groups left early compared to CBT groups. Results were not robust enough to make firm conclusions. </p> <p><b>Conclusions</b> </p> <p>No firm conclusions can be made regarding the effectiveness of CBT compared to other psychosocial treatments for people with schizophrenia until results from further good‐quality trials are available. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008712-sec-0339" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008712-sec-0339"></div> <h3 class="title" id="CD008712-sec-0340">Implications for practice</h3> <section id="CD008712-sec-0340"> <section id="CD008712-sec-0341"> <h5 class="title">1. For people with schizophrenia</h5> <p>The use of cognitive behavioural therapy (CBT) has been associated with some reduction in symptoms of psychosis, particularly the positive symptoms of schizophrenia. However, there is considerable variability in the findings of the various studies and effect sizes tend to be quite modest. Therefore, at present, it is not possible to assert any substantial benefit for CBT in contrast to other psychological therapies. </p> </section> <section id="CD008712-sec-0342"> <h5 class="title">2. For clinicians</h5> <p>Currently, CBT for people with schizophrenia is a scarce commodity, often provided by highly‐skilled and experienced therapists. These data are not convincing of clear benefit over other ‐ and sometimes less sophisticated ‐ therapies for people with schizophrenia. There is some indication that CBT may help the positive symptoms of schizophrenia and there is mixed and inconsistent evidence for the benefit of CBT for psychosis on secondary anxiety and depression. </p> </section> <section id="CD008712-sec-0343"> <h5 class="title">3. For policy makers</h5> <p>Cognitive behavioural therapy may provide a useful add‐on to traditional treatment of people with schizophrenia. The nature of the randomised controlled trials of CBT included in this review and their small sample sizes demands caution until such time as data from larger, more methodologically coherent randomised controlled trials are available to supplement these findings. </p> </section> </section> <h3 class="title" id="CD008712-sec-0344">Implications for research</h3> <section id="CD008712-sec-0344"> <section id="CD008712-sec-0345"> <h5 class="title">1.General</h5> <section id="CD008712-sec-0346"> <h6 class="title">1.1 Study design</h6> <p>More, large, generally applicable, clinically‐meaningful trials are needed. More comparisons of CBT with supportive approaches would seem of particular interest. Further research should address the issue of the use of CBT in specific settings and contexts (e.g. tertiary psychiatric services, long‐stay institutions, and day hospitals). If all of the trials within this review had conformed to the suggestions within the CONSORT statement on trials reporting (<a href="./references#CD008712-bbs2-0134" title="BeggC , ChoM , EastwoodS , HortonR , MoherD , OlkinI , et al. Improving the quality of randomized controlled trials. The CONSORT statement. JAMA1996;276:637‐9. ">Begg 1996</a>; <a href="./references#CD008712-bbs2-0188" title="MoherD , SchulzKF , AltmanD . The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomized trials. JAMA2001;285:1987‐91. ">Moher 2001</a>), much more may be known on the effect of CBT for people with schizophrenia. </p> </section> <section id="CD008712-sec-0347"> <h6 class="title">1.2 Randomisation</h6> <p>Allocation concealment is a fundamental part of trial methodology. If readers are to be reassured that selection bias was minimised then the randomisation process should be clearly described. </p> </section> <section id="CD008712-sec-0348"> <h6 class="title">1.3 Blinding</h6> <p>Double‐blind evaluation of the outcomes of a psychosocial intervention is extremely difficult, and probably impossible. Trialists should, however, take every precaution to minimise the effect of biases by using blinded or independent raters (quoting inter‐rater reliability and measuring their blindness) and, probably more importantly, using 'harder' outcomes such as relapse, self‐harm, and relapse or admission rather than scale data. </p> </section> <section id="CD008712-sec-0349"> <h6 class="title">1.4 Withdrawals</h6> <p>Intention‐to‐treat analysis is preferable. If possible, all trials should describe from which groups withdrawals came, why they occurred and what was their outcome. </p> </section> </section> <section id="CD008712-sec-0350"> <h5 class="title">2. Specific to cognitive behavioural therapy trials</h5> <p>For a suggested design of future study (see <a href="#CD008712-tbl-0004">Table 3</a>), modified from that included in the full version of the Cochrane psychoeducation review (<a href="./references#CD008712-bbs2-0209" title="ZhaoS , SampsonS , XiaJ , JayaramMB . Psychoeducation (brief) for people with serious mental illness. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD010823.pub2] ">Zhao 2015</a>). </p> <div class="table" id="CD008712-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Suggested design of study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: randomised, fully explicit description of methods of randomisation and allocation concealment.<br/> Blinding: single, tested.<br/> Setting: community rather than hospital.<br/> Duration: 12 weeks treatment, and then follow‐up to at least 52 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: schizophrenia (ICD).<br/> N = 300.*<br/> Age: adults.<br/> Sex: both. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Cognitive behaviour therapy + standard care. N = 150.</p> <p>Content:</p> <p> <ol id="CD008712-list-0008"> <li> <p>a discrete psychological intervention, which is in addition to, and separate from, other therapeutic interventions (for example, behavioural family therapy) and </p> </li> <li> <p>recipients establish links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour and </p> </li> <li> <p>the re‐evaluation of their perceptions, beliefs or reasoning relating to the target symptoms; this may include the re‐evaluation of specific "inferential" beliefs or more global "evaluative" beliefs. </p> </li> </ol> </p> <p>Delivered by: experienced therapists.</p> <p>2. Other psychosocial therapy + standard care . N = 150.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General: time to all‐cause treatment failure marked by its discontinuation, relapse/rehospitalisation, general impression of clinician (CGI), career/other, compliance with treatment.<br/> Mental state: BPRS and PANSS.<br/> Global state: CGI (Clinical Global Impression).<br/> Quality of life. QOL (Quality of Life Questionnaire).<br/> Social functioning: return to everyday living for 80% of time.*<br/> Economic outcomes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* Powered to be able to identify a difference of ˜ 20% between groups for primary outcome with adequate degree of certainty. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BPRS: Brief Psychiatric Rating Scale; ICD: International Classification of Diseases; PANSS: Positive and Negative Syndrome Scale </p> </div> </div> <section id="CD008712-sec-0351"> <h6 class="title">2.1 The issue of practitioners</h6> <p>Cognitive behavioural therapy holds the promise of providing a valuable adjunct to traditional treatments for people with psychotic disturbances. Despite the fact that it may be an effective therapy, it is currently inaccessible to large numbers of those with schizophrenia, even within well‐resourced care services. This situation will remain until either the basic skills of cCBTcan be generalised to other healthcare professionals; or there can be increased availability of specialists specifically practising CBT for those with schizophrenia. </p> </section> <section id="CD008712-sec-0352"> <h6 class="title">2.2 Power</h6> <p>Estimates of statistical power based on data obtained from this review indicate that using data from within this review for the outcome of 'no important improvement' about 70 people per group are required to show a statistically clear difference in the outcome over a period of at least six months (alpha 0.05, beta 0.8). This computation assumes that the difference in proportions is ‐0.29 (specifically, 0.58 versus 0.87). Given an attrition rate of approximately 30%, researchers should aim for a minimal sample size of 100 persons per intervention. </p> </section> <section id="CD008712-sec-0353"> <h6 class="title">2.3 Outcomes measured</h6> <p>Outcomes should be clear and clinically useful, but if authors are to persist in using continuous scale‐derived data, these tools should be standardised, and peer‐reviewed (<a href="./references#CD008712-bbs2-0185" title="MarshallM , LockwoodA , AdamsC , BradleyC , JoyC , FentonM . Unpublished rating scales ‐ a major source of bias in randomised controlled trials of treatments for schizophrenia?. British Journal of Psychiatry2000;176:249‐52. ">Marshall 2000</a>). Trialists often did not present clear measures of association between intervention and outcome, for example, risk ratios, odds ratios, risk or mean difference, as well as the raw data. Wherever possible, binary outcomes should be reported in preference to continuous scale‐derived data as they are easier to interpret and clinically relevant. If P values are used, the exact value should be reported. </p> <p>Concrete outcomes of disturbance such as 'disturbed episode', 'use of detention order', 'use of special nursing observation' or, for those in the community, 'avoiding hospitalisation' would be of interest. Data on quality of life, social functioning, occupational status, general impression of carer or other, unwanted effects, such as anxiety, depression and dependence on the relationship with the therapist, staff fatigue and economic outcomes would be very welcome. </p> <p>The present data provide little indication of how effective CBT procedures might be when they are applied by less experienced practitioners and in routine clinical settings. It would be useful to know whether the effects of CBT are sustained after the therapy course has finished, whether booster sessions are beneficial, and whether continued (long‐term) therapy is required to sustain the treatment effect. A cost/benefit analysis would enable clinicians and purchasers to manage service provision and make best use of resources. </p> </section> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008712-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008712-sec-0029"></div> <div class="table" id="CD008712-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">CBT compared to ALL OTHER PSYCHOLOGICAL THERAPIES for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CBT compared to OTHER PSYCOSOCIAL THERAPIES for people with schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia </p> <p><b>Setting:</b> inpatients and outpatients<br/> <b>Intervention:</b> CBT+ standard care<br/> <b>Comparison:</b> Other psychological therapies + standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with ALL OTHER PSYCHOLOGICAL THERAPIES</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with CBT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: relapse<br/> follow‐up: range 8 weeks to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.85 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>375<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>463 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>486 per 1,000<br/> (393 to 597) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: rehospitalisation*<br/> follow‐up: range 70 days to 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.82 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>943<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Data for pre‐defined outcome 'clinically important change' not reported.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1,000<br/> (307 to 427) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mental state: General ‐ clinically important change (no improvement)<br/> follow‐up: range 12 months to 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.82<br/> (0.67 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>249<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>636 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>522 per 1,000<br/> (426 to 643) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effect/event: death ‐ any cause<br/> follow‐up: range 70 days to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.57<br/> (0.62 to 3.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>627<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1,000<br/> (10 to 64) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning ‐ average scores (Social Functioning Scale, high = good)<br/> follow‐up: mean 12 months * </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functioning ‐ average scores (Social Functioning Scale, high = good, long term) was 128.5 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 8.80 higher<br/> (4.07 lower to 21.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2, 5, 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data for pre‐defined outcome 'clinically important change' not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: average scores (MSQOL, high = good, medium term)<br/> follow‐up: mean 6 months * </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life: average scores (MSQOL, high = good, medium‐term) was 60.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.50 lower<br/> (15.66 lower to 6.66 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2,6 ,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data for pre‐defined outcome 'clinically important change' not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Satisfaction with treatment ‐ leaving the study early for any reason</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.75 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2392<br/> (26 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>247 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>217 per 1,000<br/> (192 to 256) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>MD:</b> mean difference; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level due to risk of bias: some studies had unclear or high risk of bias with blinding of participants and outcome assessments, as well as attrition issues. </p> <p><sup>2</sup> Downgraded by one level due to imprecision: small sample size and wide confidence interval. </p> <p><sup>3</sup> Downgraded by one level due to risk of bias: majority of the included studies had unclear risk of blinding of participants and outcome assessments. </p> <p><sup>4</sup> Downgraded by one level due to imprecision: small event rate and wide confidence interval around effect estimate. </p> <p><sup>5</sup> Downgraded by one level due to risk of bias: high risk of detection bias due to unblinded assessment. </p> <p><sup>6</sup> Downgraded by one level due to indirectness: scores from scale were employed as a surrogate index of the intended outcome. </p> <p><sup>7</sup> Downgraded by one level due to risk of bias: high risk of allocation concealment bias, and unclear risk around blinding. </p> <p><sup>8</sup> Downgraded by one level due to imprecision: small sample size and wide confidence interval which included appreciable benefit and no effect. </p> <p><sup>9</sup> Downgraded one level due to indirectness: leaving the study early used to predict satisfaction with treatment </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008712-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008712-sec-0030"></div> <section id="CD008712-sec-0031"> <h3 class="title" id="CD008712-sec-0031">Description of the condition</h3> <p>Schizophrenia is a serious mental illness. It appears in all countries and societies with a rate of approximately 0.5%. Variations occur with men being more affected along with ethnic minorities. Onset is usually in young adulthood. The course is worse if there is an early or insidious onset, if negative symptoms are dominant, or if there is a history of substance abuse (<a href="./references#CD008712-bbs2-0143" title="Castle DavidJ , MorganV . Epidemiology Chapter 2. In: MueserK.T , JesteD.V editor(s). Clinical Handbook of Schizophrenia. Guilford Press, 2008:14‐25. ">Castle and Morgan 2008</a>). Some of those affected have difficulties with their thoughts, making illogical associations and developing false and sometimes bizarre false explanations (i.e. delusions) for their experiences or symptoms. Problems with false perceptions may occur, for example, hearing voices or seeing visions (hallucinations). Difficulties with concentration, attention and motivation may also lead to poor social and occupational functioning. The range of emotional expression, capacity to think and act may be reduced, together with an inability to experience pleasure. It is customary to view the symptoms of schizophrenia as falling into two broad categories: (i) 'positive' symptoms, which are unusual by their presence (for example, hearing voices); and (ii) 'negative' symptoms, which are unusual by their absence (for example, restricted range and intensity of emotional expression). </p> </section> <section id="CD008712-sec-0032"> <h3 class="title" id="CD008712-sec-0032">Description of the intervention</h3> <p>Medication is the mainstay of treatment for schizophrenia but 5% to 25% of people continue to experience symptoms in spite of medication (<a href="./references#CD008712-bbs2-0144" title="ChristisonGW , KirchDG , WyattRJ . When symptoms persist: choosing among alternative somatic symptoms for schizophrenia. Schizophrenia Bulletin1991;17:217‐45. ">Christison 1991</a>; <a href="./references#CD008712-bbs2-0146" title="DavisJM , CasperR . Antipsycotic drugs: clinical pharmacology and therapeutic use. Drugs1977;14:260‐82. ">Davis 1977</a>; <a href="./references#CD008712-bbs2-0187" title="MeltzerHY . Treatment of the neuroleptic‐nonresponsive schizophrenic patient. Schizophrenia Bulletin1992;18:515‐42. ">Meltzer 1992</a>) and may experience side effects that are unwanted and unpleasant. </p> <p>Talking therapies are often used in addition to medication. In cognitive behaviour therapy (CBT), links are made between the person's feelings and patterns of thinking which underpin their distress. The participant is encouraged to take an active part by using the following techniques. </p> <p> <ol id="CD008712-list-0001"> <li> <p>People are encouraged to establish links between their thoughts, feelings or actions and their current or past symptoms, and/or functioning. It should promote re‐evaluation of people's perceptions, beliefs or reasoning related to the target symptoms and include at least one of the following: people monitoring their own thoughts, feelings or behaviours with respect to their symptoms or recurrence of symptoms promoting alternative ways of coping with the target symptom reducing distress improving functioning. </p> </li> <li> <p>Examining and disputing the evidence for and against the problematic and/or distressing beliefs and reasons for maintaining problematic behaviours. </p> </li> <li> <p>Using reasoning abilities and personal experience to develop rational, useful and personally acceptable alternative explanations and interpretations (<a href="./references#CD008712-bbs2-0126" title="AlfordBA , BeckAT . Cognitive therapy of delusional beliefs. Behaviour Research and Therapy1994;32:369‐80. ">Alford 1994</a>); and to test these alternative explanations and abandon associated safety behaviours in real‐world situations. <a href="./references#CD008712-bbs2-0097" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , SharpeL , BeckettR , HarwoodS , BakerA , YusopoffL . A trial of two cognitive behavioural methods of treating drug resistant residual psychotic symptoms in schizophrenic patients: II. Treatment specific changes in coping and problem solving skills. Social Psychiatry and Psychiatric Epidemiology1993;28:5‐10. ">Tarrier 1993</a> has also stressed the beneficial effects of enhancing coping strategies and general problem‐solving skills. </p> </li> </ol> </p> <p>We note that the above description of CBT is consistent with that within the National Institute for Health and Care Excellence (NICE) guidance for CBT‐P (<a href="./references#CD008712-bbs2-0191" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. www.nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018. ">NICE 2014</a>). NICE guidance proposes that CBT should be delivered on a one‐to‐one basis over at least 16 planned sessions and follow a treatment manual. </p> <p>During the evolution of CBT for schizophrenia, a variety of interventions have been labelled as CBT. We note that not all of these interventions specifically target beliefs (e.g. psychoeducation, relapse prevention, symptom‐focused coping strategies, etc), and it is difficult to provide a single, unambiguous definition of the interventions which can be included under the rubric of CBT. Many of the trials of CBT for psychosis have incorporated additional active therapeutic elements (e.g. psychoeducation and relapse prevention, etc) that would be considered adjunctive to techniques which are specifically targeted at eliciting beliefs and behavioural changes (e.g. guided discovery or behavioural experiments). In recognition, the review authors have constructed criteria that are felt to be workable and to capture the elements of good practice in CBT. These criteria are described below. </p> </section> <section id="CD008712-sec-0033"> <h3 class="title" id="CD008712-sec-0033">How the intervention might work</h3> <p>Cognitive behavioural therapy (CBT) aims to reduce distressing emotional experiences or problematic behaviour by changing the way in which the individual appraises, interprets and evaluates their experiences. CBT encourages the person to identify and challenge unhelpful and distressing interpretations of their experiences. Many CBT programmes (e.g. <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>), are based upon a stress‐vulnerability model of symptom onset and relapse. The empirical evidence for the stress‐vulnerability model has been questioned (<a href="./references#CD008712-bbs2-0186" title="McKennaPJ . Schizophrenia and Related Syndromes. 2nd Edition. London: Routledge, 2007. ">McKenna 2007</a>). Alternatively, in a theoretical review of the potential change processes that CBT for psychosis might possess, <a href="./references#CD008712-bbs2-0138" title="BirchwoodM , TrowerP . The future of cognitive–behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry2006;188:107‐8. ">Birchwood 2006</a> distinguishes between "quasi‐neuroleptic" effects of CBT upon psychotic symptoms (e.g. hallucination) and the emotional and behavioural consequences of such experiences or their treatment. Accordingly, <a href="./references#CD008712-bbs2-0138" title="BirchwoodM , TrowerP . The future of cognitive–behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry2006;188:107‐8. ">Birchwood 2006</a> distinguishes between psychotic symptomatology and the emotional distress or problem behaviours that may result from such symptomatology. <a href="./references#CD008712-bbs2-0138" title="BirchwoodM , TrowerP . The future of cognitive–behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry2006;188:107‐8. ">Birchwood 2006</a> asserts that, similar to the focus of CBT in affective disorders, the appropriate goal of the CBT intervention is to reduce emotional distress and problem behaviours. Specifically, <a href="./references#CD008712-bbs2-0138" title="BirchwoodM , TrowerP . The future of cognitive–behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry2006;188:107‐8. ">Birchwood 2006</a> suggests that CBT might focus upon the following. </p> <p> <ol id="CD008712-list-0002"> <li> <p>Reduction of distress and/or problem behaviour associated with beliefs about psychotic symptomatology. </p> </li> <li> <p>The emotional and interpersonal difficulty in individuals at high risk of developing psychosis. </p> </li> <li> <p>Relapse prodromes to prevent relapse in psychosis.</p> </li> <li> <p>Comorbid depression and social anxiety, including the patient’s appraisal of the diagnosis and its stigmatising consequences. </p> </li> <li> <p>General stress reactivity, thereby increasing resilience to life stress and preventing psychotic relapse. </p> </li> <li> <p>Increasing self‐esteem and social confidence in people with psychosis.</p> </li> </ol> </p> <p>Nevertheless, many of the current trials of CBT for psychosis have defined their outcomes in terms of psychotic symptomatology (e.g. hallucinatory and delusional experiences,) rather than in terms of distress, problem behaviour or stigma and self‐esteem. In clinical practice, interventions are often broad and multifaceted, but when applied to clinical trials such approaches may not specifically address the psychological mechanisms purported by CBT theory to underpin the individuals distress and problem behaviour. </p> <p>Similarly, more recent developments in psychological therapies have incorporated some of the principles of CBT. However these therapies,such as Acceptance and Committment Therapy and Compassion Focused Therapy do not explicitly target beliefs regarding psychotic experiences and their implications. Rather, the focus is on accepting mental experience and developing compassion with greater focus on modifying affect rather than cognition. These therapies, which are often referred to as "third wave therapies", address mental events and distress more broadly and focus on beliefs about mental life in general (rather than specific beliefs related to symptoms). </p> </section> <section id="CD008712-sec-0034"> <h3 class="title" id="CD008712-sec-0034">Why it is important to do this review</h3> <p>Despite national treatment guidelines recommending CBT as an adjunct therapy for serious mental illness (<a href="./references#CD008712-bbs2-0191" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. www.nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018. ">NICE 2014</a>), CBT is still not as widely available for people with schizophrenia as it is for people with other disorders (for example, depression and panic disorder). </p> <p>The first case report of CBT for delusional beliefs in 1952, reported by <a href="./references#CD008712-bbs2-0133" title="BeckAT . The current state of cognitive therapy. Archives of General Psychiatry2005;62:953‐9. ">Beck 2005</a>, did not lead to widespread development of CBT for schizophrenia or its symptoms. Psychological interventions have become more widely accepted over the past two decades and are now seen as part of a comprehensive set of routine interventions in the treatment and management of schizophrenia (<a href="./references#CD008712-bbs2-0191" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. www.nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018. ">NICE 2014</a>). However, the availability of CBT and other evidence‐based therapies on the NHS is extremely limited. The 2012 National Audit reveals that 34% had not been offered psychological therapy with 20% waiting over a year (<a href="./references#CD008712-bbs2-0197" title="Royal College of Psychiatrists (2012). Report of the National Audit of Schizophrenia (NAS) 2012. London: Healthcare Quality Improvement Partnership. ">Royal College of Psychiatrists 2012</a>). The delivery of CBT to people with schizophrenia also depends upon having a commitment from health service managers to support and facilitate training and supervision (<a href="./references#CD008712-bbs2-0202" title="TurkingtonD , DudleyR , WarmanDM , BeckAT . Cognitive‐behavioral therapy for schizophrenia: a review. Journal of Psychiatric Practice2004;10(1):5‐16. ">Turkington 2004</a>). </p> <p>Since the publication of the original Cochrane Review of <i>Cognitive behavioural therapy for schizophrenia</i> (<a href="./references#CD008712-bbs2-0172" title="JonesC , CormacI , MotaJ , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524.pub2] ">Jones 2004</a>), there has been a substantial increase in the number of published and relevant randomised controlled trials (RCTs), and a refinement in the definition and working models of CBT. In addition, there has also been a diversification of research, with trials not only assessing overall effectiveness of CBT but investigating more specific aspects of CBT. It was necessary to update and split the original review of CBT to create a family of CBT reviews (<a href="./references#CD008712-bbs2-0173" title="JonesC , CormacI , CampbellC , MeadenA , HackerD , IrvingCB . Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007965] ">Jones 2009a</a> and <a href="./references#CD008712-bbs2-0174" title="JonesC , CampbellC , CormacI , HackerD , MeadenA , IrvingCB . Cognitive behaviour therapy versus standard care for schizophrenia. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007964] ">Jones 2009b</a>) to incorporate and address these new more diverse data. This particular review provides information about CBT's relative effectiveness compared with other similar adjunct psychosocial therapies. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008712-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008712-sec-0035"></div> <p>To assess the effects of cognitive behavioural therapy (CBT) compared with other psychosocial therapies as add‐on treatments for people with schizophrenia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008712-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008712-sec-0036"></div> <section id="CD008712-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008712-sec-0038"> <h4 class="title">Types of studies</h4> <p>All relevant randomised controlled trials (RCTs). We excluded quasi‐randomised trials, such as those where allocation is undertaken on surname. If a trial had been described as double‐blind, but it was implied it had been randomised, we would have included these trials in a sensitivity analysis (see <a href="#CD008712-sec-0110">Sensitivity analysis</a>). If identified, we would have included randomised cross‐over studies, but only used data up to the point of first cross‐over because of the instability of the outcomes and the likely carry‐over effects of all treatments. </p> <p>As CBT requires the person to actively engage and participate in the therapy, it may not be possible to blind the participant to treatment condition (that is, it may not be possible to provide a placebo control condition to reduce the effects of an anticipated outcome on behalf of the participant). However, it is both possible and desirable to blind the researcher to condition (that is, the person collecting outcome data is unaware of the allocation of the individual participant). Accordingly, single‐blind trials are considered of appropriate methodological quality for the assessment of this type of intervention. </p> <p>We would have compared the outcomes of trials that described a single‐blind procedure with trials that did not describe any blinding procedure. If there was no substantive difference within primary outcomes (see <a href="#CD008712-sec-0044">Types of outcome measures</a>), when these non‐blinded studies were added, then we would have included them in the final analysis. If there was a substantive difference, we would have used only single‐blinded randomised trials and the results of the sensitivity analysis would have been described in the text. </p> </section> <section id="CD008712-sec-0039"> <h4 class="title">Types of participants</h4> <p>People with a current diagnosis of schizophrenia, diagnosed by any criteria, irrespective of gender or race. We did not include participants who had very late onset of illness (onset after the age of 60 years) or those with other psychotic disorders such as bipolar affective disorder, substance‐induced psychosis, significant physical or sensory difficulties or people with co‐existing developmental disorders and/or learning disabilities. If studies randomised people with schizophrenia and those with the above disorders, we only included trials where more than 50% of the participants had a diagnosis of schizophrenia. </p> <p>This review does not include trials that report outcomes from participants deemed to be "at‐risk" of developing schizophrenia in the future. </p> <p>We are interested in making sure that information is as relevant as possible to the current care of people with schizophrenia, so aimed to highlight the current clinical state clearly (acute, early post‐acute, partial remission, remission), as well as the stage (prodromal, first episode, early illness, persistent), and whether the studies primarily focused on people with particular problems (for example, negative symptoms, treatment‐resistant illnesses). </p> </section> <section id="CD008712-sec-0040"> <h4 class="title">Types of interventions</h4> <section id="CD008712-sec-0041"> <h5 class="title">1. Cognitive behavioural therapy (CBT)</h5> <p>The label cognitive behavioural therapy has been applied to a variety of interventions, accordingly, is difficult to provide a single, unambiguous definition. Recognising this, the review authors constructed criteria that were felt to be both workable and to capture the elements of good practice in CBT. </p> <p>In order to be classified as 'well‐defined', the intervention must clearly demonstrate the following components: </p> <p> <ol id="CD008712-list-0003"> <li> <p>a discrete psychological intervention, which is in addition to, and separate from, other therapeutic interventions (for example, behavioural family therapy) and </p> </li> <li> <p>recipients establish links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour and </p> </li> <li> <p>the re‐evaluation of their perceptions, beliefs or reasoning relating to the target symptoms; this may include the re‐evaluation of situation specific "inferential" beliefs or more global "evaluative" beliefs. </p> </li> </ol> </p> <p>All therapies that did not meet these criteria (or that provided insufficient information) but were labelled as 'CBT' or 'Cognitive Therapy' were included as 'less‐well‐defined CBT'. We conducted a sensitivity analysis on the primary outcomes of this review<i>(see</i><a href="#CD008712-sec-0044">Types of outcome measures</a><i>) i</i>n order to investigate whether a 'well‐defined' implementation of this therapy presents with differential outcomes. </p> <p>In addition, for primary outcomes, we undertook sensitivity analyses between studies that employed experienced CBT therapists compared with relatively inexperienced CBT therapists. Experienced CBT therapists were defined as: </p> <p> <ol id="CD008712-list-0004"> <li> <p>persons possessing appropriate professional qualifications for the provision of CBT (e.g. British Association of Behavioural and Cognitive Psychotherapy (BABCP) accreditation, Diploma in CBT, or other professionally‐accredited qualifications involving CBT as major part of training (e.g. Clinical or Counselling Psychologist)) or </p> </li> <li> <p>in situations where the qualifications of the therapist are unclear but they appear to have received training in CBT or specific training for the trial and there is clear evidence of the use a thorough adherence protocol. </p> </li> </ol> </p> <p>Unqualified CBT therapists may be defined as persons not possessing appropriate professional qualifications or with no appropriate accreditation, report of training and use of an adherence protocols. </p> </section> <section id="CD008712-sec-0042"> <h5 class="title">2. Other psychosocial treatments</h5> <p>Other psychosocial treatments includes standard care that has been supplemented by additional psychological or social interventions, or both, such as supportive therapy, psychoeducation, family therapy and other 'talking therapies'. </p> <p>This review distinguishes between trials that described 'active' psychosocial interventions (e.g. family therapy) aimed at a meaningful symptom reduction and those trials which have used 'non active' psychosocial interventions (e.g, unstructured conversations), which act as merely a control for the non‐specific effects of therapy (e.g. time spent with a therapist). Study labels are prefaced with an "A‐" or an "NA‐" to indicate whether an active or non active intervention was used as a comparison condition and the pooled effect of these trials is also presented. </p> </section> <section id="CD008712-sec-0043"> <h5 class="title">3. Standard care</h5> <p>The care a person with schizophrenia would normally receive had they not been involved in the trial. This normally includes a biological, psychological and social approach to care including antipsychotic medication, and utilisation of services including hospital stay, day hospital attendance and community psychiatric nursing involvement. </p> </section> </section> <section id="CD008712-sec-0044"> <h4 class="title">Types of outcome measures</h4> <p>Outcomes can be categorised as being of short‐, medium‐ or long duration. A short‐term outcome is defined as occurring within the period typically associated with active treatment. The National Institute for Health and Care Excellence (NICE) asserts that "for it to make a difference, [the patient] should have CBT treatment for more than 16 planned sessions" (<a href="./references#CD008712-bbs2-0191" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. www.nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018. ">NICE 2014</a>). Accordingly, in this review, we have grouped outcomes into those measured in the short term (within 24 weeks of the onset of therapy), medium term (within 24 to 52 weeks of the onset of therapy) and long term (over 52 weeks since the onset of therapy). </p> <p>Outcomes can also be grouped into broad areas (<a href="#CD008712-tbl-0002">Table 1</a>). </p> <div class="table" id="CD008712-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Outcome categories</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These relate to meaningful changes in symptomatology and general clinical condition, recovery and well‐being. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mental state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These refer to presence or absence of symptoms of psychosis as well as continuous measures relating to characteristics of psychotic symptoms (e.g. preoccupation; conviction; frequency; duration; intensity, loudness; perceived interference with daily living) and insight. Measures of general affect are also considered (e.g. anxiety, depression, shame, hopelessness, anger; self‐esteem) and symptom‐related affect measures (e.g. voice‐related distress; delusional distress).The presence or frequency of problematic behaviours are included (such as suicide attempts; deliberate self‐harm; violence to others, etc) and functional and adaptive behaviours (e.g. increased coping strategies) . </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All health interventions have the capacity for unintended and unwanted side effects. To‐date there has been a paucity of studies that have attempted to identify adverse effects of psychological therapies. Such outcomes might include dependency, increased distress, increased family dysfunction and disengagement from mental health services. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Service utilisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of service utilisation and functional outcomes may convey important information regarding health economic benefits, as well as provide indirect markers of personal independence. Such outcomes might include number of acute hospital or inpatient days, number of acute hospital admissions or equivalent (e.g. home treatment/crisis team intervention; respite admissions), changes in legal status under mental health legislation (<a href="./references#CD008712-bbs2-0149" title="Department of Health. Mental Health Act. www.legislation.gov.uk/ukpga/1983/20/contents (accessed prior to 02 June 2017). ">Department of Health 1983</a>), changes in level of care (including accommodation type and intensity of service (Assertive Outreach Team versus Community Mental Health Team)). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Functional outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include changes in employment, occupational and educational status, level of received social security benefits or social welfare, perceived quality of life and level of social functioning. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacological treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes would include alterations in the degree of compliance with the prescribed medication regimen, as well as alterations to the prescribed medication including changes in type of medication and prescribed dosage. Unwanted side effects will also be assessed. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Economic outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes would include both the direct costs of CBT (e.g. costs relating to the provision of therapy) and the indirect costs of CBT (e.g. reduction in medication, reduction in relapse, etc). </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CBT: Cognitive behavioural therapy</p> </div> </div> <p>We aimed to report binary outcomes recording clear and clinically meaningful degrees of change (e.g. global impression of much improved, or more than 50% improvement on a rating scale ‐ as defined within the trials) before any others. Thereafter, we listed other binary outcomes and then those that are continuous. </p> <p>* see <a href="#CD008712-sec-0440">Differences between protocol and review</a>. </p> <section id="CD008712-sec-0045"> <h5 class="title">Primary outcomes</h5> <section id="CD008712-sec-0046"> <h6 class="title">1. Global state</h6> <p>1.1 Relapse<br/> 1.2 Clinically important change ‐ as defined by the individual studies (for example, global impression much improved, or less than 50% reduction on a specified rating scale) ‐ short‐, medium‐ and long term. </p> </section> <section id="CD008712-sec-0047"> <h6 class="title">2. Mental state</h6> <p>2.1 Clinically important change ‐ as defined by the individual studies (for example, mental state much improved, or less than 50% reduction on a specified rating scale) ‐ short‐, medium‐ and long term. </p> </section> </section> <section id="CD008712-sec-0048"> <h5 class="title">Secondary outcomes</h5> <section id="CD008712-sec-0049"> <h6 class="title">1. Global state</h6> <p>1.1 Hospitalisation.<br/> 1.2 Healthy days.<br/> 1.3 Average endpoint/change score global state scale. </p> </section> <section id="CD008712-sec-0050"> <h6 class="title">2. Mental state</h6> <p>2.1 Any change in general mental state.<br/> 2.2 Average endpoint general mental state score.<br/> 2.3 Average change in general mental state scores.<br/> 2.4 Clinically important change in specific symptoms.<br/> 2.5 Any change in specific symptoms.<br/> 2.6 Average endpoint specific symptom score.<br/> 2.7 Average change in specific symptom scores. </p> </section> <section id="CD008712-sec-0051"> <h6 class="title">3. Adverse effect/event(s)</h6> <p>3.1 Any adverse effect/event(s)<br/> 3.2 Average endpoint general adverse effect score.<br/> 3.3 Average change in general adverse effect scores.<br/> 3.4 Clinically important adverse effect/event ‐ as defined by individual studies.<br/> 3.5 Any specific adverse effects.<br/> 3.6 Average endpoint specific adverse effects.<br/> 3.7 Average change in specific adverse effects. </p> </section> <section id="CD008712-sec-0052"> <h6 class="title">4. Functioning</h6> <p>4.1 Average endpoint general functioning score.<br/> 4.2 Average change in general functioning scores.<br/> 4.3 Clinically important change in specific aspects of functioning, such as social or life skills.<br/> 4.4 Any change in specific aspects of functioning, such as social or life skills.<br/> 4.5 Average endpoint specific aspects of functioning, such as social or life skills.<br/> 4.6 Average change in specific aspects of functioning, such as social or life skills. </p> </section> <section id="CD008712-sec-0053"> <h6 class="title">5. Quality of life</h6> <p>5.1 Clinically important change in quality of life ‐ as defined by individual studies.<br/> 5.2 Any change in quality of life.<br/> 5.3 Average endpoint quality of life score.<br/> 5.4 Average change in quality of life scores.<br/> 5.5 Clinically important change in specific aspects of quality of life ‐ as defined by individual studies.<br/> 5.6 Any change in specific aspects of quality of life.<br/> 5.7 Average endpoint specific aspects of quality of life.<br/> 5.8 Average change in specific aspects of quality of life. </p> </section> <section id="CD008712-sec-0054"> <h6 class="title">6. Satisfaction with treatment</h6> <p>6.1 Leaving the study early: specific reason<br/> 6.2 Recipient of care satisfied with treatment.<br/> 6.3 Recipient of care average satisfaction score.<br/> 6.4 Recipient of care average change in satisfaction scores.<br/> 6.5 Carer satisfied with treatment.<br/> 6.6 Carer average satisfaction score.<br/> 6.7 Carer average change in satisfaction scores. </p> </section> <section id="CD008712-sec-0055"> <h6 class="title">7. Engagement with services</h6> <p>7.1 Clinically important engagement ‐ as defined by individual studies.<br/> 7.2 Any engagement.<br/> 7.3 Average endpoint engagement score.<br/> 7.4 Average change in engagement scores.<br/> 7.5 Compliance with medication/treatment. </p> </section> <section id="CD008712-sec-0056"> <h6 class="title">8. Economic</h6> <p>8.1 Direct costs.<br/> 8.2 Indirect costs. </p> </section> <section id="CD008712-sec-0057"> <h6 class="title">'Summary of findings' tables</h6> <p>We used the GRADE approach to interpret findings (<a href="./references#CD008712-bbs2-0198" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>); and used <a href="http://community.cochrane.org/tools/review-production-tools/gradepro-gdt" target="_blank">GRADEpro GDT</a> to export data from our review to create a 'Summary of findings' table. These tables provide outcome‐specific information concerning the overall certainty of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rate as important to patient care and decision making. We selected the following main outcomes for inclusion in the 'Summary of findings' table. </p> <p> <ol id="CD008712-list-0005"> <li> <p>Global state: relapse</p> </li> <li> <p>Global state: clinically important change ‐ as defined by individual studies</p> </li> <li> <p>Mental state: general ‐ clinically important change ‐ as defined by individual studies</p> </li> <li> <p>Adverse effect: clinically important adverse effect/event ‐ as defined by individual studies </p> </li> <li> <p>Functioning: clinically important change in social functioning</p> </li> <li> <p>Quality of life: clinically important change</p> </li> <li> <p>Satisfaction with treatment ‐ leaving the study early for any reason</p> </li> </ol> </p> <p>If data were not available for these pre‐specified outcomes but were available for ones that are similar, we presented the closest outcome to the pre‐specified one in the table but took this into account when grading the finding. </p> </section> </section> </section> </section> <section id="CD008712-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008712-sec-0059"> <h4 class="title">Electronic searches</h4> <section id="CD008712-sec-0060"> <h5 class="title">1. Electronic searches</h5> <section id="CD008712-sec-0061"> <h6 class="title">1.1 The Cochrane Schizophrenia Group's Register (March 2010 to 6 March 2017)</h6> <p>This was searched by the Information Specialist of the Cochrane Schizophrenia Group, Samantha Roberts, using the phrase: </p> <p>{[(*cogniti* AND (*behavio* or therap*)) OR (*cogniti* and (*technique* or *restructur* or *challeng*)) OR (*self* and (*instruct* or *management* or *attribution*)) OR (*rational* and *emotiv*) in title, abstract, index terms of REFERENCE] or [Cognitive* in interventions of STUDY]} </p> <p>This register is compiled by systematic searches of major databases, handsearches and conference proceedings (see <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/SCHIZ/frame.html" target="_blank">group module</a>). </p> </section> </section> <section id="CD008712-sec-0062"> <h5 class="title">2. Details of previous searches for previous CBT review</h5> <p>For search details used in previous versions, please see <a href="./appendices#CD008712-sec-0357">Appendix 1</a>. </p> </section> </section> <section id="CD008712-sec-0063"> <h4 class="title">Searching other resources</h4> <section id="CD008712-sec-0064"> <h5 class="title">1. Reference lists</h5> <p>We searched all references of included articles for further relevant trials.</p> </section> <section id="CD008712-sec-0065"> <h5 class="title">2. Authors</h5> <p>For this update, we did not contact the first author of each of the included papers to request additional published and unpublished materials. </p> </section> </section> </section> <section id="CD008712-sec-0066"> <h3 class="title" id="CD008712-sec-0066">Data collection and analysis</h3> <p>Below are methods used for 2015 and 2017 searches. Previous methods can be seen in <a href="./appendices#CD008712-sec-0359">Appendix 2</a>. </p> <section id="CD008712-sec-0067"> <h4 class="title">Selection of studies</h4> <p>Review authors (JX, SZ, DH, and CJ) independently inspected all identified citations. When disputes arose as to which category a citation should be allocated, resolution was achieved by either discussion with the other review authors, or obtaining a full report of the citation. Review authors (JX, SZ, DH and CJ) obtained and independently inspected full reports of citations meeting the review inclusion criteria. When disputes arose as to whether an full report should be included or excluded from the review, JX, SZ, DH and CJ resolved by discussion. If it had not been possible to resolve by discussion, we would have asked another review author (CI) to read the full report and to make a final judgement. </p> </section> <section id="CD008712-sec-0068"> <h4 class="title">Data extraction and management</h4> <section id="CD008712-sec-0069"> <h5 class="title">1. Extraction</h5> <p>Review authors JX, SZ, DH and CJ extracted data from all included studies. We resolved disputes by discussion. When it was not possible to extract data or if further information was needed, we attempted to contact the authors in order to obtain missing information or for clarification whenever necessary. Where multi‐centre studies reported outcomes separately for each component centre, we extracted data relevant to each component centre and reported these separately.The reporting of data from component centres was only undertaken when this procedure did not bias the overall sample size for the statistical tests. </p> </section> <section id="CD008712-sec-0070"> <h5 class="title">2. Management</h5> <section id="CD008712-sec-0071"> <h6 class="title">2.1 Forms</h6> <p>We extracted data onto standard, simple forms.</p> </section> <section id="CD008712-sec-0072"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:</p> <p> <ol id="CD008712-list-0006"> <li> <p>the psychometric properties of the measuring instrument have been described in a peer‐reviewed journal (<a href="./references#CD008712-bbs2-0185" title="MarshallM , LockwoodA , AdamsC , BradleyC , JoyC , FentonM . Unpublished rating scales ‐ a major source of bias in randomised controlled trials of treatments for schizophrenia?. British Journal of Psychiatry2000;176:249‐52. ">Marshall 2000</a>); </p> </li> <li> <p>the measuring instrument has not been written or modified by one of the trialists for that particular trial; and </p> </li> <li> <p>the instrument should be a global assessment of an area of functioning and not sub‐scores which are not, in themselves, validated or shown to be reliable. </p> </li> </ol> </p> <p>It should be noted that some sub‐scale scores were included in this review (for instance, we did include sub‐scores from mental state scales measuring positive and negative symptoms of schizophrenia), however, in all cases the sub‐scale scores were well‐validated and are in common use within the empirical literature. </p> <p>Ideally, the measuring instrument would either be i. a self‐report or ii. completed by an independent rater or relative (not the therapist). We realise that this is not often reported clearly; in <a href="#CD008712-sec-0120">Description of studies</a>, where possible, we noted if this was the case or not. </p> </section> <section id="CD008712-sec-0073"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data: change data can remove a component of between‐person variability from the analysis; however, calculation of change needs two assessments (baseline and endpoint) that can be difficult to obtain in unstable and difficult‐to‐measure conditions such as schizophrenia. We preferred to use endpoint data throughout. </p> </section> <section id="CD008712-sec-0074"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non‐parametric data, we applied the following standards to relevant continuous endpoint data before inclusion. </p> <p>For endpoint data from studies including fewer than 200 participants:</p> <p>a) when a scale starts from the finite number zero, we subtracted the lowest possible value from the mean, and divided this by the standard deviation (SD). If this value was lower than one, it strongly suggests that the data are skewed and we excluded these data. If this ratio was higher than one but less than two, there is suggestion that the data are skewed: we entered these data and tested whether their inclusion or exclusion would change the results substantially. If the data changed results, we presented them as 'other' data. Finally, if the ratio was larger than two, we included these data, because it is less likely they are skewed (<a href="./references#CD008712-bbs2-0127" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313:1200. ">Altman 1996</a>; <a href="./references#CD008712-bbs2-0166" title="HigginsJPT , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>b) if a scale starts from a positive value (such as the Positive and Negative Syndrome Scale (PANSS), which can have values from 30 to 210 (<a href="./references#CD008712-bbs2-0175" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. 1986. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>)), we modified the calculation described above to take the scale starting point into account. In these cases skewed data are present if 2 SD &gt; (S − S min), where S is the mean score and 'S min' is the minimum score. </p> <p>Please note: we entered all relevant data from studies of more than 200 participants in the analysis irrespective of the above rules, because skewed data posed less of a problem in large studies. </p> </section> <section id="CD008712-sec-0075"> <h6 class="title">2.5 Common measure</h6> <p>To facilitate comparison between trials, where possible, we converted variables that were reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD008712-sec-0076"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Where possible, we converted continuous outcome measures to dichotomous data. This could be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there had been a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD008712-bbs2-0193" title="OverallJ , GorhamD . The brief psychiattric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>) or the PANSS (<a href="./references#CD008712-bbs2-0176" title="KaySR , FiszbeinA , OplerLA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13(2):261‐76. ">Kay 1987</a>), this can be considered as a clinically significant response (<a href="./references#CD008712-bbs2-0182" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . What does the PANSS mean?. Schizophrenia Research2005;79:231‐8. ">Leucht 2005a</a>; <a href="./references#CD008712-bbs2-0183" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry2005;187:366‐71. ">Leucht 2005b</a>). If data based on these thresholds were not available, we used the primary cut‐off presented by the original authors. </p> </section> <section id="CD008712-sec-0077"> <h6 class="title">2.7 Direction of graphs</h6> <p>We aimed to enter data in such a way that the area to the left of the line of no effect indicates a favourable outcome for CBT. </p> </section> </section> </section> <section id="CD008712-sec-0078"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Review authors (JX, SZ DH and CJ) assessed risk of bias using the tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008712-bbs2-0167" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011a</a>). This tool encourages consideration of how the randomisation sequence was generated, how allocation was concealed, the integrity of blinding at outcome measurement, the completeness of outcome data, selective reporting and other biases. We excluded studies where sequence generation was at a high risk of bias or where allocation was clearly not concealed. If disputes arose as to the correct category for a trial, this was resolved through discussion and, if necessary, adjudication by the other review authors (AM, CI and IC). If this was not possible because further information was necessary, we intended not to enter the data but to allocate the trial to the list of those awaiting assessment. Review authors were not blinded to the names of the authors, institutions, journal of publication, or results of the trials. </p> </section> <section id="CD008712-sec-0079"> <h4 class="title">Measures of treatment effect</h4> <p>We adopted P = 0.05 as the conventional level of a clear difference (statistically significant), but we were especially cautious where results were only slightly below this, and in these situations we reported 95% confidence intervals (CI) in preference to P values. </p> <section id="CD008712-sec-0080"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% CI as it has been shown that RR is more intuitive than odds ratios (<a href="./references#CD008712-bbs2-0140" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie1999;54(4):405‐11. ">Boissel 1999</a>); and that odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD008712-bbs2-0147" title="DeeksJ . Issues in the selection for meta‐analyses of binary data. 8th International Cochrane Colloquium; 2000 Oct 25‐28th; Cape Town, South Africa. 2000. ">Deeks 2000</a>). Although the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH), with their CIs, are intuitively attractive to clinicians, they are problematic to calculate and interpret in meta‐analyses (<a href="./references#CD008712-bbs2-0171" title="HuttonJL . Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology2009;146(1):27‐30. ">Hutton 2009</a>). For binary data presented in the 'Summary of findings' table(s) where possible, we calculated illustrative comparative risks. </p> </section> <section id="CD008712-sec-0081"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes we estimated mean differences (MD) and the 95% CI between groups. We preferred not to calculate effect size measures (standardised mean difference (SMD)). However, if scales that are very similar had been used, we would have presumed there is a small difference in measurement, and we would have calculated effect size and transform the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD008712-sec-0082"> <h4 class="title">Unit of analysis issues</h4> <section id="CD008712-sec-0083"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice), but analysis and pooling of clustered data poses problems. Firstly, authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD008712-bbs2-0151" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7(6):623‐9. ">Divine 1992</a>), whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated. This causes type I errors (<a href="./references#CD008712-bbs2-0139" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315:600. ">Bland 1997</a>; <a href="./references#CD008712-bbs2-0159" title="GullifordMC . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). </p> <p>Where clustering was not accounted for in primary studies, we had planned to present data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, if such data are reported, we will seek to contact first authors of studies to obtain intra‐class correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD008712-bbs2-0159" title="GullifordMC . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). Where clustering has been incorporated into the analysis of primary studies, we will present these data as if from a non‐cluster randomised study, but adjust for the clustering effect. </p> <p>We have sought statistical advice and been advised that the binary data presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC [Design effect = 1+(m‐1)*ICC] (<a href="./references#CD008712-bbs2-0152" title="DonnerA , KlarN . Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine2002;21:2971‐80. ">Donner 2002</a>). If the ICC is not reported, it is assumed to be 0.1 (<a href="./references#CD008712-bbs2-0203" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPGJ . Methods for evaluating area‐wide and organistation‐based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):1‐75. ">Ukoumunne 1999</a>). </p> <p>If cluster studies had been appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies would have been possible using the generic inverse variance technique. </p> </section> <section id="CD008712-sec-0084"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase, the participants can differ systematically from their initial state despite a wash‐out phase. For the same reason cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD008712-bbs2-0154" title="ElbourneD , AltmanDG , HigginsJPT , CurtinaF , WorthingtondHV , VaileA . Meta‐analyses involving cross‐over trials: Methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). As both effects are very likely in severe mental illness, we planned to use only the data from the first phase of the study. </p> </section> <section id="CD008712-sec-0085"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involves more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. If data were binary we simply added these and combine within the two‐by‐two table. If data were continuous, we combined data following the formula in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008712-bbs2-0166" title="HigginsJPT , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). Where additional treatment arms are not relevant, we did not reproduce these data. </p> </section> </section> <section id="CD008712-sec-0086"> <h4 class="title">Dealing with missing data</h4> <section id="CD008712-sec-0087"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss to follow‐up, the findings of a trial must lose credibility (<a href="./references#CD008712-bbs2-0208" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El‐SayehH , et al. Losing participants before the trial ends erodes credibility of findings. Psychiatric Bulletin2009;33:254‐7. ">Xia 2009</a>). We were forced to make a judgment where the level of loss to follow‐up was too great for short‐term trials to be included in this review. If more than 40% of data were unaccounted for at eight weeks, we did not use these data within the analyses. </p> </section> <section id="CD008712-sec-0088"> <h5 class="title">2. Binary</h5> <p>If attrition for a binary outcome was between 0% and 40% and if the outcomes of these participants were described, we included these data as reported. Where these data were not clearly described for the primary outcome, we assumed the worst for each person who was lost to follow‐up, and for adverse effects, we assumed rates similar to those among participants who continued to have their data recorded. </p> </section> <section id="CD008712-sec-0089"> <h5 class="title">3. Continuous</h5> <section id="CD008712-sec-0090"> <h6 class="title">3.1 Attrition</h6> <p>We have reported data where attrition for a continuous outcome was between 0% and 40% and completer‐only data were reported in the study. </p> </section> <section id="CD008712-sec-0091"> <h6 class="title">3.2 Standard deviations</h6> <p>We first tried to obtain the missing values from the authors. If not available, where there were missing measures of variance for continuous data but an exact standard error (SE) and CI were available for group means, and either 'P' value or 't' value were available for differences in mean, we noted these, and in future versions of this review we will calculate them according to the rules described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008712-bbs2-0166" title="HigginsJPT , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>): When only the SE is reported, standard deviations (SDs) can be calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008712-bbs2-0166" title="HigginsJPT , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>) present detailed formulae for estimating SDs from P values, t or F values, CIs, ranges or other statistics. If these formulae do not apply, in the future we will calculate SDs according to a validated imputation method which is based on the SDs of the other included studies (<a href="./references#CD008712-bbs2-0156" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(7):7‐10. ">Furukawa 2006</a>). Some of these imputation strategies can introduce error. The alternative would be to exclude a given study’s outcome and thus to lose information. We will examine the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD008712-sec-0092"> <h6 class="title">3.3 Assumptions about participants who left the trials early or were lost to follow‐up</h6> <p>Various methods are available to account for participants who left the trials early or were lost to follow‐up. Some trials just present the results of study completers; others use the method of last observation carried forward (LOCF); while more recently, methods such as multiple imputation or mixed‐effects models for repeated measurements (MMRM) have become more of a standard. While the latter methods seem to be somewhat better than LOCF (<a href="./references#CD008712-bbs2-0181" title="LeonAC , MallinckrodtCH , Chuang‐SteinC , ArchibaldDG , ArcherGE , ChartierK . Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry2006;59(11):1001‐5. ">Leon 2006</a>), we feel that the high percentage of participants leaving the studies early and differences between groups in their reasons for doing so is often the core problem in randomised schizophrenia trials. Therefore, we did not exclude studies based on the statistical approach used. However, by preference we used the more sophisticated approaches, i.e. we preferred to use MMRM or multiple‐imputation to LOCF, and we only presented completer analyses if some kind of intention‐to‐treat (ITT) data were not available at all. Moreover, we addressed this issue in the item 'Incomplete outcome data' of the 'Risk of bias' tool. </p> </section> </section> </section> <section id="CD008712-sec-0093"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD008712-sec-0094"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying situations or people which we had not predicted would arise. When such situations or participant groups arose, these were fully discussed. </p> </section> <section id="CD008712-sec-0095"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise. When such methodological outliers arose, these were fully discussed. </p> </section> <section id="CD008712-sec-0096"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD008712-sec-0097"> <h6 class="title">3.1 Visual inspection</h6> <p>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD008712-sec-0098"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>Heterogeneity between studies was investigated by considering the I<sup>2</sup> method alongside the Chi<sup>2</sup> 'P' value. The I<sup>2</sup> provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD008712-bbs2-0165" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on i. magnitude and direction of effects and ii. strength of evidence for heterogeneity (e.g. 'P' value from Chi<sup>2</sup>  test, or a CI for I<sup>2</sup>). We interpreted an I<sup>2</sup> estimate greater than or equal to 75% accompanied by a statistically significant Chi<sup>2</sup> statistic as evidence of substantial levels of heterogeneity (<a href="./references#CD008712-bbs2-0148" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Deeks 2011</a>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for heterogeneity (<a href="#CD008712-sec-0103">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD008712-sec-0099"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD008712-bbs2-0153" title="EggerM , Davey‐SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple graphical test. BMJ1997;315:629‐34. ">Egger 1997</a> ). These are described in section 10.1 of the <i>Cochrane Handbook for Systematic reviews of Interventions</i> (<a href="./references#CD008712-bbs2-0199" title="SterneJAC , EggerM , MoherD editor(s) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Intervention.. Available from www.handbook.cochrane.org. ">Sterne 2011</a>). </p> <section id="CD008712-sec-0100"> <h5 class="title">1. Protocol versus full study</h5> <p>We attempted to locate protocols of included randomised trials. If the protocol was available, we compared outcomes in the protocol and in the published report. If the protocol was not available, we compared outcomes listed in the methods section of the trial report with actually reported results. </p> </section> <section id="CD008712-sec-0101"> <h5 class="title">2. Funnel plot</h5> <p>We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small‐study effects. We did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies were of similar size. In other cases, where funnel plots were possible, we sought statistical advice in their interpretation. </p> </section> </section> <section id="CD008712-sec-0102"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. To us, this often seems to be true and the random‐effects model takes into account differences between studies, even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random‐effects model: it puts added weight onto small studies, which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. We chose to use fixed‐effect for all analyses, except where if was high heterogeneity where the source of heterogeneity could not be identified. </p> </section> <section id="CD008712-sec-0103"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD008712-sec-0104"> <h5 class="title">1. Subgroup analyses</h5> <p>We anticipated subgroup analyses to test the hypothesis that CBT may be highlighted to have different effects when compared with the following. </p> <section id="CD008712-sec-0105"> <h6 class="title">1.1 Active versus non active control therapies</h6> <p>Active psychological treatments as opposed to inactive ones.</p> <p>We aimed to undertake the analysis for only the primary outcomes of this review or the nearest we could find to them (see <a href="#CD008712-sec-0044">Types of outcome measures</a>), and if data were available discussed the findings. </p> </section> </section> <section id="CD008712-sec-0106"> <h5 class="title">2. Investigation of methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise and would have discussed any such methodological outliers if they had arisen. </p> </section> <section id="CD008712-sec-0107"> <h5 class="title">3. Investigation of statistical heterogeneity</h5> <section id="CD008712-sec-0108"> <h6 class="title">3.1 Visual inspection</h6> <p>We inspected graphs visually to investigate statistical heterogeneity.</p> </section> <section id="CD008712-sec-0109"> <h6 class="title">3.2 Employing the I² statistic</h6> <p>We investigated statistical heterogeneity between studies by considering the I² statistic alongside the Chi² P value. The I² statistic provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="https://archie.cochrane.org/sections/documents/view?version=z1804091128072629408586176405915%26format=REVMAN#REF-Higgins-2003" target="_blank">Higgins 2003</a>). The importance of the observed value of I² depends on the magnitude and direction of effects as well as the strength of evidence for heterogeneity (e.g. P value from Chi²¬test, or a confidence interval for I²). We interpreted an I² estimate greater than or equal to 50% and accompanied by a statistically significant Chi² statistic as evidence of substantial heterogeneity (Chapter 9. <i>Cochrane Handbook for Systematic Reviews of Interventions</i> )<i>(</i><a href="./references#CD008712-bbs2-0148" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Deeks 2011</a>). When substantial levels of heterogeneity were found, we explored reasons for heterogeneity and discussed the findings. </p> <p>Where unanticipated clinical or methodological heterogeneity were obvious, we simply stated hypotheses regarding these for future reviews or versions of this review. We did not anticipate undertaking additional analyses relating to these. </p> </section> </section> </section> <section id="CD008712-sec-0110"> <h4 class="title">Sensitivity analysis</h4> <p>If there were substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed below, we would not have added data from the lower‐quality studies to the results of the higher‐quality trials, but would have presented these data within a subcategory. If their inclusion did not result in a substantive difference, they remained in the analyses. </p> <section id="CD008712-sec-0111"> <h5 class="title">1. Implication of randomisation</h5> <p>We planned to include trials in a sensitivity analysis if they were described in some way as to imply randomisation. For the primary outcomes, if there was no substantive difference when the implied randomised studies were added to those studies with better description of randomisation, we would have included these studies. </p> </section> <section id="CD008712-sec-0112"> <h5 class="title">2. Blinding</h5> <p>We planned to include trials in a sensitivity analysis if they were described in a way that suggested they were blinded for assessment of outcome as opposed to not blinding at all. </p> </section> <section id="CD008712-sec-0113"> <h5 class="title">3. Well‐defined CBT versus less‐well‐defined CBT</h5> <p>For the primary outcomes, we compared findings for trials meeting our criteria for 'well‐defined' CBT as opposed to those studies that labelled the therapy as CBT, but either did not contain the 'inferential' and 'evaluative' component or which did not provide enough information for this discrimination to be made (see <a href="#CD008712-sec-0040">Types of interventions</a>). </p> </section> <section id="CD008712-sec-0114"> <h5 class="title">4. Therapist experience</h5> <p>For the primary outcomes, we compared findings for trials meeting the criteria for experienced CBT therapists compared with trials using relatively inexperienced CBT therapists or who did not provide enough information for this discrimination to be made (see <a href="#CD008712-sec-0040">Types of interventions</a>). </p> </section> <section id="CD008712-sec-0115"> <h5 class="title">5. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD008712-sec-0086">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumption and where we compared with completer data only. If there was a substantial difference, we reported these results and discussed them, but continued to employ our assumption. </p> <p>If assumptions had to be made regarding missing SDs (see <a href="#CD008712-sec-0086">Dealing with missing data</a>), we compared the findings on primary outcomes when we use our assumption compared with completer data only. We would have undertaken a sensitivity analysis to test how prone results were to change when 'completer' data only were compared to the imputed data using the above assumption. If there was a substantial difference, we would have reported results and discussed them, but would have continued to employ our assumption. </p> </section> <section id="CD008712-sec-0116"> <h5 class="title">6. Risk of bias</h5> <p>For the primary outcomes, we analysed the effects of excluding trials that had at high risk of bias across one or more of the domains (see <a href="#CD008712-sec-0078">Assessment of risk of bias in included studies</a>). </p> </section> <section id="CD008712-sec-0117"> <h5 class="title">7. Imputed values</h5> <p>We would have undertaken a sensitivity analysis to assess the effects of including data from trials where we had used imputed values for ICC in calculating the design effect in cluster‐randomised trials. </p> </section> <section id="CD008712-sec-0118"> <h5 class="title">8. Fixed‐ and random‐effects</h5> <p>For the primary outcomes, we synthesised data using a random‐effects model to evaluate whether this altered the significance of the results. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008712-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008712-sec-0119"></div> <section id="CD008712-sec-0120"> <h3 class="title">Description of studies</h3> <p>Thirty‐six studies with 3542 participants are included. Three of these studies (<a href="./references#CD008712-bbs2-0028" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002 (L)</a>; <a href="./references#CD008712-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002 (M)</a>; <a href="./references#CD008712-bbs2-0030" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002 (N)</a>) were actually specific sites of a multicentre trial, <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>. As some outcome data were only reported with respect to the specific sites, rather than lose these data we have included their outcomes as individual studies. </p> <p>A summary of the included studies is provided in <a href="./references#CD008712-sec-0447" title="">Characteristics of included studies</a>, and a summary of the excluded studies is provided in <a href="./references#CD008712-sec-0448" title="">Characteristics of excluded studies</a>. Those studies awaiting classification or are ongoing are described in <a href="./references#CD008712-sec-0449" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD008712-sec-0450" title="">Characteristics of ongoing studies</a>, respectively. </p> <section id="CD008712-sec-0121"> <h4 class="title">Results of the search</h4> <p>For this update, we ran searches in 2014 (1168 results), 2015 (577 results), and 2017 (93 studies), see <a href="#CD008712-fig-0001">Figure 1</a> and <a href="#CD008712-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD008712-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study selection from 2014 and 2015 searching" data-id="CD008712-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study selection from 2014 and 2015 searching</p> </div> </div> </div> <div class="figure" id="CD008712-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study selection from 2017 searching" data-id="CD008712-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study selection from 2017 searching</p> </div> </div> </div> <p>For the previous version of this review (<a href="./references#CD008712-bbs2-0212" title="JonesC , HackerD , CormacI , MeadenA , IrvingCB . Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD008712.pub2] ">Jones 2012</a>), electronic searches identified 2279 references. Seventy‐four of these reports (62 studies) did not meet the inclusion criteria (see <a href="https://archie.cochrane.org/sections/documents/view?version=z1509251237358069645416084549954%26format=REVMAN#CHARACTERISTICS_OF_EXCLUDED_STUDIES" target="_blank">Characteristics of excluded studies</a>) and 31 full‐text reports (referring to 20 studies) were placed in included studies. For this update, searches were carried out in 2014, 2015 and 2017. We have added 13 new studies to the included studies table. One multicentre trial had three sites, resulting in 36 studies contributing data for analyses. </p> <section id="CD008712-sec-0122"> <h5 class="title">2014 and 2015 searches</h5> <p>One thousand seven hundred and forty‐five additional records were identified; 1701 of these records were excluded at the first screening stage and 44 full‐text articles were obtained for further assessment. Twenty‐four of these full‐text articles (referring to eight studies) were relevant to the review and placed in the included studies table. (<a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>; <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a>; <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>; <a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a>). Three full‐text articles (referring to three studies) were excluded. Fifteen full‐text articles (referring to 10 studies) were awaiting assessment. Two studies were ongoing. See <a href="#CD008712-fig-0001">Figure 1</a>. </p> </section> <section id="CD008712-sec-0123"> <h5 class="title">2017 search</h5> <p>In this search, 93 additional records were identified. Seventy two of these records were excluded at first screening stage and 21 full‐text articles were obtained for further screening. Ten of these full‐text articles (referring to five studies) were relevant to the review and placed in the included studies table (<a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>; <a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a>; <a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0036" title="ZhangY . Effect of cognitive behavior on coping style in patients with schizophrenia. World Latest Medicine Information [世界最新医学信息文摘]2015;13(72):63. [CSzG: Ref34641] ">NA ‐ Zhang 2015</a>). Four full‐text articles (referring to four studies) were excluded. Five full‐text articles (referring to four studies) are awaiting assessment. Two further studies were placed in the ongoing studies table.<i>See</i><a href="#CD008712-fig-0002">Figure 2</a>. </p> <p>Overall, review authors for this review have screened 4117 records so far and 3950 records have been excluded at the first screening stage. One hundred and sixty‐seven full‐text articles have been obtained for further screening, of which, 69 studies from 81 full‐text reports did not meet the inclusion criteria. Sixteen studies from 21 full‐text articles are awaiting assessment; six of these studies were not printed in English (<a href="./references#CD008712-bbs2-0106" title="ChungYC , KimJH , EunHB , HwangIK . Effect of cognitive‐behavioral therapy on the delusion in schizophrenic patients. Journal of the Korean Neuropsychiatric Association2001;40(1):63‐71. ">Chung 2001</a>; <a href="./references#CD008712-bbs2-0109" title="DelahayeN , PietersG . Cognitive behavior therapy and family therapy for relapse prevention and symptom reduction in psychosis: randomized controlled efficacy study. Tijdschrift voor Psychiatrie Netherlands2009;51(10):779‐80. ">Delahaye 2009</a>; <a href="./references#CD008712-bbs2-0112" title="KlingbergS , WiedemannG , BuchkremerG . Cognitive‐behavioural therapy for schizophrenic patients ‐ design and preliminary results of a randomised effectiveness trial. Zeitschrift Für Klinische Psychologie Und Psychotherapie2001;30(4):259‐67. ">Klingberg 2001</a>; <a href="./references#CD008712-bbs2-0114" title="LeeHS , HyunMH , ChoHS , LeeYH , KimTY , ChangSA , et al. Effects of cognitive differentiation training of intergrated psychological therapy to the basic cognitive functions in schizophrenic patients. Journal of the Korean Neuropsychiatric Association1998;37:801‐10. LeeMH , LeeHS , ChoHS , AnSK , HyunMH , KimTY , et al. Development of a cognitive rehabilitation program for patients with schizophrenia. Journal of the Korean Neuropsychiatric Association1999;38:375‐88. ">Lee 1999</a>; <a href="./references#CD008712-bbs2-0116" title="MirabellaF , RosicarelliML , BroccoliG , LeonciniL , MarchesiniN , MorosiniP . Effectiveness assessment of a structured cognitive‐behavioural group therapy on psychiatric inpatients in day centres. Psicoterapia Cognitiva e Comportamentale2009;15:329‐52. ">Mirabella 2009</a>; <a href="./references#CD008712-bbs2-0121" title="WuN , WangQ , KongL . A controlled study of cognitive behaviour therapy in chronic schizophrenia. Journal of Clinical Psychosomatic Diseases2008;14(3):206. ">Wu 2008</a>) and the remaining 10 studies are awaiting publication of outcome data (<a href="./references#CD008712-bbs2-0107" title="ClarkeS . A randomised control trial comparing the effectiveness of acceptance and commitment therapy with treatment as usual, cognitive behavioural therapy, with treatment resistant participants. public.ukcrn.org.uk (accessed prior to 02 June 2016). ">Clarke 2011</a>; <a href="./references#CD008712-bbs2-0108" title="D'SouzaR , RichD , DiamondI , GodferyK . A open randomized control study using a spiritually augmented cognitive behaviour therapy for demoralization and treatment adherence in patients with schizophrenia. Australian and New Zealand Journal of Psychiatry2002;36(6):A9‐A. ">D'Souza 2002</a>; <a href="./references#CD008712-bbs2-0110" title="ISRCTN60855021 . Social anxiety research clinic: an exploratory randomised controlled trial of standard versus enhanced cognitive behavioural therapy for social anxiety in early psychosis. www.isrctn.com/ISRCTN60855021 (retrospectively received 21 October 2010). ">ISRCTN60855021 2009</a>; <a href="./references#CD008712-bbs2-0113" title="KlingbergS , WittorfA , MeisnerC , WolwerW , WiedemannG , BechdolfA , et al. Specific efficacy of cognitive behavioral therapy for the treatment of persistent positive symptoms in schizophrenia patients. Schizophrenia Bulletin2013;39:S338‐9. KlingbergS , WittorfA , MeisnerC , WolwerW , WiedemannG , HerrlichJ , et al. Cognitive behavioral therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: major results of the positive study. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13. KlingbergS , WittorfA , MeisnerC , WolwerW , WiedemannG , HerrlichJ , et al. Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the positive study, a multicenter, prospective, single‐blind, randomised controlled clinical trial. Trials2010;11:123. KonnopkaA , StuhldreherN , KlingbergS , WittorfA , BechdolfA , MullerB , et al. Costs of psychotic disorders and cost‐effectiveness of cognitive behavioural therapy compared to supportive treatment. Journal of Mental Health Policy and Economics2013;16:S19. WagnerM . Cognitive biases and cognitive deficits in patients with positive symptoms: relationship with symptoms and with symptom change during psychotherapy. European Archives of Psychiatry and Clinical Neuroscience2011;261:S14. WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. ">Klingberg 2013</a>; <a href="./references#CD008712-bbs2-0115" title="LystadJU , BullHC , UelandT , FalkumE . A randomized clinical trial of cognitive remediation versus cognitive behavioral therapy techniques in vocational rehabilitation for adults with schizophrenia spectrum disorders ‐ sample characteristics of the first 40 participants in each intervention. Schizophrenia Bulletin2013;39:S297. ">Lystad 2013</a>; <a href="./references#CD008712-bbs2-0117" title="NCT00980252 . Medication adherence in schizophrenia: development of a CBT‐based intervention. www.clinicaltrials.gov/show/NCT00980252 (first received 18 September 2009). ">NCT00980252 2009</a>; <a href="./references#CD008712-bbs2-0118" title="NCT01139502 . Cognitive behaviour therapy and cognitive training in work rehabilitation for persons with severe mental illness. ClinicalTrials.gov/show/NCT01139502 Vol. (first received 2 June 2 2010). ">NCT01139502 2010</a>; <a href="./references#CD008712-bbs2-0119" title="PenadesR , CatalanR , SalameroM , GastoC . Randomised controlled trial of cognitive remediation therapy for outpatients with chronic schizophrenia. 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4‐10; Davos, Switzerland. Davos, SWITZERLAND: Elsevier Science Bv, 2006:102‐3. ">Penades 2006</a>; <a href="./references#CD008712-bbs2-0120" title="ValmaggiaLR , Van derGaagM . A randomised controlled trial of cognitive behaviour therapy for treatment refractory schizophrenia. 9th International Congress on Schizophrenia Research; 2003 Mar 29‐Apr 2; Colorado Spings, Colorado, USA. Colorado Spings, Colorado: Elsevier Science Bv, 2003:305. ">Valmaggia 2003</a>; <a href="./references#CD008712-bbs2-0111" title="JonesP . Cts: cognitive training for schizophrenia. public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=11571. (accessed prior to 01 June 2017). ">Jones 2012</a>). Four studies are ongoing trials (<a href="./references#CD008712-bbs2-0123" title="NCT02170051 . Improving negative symptoms of psychosis in real‐world environments. http://Clinicaltrials.gov/show/NCT02170051 (first received 18 June 2014). ">NCT02170051 2014</a>; <a href="./references#CD008712-bbs2-0124" title="NCT02349880 . A shared decision‐making training for inpatients with schizophrenia. https://Clinicaltrials.gov/ct2/show/NCT02349880 (first received 23 January 2015). ">NCT02349880 2015</a>; <a href="./references#CD008712-bbs2-0122" title="NCT01992913 . Integrated cognitive behavior therapy to improve work outcomes in schizophrenia. Clinicaltrials.gov/show/NCT01992913 (first received 01 November 2013). ">NCT01992913 2014</a>; <a href="./references#CD008712-bbs2-0125" title="XuZ , LiZ . A randomized controlled trial of cognitive‐behavioral therapy for schizophrenia. www.chictr.org/ (accessed prior to 02 June 2017). ">Xu 2008</a>). Thirty‐six studies are now included in this review <a href="./references#CD008712-sec-0447" title="">Characteristics of included studies</a>. See <a href="#CD008712-fig-0003">Figure 3</a> </p> <div class="figure" id="CD008712-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Merged study flow diagrams for all searching up to March 2017" data-id="CD008712-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Merged study flow diagrams for all searching up to March 2017</p> </div> </div> </div> </section> </section> <section id="CD008712-sec-0124"> <h4 class="title">Included studies</h4> <section id="CD008712-sec-0125"> <h5 class="title">1. Duration of trial</h5> <p>The trial duration ranged from six weeks (<a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>) to 24 months (<a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>). In 16 studies, the duration of the trial was within six months (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a>; <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>; <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a>; <a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>; <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>); For another nine studies, the treatment duration was between six to 12 months (<a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>;<a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0036" title="ZhangY . Effect of cognitive behavior on coping style in patients with schizophrenia. World Latest Medicine Information [世界最新医学信息文摘]2015;13(72):63. [CSzG: Ref34641] ">NA ‐ Zhang 2015</a> ), and the remaining eight studies observed the effect of a long‐term CBT which is more than 12 months (<a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>; <a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>). </p> </section> <section id="CD008712-sec-0126"> <h5 class="title">2. Participants</h5> <p>People in these studies were aged between 18 and 65. Participants were selected from in‐patient and out‐patient populations, at varying phases of illness (from acute phase to relatively stable but with treatment resistant symptoms), and with a range of typical co‐morbidities. However, many trials excluded people with co‐morbid substance misuse, evidence of organic brain disorder, learning disability or marked thought disorder and/or conceptual disorganisation. </p> <p>All 36 trials focused on people with psychosis, whether schizophrenia, delusional disorder or schizoaffective disorder, and all employed operational criteria for diagnoses (DSM III‐R, DSM IV, DSM‐IV TR or ICD‐10). Many people were reported to have co‐morbid mental disorders, such as depression or anxiety disorder. </p> <p><a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> report outcomes for participants with a first episode psychosis. The 28 trials included participants with a representative range of duration of illness. For example, <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> reports outcomes from participants with approximate two years length of illness, whereas <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>, <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>, <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> and <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> included participants with an average of five to 10 years length of illness. <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> and <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a> included participants with an average duration of illness in excess of 10 years. <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>, <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> included participants with an approximate average of 22.9 years length of illness. Ten studies (<a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a>; <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>) did not report the length of illness of participants. </p> <p>Participants were recruited from inpatient or outpatients settings from the UK (<a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>), Germany (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>), the USA (<a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>), China (<a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>), India (<a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a>), Australia(<a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>), Israel (<a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>), Belgium (<a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>), and Canada (<a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>). It should be noted that several studies were conducted over 10 years ago. </p> <p>All participants received standard care in addition to CBT or other adjunctive therapies. Standard care would typically include antipsychotic medication. For example, <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a> only included participants treated with olanzapine for at least six months, whereas <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> intentionally selected people with medication‐resistant symptoms. </p> </section> <section id="CD008712-sec-0127"> <h5 class="title">3. Interventions</h5> <section id="CD008712-sec-0128"> <h6 class="title">3.1 CBT</h6> <section id="CD008712-sec-0129"> <p><b>3.1.1 CBT with other therapeutic activities</b></p> <p>In addition to cognitive restructuring, hypothesis testing and behavioural experiments, most CBT interventions commonly included other therapeutic activities such as psychoeducation, relapse prevention, coping strategy enhancement, problem‐solving strategies or relaxation training. Some CBT interventions were administered on a group basis (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>; <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>; <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>), whereas others utilised individual therapy (<a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>). <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>, and <a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a> employed a combination of both group and individual therapy. </p> <p>The CBT interventions varied with regard to both the target of the therapy and the degree of specificity of the focus of the intervention. For example, <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> and <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> used a CBT intervention focused specifically on medication compliance, whereas the CBT intervention described by <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> had a wider focus incorporating auditory hallucinations and delusions, anxiety, depression, relapse prevention and enhancing medication compliance. Most trials targeted positive symptoms of psychosis, some with an explicit focus on auditory hallucinations (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>), and/or delusions (<a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>). It was less common for the CBT intervention to target negative symptoms of psychosis (<a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>). Strategies for relapse prevention were a common component in the CBT intervention and a specific focus in some trials (e.g. <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>). Emotional distress (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>) and self‐esteem (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>), either in general or specifically related to the experience of psychosis, was a target in some trials that also targeted other symptoms. Finally, one trial, <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>, focused specifically on psychotic symptoms and anger relating to aggression and violence. </p> </section> <section id="CD008712-sec-0130"> <p><b>3.1.2 CBT arm does not include other active therapies</b></p> <p>In 23 trials, the CBT arm was not 'contaminated' by other contemporaneous active psychological therapies, which would not normally be a standard component of CBT for psychosis. However, <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> reported a CBT intervention which variously included medication‐management training or key‐person counselling, or both. The differential effects of the CBT and the medication management training or key‐person counselling were not evaluated. <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a> reported a CBT intervention that consisted of both individual and group cognitive therapy as well as family engagement (aimed at developing familial coping strategies). In addition, it included a structured activity programme (cooking, creative therapy and discussion groups) for an average of five hours per week. Thus, in <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>, the intervention incorporates CBT within a broader rehabilitation framework. The differential effects of the CBT and the rehabilitation were not evaluated. <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> and <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a> used CBT that consisted of thought‐challenging, social skills training, and problem‐solving training. Finally, <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> included social skills training in the CBT arm of the trial and also included psychoeducation in the control arm of the trial. Accordingly, the differential effects of these interventions cannot be evaluated. </p> </section> <section id="CD008712-sec-0131"> <p><b>3.1.3 Well‐defined CBT</b></p> <p>All studies employed a cognitive behavioural intervention in addition to standard care. In order to be classified as 'well‐defined' the intervention had to clearly demonstrate the components outlined above (<a href="#CD008712-sec-0040">Types of interventions</a>). Only 12 trials met our criteria for 'well‐defined CBT' (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>; <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>) in that they clearly reported a therapeutic focus on belief change or re‐evaluating the subjective meaning of symptoms. </p> <p><a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> and <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> describe their intervention as CBT and for this reason are included in this review. However, the therapeutic focus appears to be on problem‐solving skills and the development of coping strategies rather than on the re‐evaluation of the subjective symptoms. <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a> was unique in having a specific focus on negative symptoms, however, reflecting this focus, the intervention incorporated goal setting, initiation, planning and increasing activity levels. Accordingly, the re‐evaluation of the subjective symptoms was not clearly a focus in this intervention. <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> focused on CBT for auditory hallucinations based on <a href="./references#CD008712-bbs2-0207" title="WykesT . Psychological treatment for voices in psychosis. Cognitive Neuropsychiatry2004;9:25‐41. ">Wykes 2004</a> treatment protocol. The authors, however, acknowledge that their intervention in the CBT arm emphasised the development of coping skills and de‐emphasised cognitive restructuring. </p> </section> <section id="CD008712-sec-0132"> <p><b>3.1.4 CBT provided by qualified therapists</b></p> <p>We defined qualified CBT therapists as:</p> <p> <ol id="CD008712-list-0007"> <li> <p>persons possessing appropriate professional qualifications for the provision of CBT (for example, BABCP accreditation, Diploma in CBT, or other professionally‐accredited qualifications involving CBT as major part of training (for example, Clinical or Counselling Psychologist)); or </p> </li> <li> <p>in situations were the qualifications of the therapist are unclear but they appear to have received training in CBT or specific training for the trial, and there is a thorough adherence to the protocol. </p> </li> </ol> </p> <p>According to these criteria, 20 trials (71%) met the criteria for qualified CBT therapists, with the remaining studies not providing sufficient information to assess this. There was wide variation in the way in which trials fulfilled this criterion with some having a clearly specified <i>a priori</i> protocol to which adherence was assessed in a structured fashion, whilst others appear to have only a broad CBT‐based agenda and to assess compliance by audio‐taping samples of sessions (<a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>), or by ensuring regular supervision. </p> </section> </section> <section id="CD008712-sec-0133"> <h6 class="title">3.2 Other psychosocial therapies</h6> <p>In all trials, the other psychosocial therapy arm of the trial was in addition to standard care. The comparison arm of the trials employed a variety of interventions. We characterised interventions aimed at meaningful symptom or distress reduction as active comparison therapy, whereas psychosocial interventions which act as merely a control for the non‐specific effects of therapy (for example, time spent with therapist) were characterised as non active comparison therapy. Some interventions such as supportive psychotherapy or counselling varied in the degree to which they were used as an active and structured therapy. In such cases, allocation to the active or non active conditions was dependent upon whether the authors had made reference to the intervention as a control for the non‐specific effects of therapy. <a href="#CD008712-tbl-0003">Table 2</a> describes the interventions in each trial in more detail than is possible in <a href="./references#CD008712-sec-0447" title="">Characteristics of included studies</a>. </p> <div class="table" id="CD008712-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">More detailed description of interventions in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Cognitive Behavioural Therapy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Control therapy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>No other active therapies</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Experienced therapists</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Well‐defined CBT</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><sub>Comments</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Active</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Nonactive</b> </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT administered by trained psychiatrist or psychologist.</sup> </p> <p><sup>CBT strategies included: formulation, guided recovery, symptom monitoring, exposure/focusing strategies for managing voices, hypothesis/reality testing, re‐framing attributions, rational responding, coping strategy enhancement, distraction techniques, role play, anxiety management, depression and self‐esteem work, medication compliance/motivational interviewing, schema work, relapse prevention and keeping well strategies.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Psychoeducation</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT included Key Working and Psychoeducation.</sup> </p> <p><sup>CBT not provided as a discrete psychological intervention and it is not explicit whether the recipients of the therapy established links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour·</sup> </p> <p><sup>Insufficient information provided regarding the experience of the therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Psychoeducation regarding medication and structured free time activity</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>No indication other active therapies In the CBT arm of the trial.</sup> </p> <p><sup>Treatment was delivered by nine therapists with an average of 7.8 years (SD = 4.77) of experience conducting CBT.</sup> </p> <p><sup>Well‐defined CBT: cognitive restructuring, goal setting and coping skills enhancement.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Psychoeducation</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT included family engagement sessions + structured activity + self‐care skills.</sup> </p> <p><sup>Insufficient information provided regarding the experience of the therapists.</sup> </p> <p><sup>CBT involved challenging and testing key beliefs.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Recreation support, leisure and social activities</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The CBT was delivered by five clinical nurse specialists with extensive professional experience of severe mental disorder. All had completed a recognised post‐registration training on standard CBT. All were registered as therapists with the British Association of Behavioural and Cognitive Psychotherapy (BABCP).</sup> </p> <p><sup>CBT included: initial emphasis on engagement, education and building a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; development of a normalising rationale for the patient’s psychotic experiences; exploration and enhancement of current coping strategies; acquisition of additional coping strategies for hallucinations and delusions; and focus on accompanying affective symptomatology using relaxation training, personal effectiveness training and problem‐solving as appropriate.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive Psychotherapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: The weekly 1‐hour CBT group therapy intervention includes presentation of didactic material, exercises designed to apply didactic material to participants' experiences at work and work feedback. The weekly 30‐45 minute individual CBT sessions offer personalised application of group material.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>supportive group</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Clinical psychologists employed full time on the trial, provided CBT for 96 individuals (72% of the total).</sup> </p> <p><sup>A further 37 participants were seen by a mix of doctoral clinical psychologists and nurses who had received specialist training in CBT.</sup> </p> <p><sup>A CBT adherence protocol was used.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Family Intervention</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Group based intervention included thought Challenging, Social Skills Training, and Problem‐Solving Training. Cognitive therapy was combined with role‐play practice of communication skills and problem‐solving training.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Goal‐Focused Supportive Contact</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Group based intervention included thought Challenging, Social Skills Training, and Problem‐Solving Training. Cognitive therapy was combined with role‐play practice of communication skills and problem‐solving training.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Goal‐Focused Supportive Contact</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT was provided by clinical psychologists with expertise in CBT for psychosis.</sup> </p> <p><sup>CBT involved formulation, guided discovery, symptom monitoring, exposure/focusing, hypothesis/ reality testing reframing attributions and coping strategy enhancement.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive counselling and Psychoeducation</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Therapists processed BABCP minimum standards for practice of CBT and were experienced at applying CBT to psychosis. </sup> </p> <p><sup>A CBT adherence protocol was used.</sup> </p> <p><sup>A therapy manual for each treatment was developed and audio tapes of sessions were assessed by supervisors using the Cognitive Therapy Scale for Psychosis.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Social activities therapy</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Authors reports that CBT was adapted from Kingdon and Turkington (1994), however, insufficient detail is given with regard to specific procedures.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Befriending</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT involves remediation of the participants' false cognition; remediation of the harmful behaviour; relaxation training; promote the participants getting involved in recreational activities.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Health education</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>No indication of other active therapy in the CBT arm of the trial.</sup> </p> <p><sup>The therapists were trained in cognitive‐behavioural psychotherapy. Regular supervision was undertaken to ensure consistency with regard to the delivery of the intervention.</sup> </p> <p><sup>Compliance therapy did not make explicit to links between beliefs and affective states, rather beliefs about medication and illness were identified and explored.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Non‐specific counselling</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT involved case formulation, goal setting, homework assignments, role play. Focus on initiative and planning, social activity, emotional participation and expression and speech activity.</sup> </p> <p><sup>CBT strategies designed specifically to reduce negative symptoms.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Cognitive Remediation therapy </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: The manual is built in 4 parts: (1) stress: how it affects me; (2) testing hypotheses and looking for alternatives, (3) drugs, alcohol, and how I feel; and (4) coping and competence.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Group social skill training</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Therapists were previously trained in inducing "cognitive dissonance in person with paranoia".</sup> </p> <p><sup>CBT involved identifying relationships between beliefs and behaviours and generating alternative explanations.</sup> </p> <p><sup>Insufficient information provided about the experience of the therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>All therapists were eligible for accreditation as cognitive behaviour therapists by the BABCP.</sup> </p> <p><sup>CBT involved identifying relationships between beliefs and behaviours and generating alternative explanations.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The trial protocol for using CBT to treat schizophrenia was compiled in Chinese and based on the principles and practice developed by Kingdon &amp; Turkington (2004).</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive Therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The CBT therapy referred to Kingdon D et. al's (Kingdon 2005) CBT handbook. The CBT mainly involves therapies for hallucination, delusion, negative symptoms or emotional symptoms, medication compliance and prevention of relapse.Trainee CBT therapists conducted the CBT.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>supportive therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>No indication of other active therapy in the CBT arm of the trial.</sup> </p> <p><sup>insufficient details provided regarding the qualifications of the therapist.</sup> </p> <p><sup>Compliance therapy did not make explicit to links between beliefs and affective states, rather beliefs about medication and illness were identified and explored.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Non‐specific counselling </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The therapists included a clinical psychologist, a psychiatrist, a social work graduate student, and doctoral students in clinical psychology with the equivalent of at least a Master's degree in psychology.</sup> </p> <p><sup>Adherence measured by rating of audio taped sessions.</sup> </p> <p><sup>CBT emphasised coping skills enhancement rather than cognitive restructuring.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Enhanced supportive therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT arm included individual CBT + social skills training + standard care.</sup> </p> <p><sup>Insufficient details provided regarding the qualifications of the therapists.</sup> </p> <p><sup>CBT emphasised the "disputation of irrational belief relating to delusions and hallucinations as well as reality testing".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT conducted by experienced psychiatric nurses, who underwent recognised training in CBT, and were registered as therapists by the United Kingdom Council for Psychotherapies.</sup> </p> <p><sup>The therapy including "developing a normalizing rationale, treating coexisting anxiety or depression, and generating a shared case formulation. Thereafter, specific techniques were used with positive psychotic symptoms. Thereafter, Socratic questioning was used, and for grandiose or systematised delusions, linked underlying beliefs were identified using inference chaining (the downward arrow technique)".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Befriending </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The therapists were all clinical psychologists.</sup> </p> <p><sup>CBT is described as including coping strategies, problem‐solving and relapse prevention. The description of CBT does not include establishing explicit links between beliefs and affective states.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive counselling</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The CBT arm does not have any other active therapies.</sup> </p> <p><sup>insufficient details provided regarding the qualifications of the therapists.</sup> </p> <p><sup>CBT is described as "disputation of irrational belief relating to delusions and hallucinations as well as reality testing".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Befriending</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT was provided by psychologists specialising in CBT and who were experienced in working with patients with schizophrenia.</sup> </p> <p><sup>Treatment fidelity was assessed.</sup> </p> <p><sup>CBT "begins with an engagement phase emphasising collaboration and focuses upon delusional distress. In the second phase a shared case formulation is identified, specific techniques are used for symptom and distress reduction. With auditory hallucinations the aim is to change the beliefs about the origin, power and dangerousness of voices. In delusions, the focus is on challenging the dysfunctional beliefs and learning to make more balanced conclusions. In the last phase of therapy, treatment focuses on relapse prevention strategies".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive counselling</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBTp is a talk therapy designed to treat persistent symptoms of psychosis and the accompanying distress. A 9‐month treatment manual was developed based upon Kingdon and Turkington and included simple handouts and homework assignments based on the work of Granhom et al. The focus of the sessions was on patient identified problems, particularly those that interfered with daily functioning or were distressing, normalizing symptoms, and using CBT techniques to develop alternative explanatory models of event.</sup> </p> <p><sup>The CBT was delivered by experienced therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Cognitive adaptation training</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>In collaboration with the patient an individual treatment plan including behaviour analyses is established and treatment goals are retrieved. This process of a ease formulation should be completed until session 9. Afterward, specific cognitive disputing strategies such as work on delusions (e.g. debating persecutory delusions; testing beliefs), hallucinations (e.g. use of a voice diary; work on reattribution with the patient's explanation of voice hearing, and test it out), and cognitive schemata (e.g. linking defectiveness schema to the content of the voices; confronting the patient with evidence that discredits the schema) are the central part of the CBT.</sup> </p> <p><sup>The CBT was conducted by 7 specifically trained female clinical psychologists. A mixture of trainees and experienced therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The author did not state who delivered CBT</sup> </p> <p><sup>the content of CBT includes: patients information and baseline condition was comprehensively collected and evaluated to pave the way for establishment of treatment plan. Towards hallucination, reasonable explanation was developed with patients to ease their anxiety; diary was kept for voices they heard; individual coping strategy was established. Similar process was followed to deal with delusion. Therapists generally adopted the process of identifying problem, establish a rational explanation, reinforce correct perception</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard psychological support + pharmacological therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: through analysis of underlying causes and developing problem‐solving models to correct patients negative/problematic behaviour, as well as improving patients understanding of the condition. Re‐build behavioural model that is beneficial to patient cognitive ability, reduces social conflict, improve medication compliance and reduce symptoms.</sup> </p> <p><sup>Delivered by: psychiatrists taking part in the present study's institution.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Family intervention or occupational therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: three stages and each with distinctive therapeutic goals. Therapy programme was developed with clear focus of each stage and homework was allocated. Initially therapeutic relationship was established by investigating patients feeling towards illness stigma and their perception of the illness. During second stage, CBT techniques were employed to correct the misconception and to incept positive thought model and coping strategy. In final stage, previous learning was reinforced and consolidated.</sup> </p> <p><sup>Delivered by: not stated.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy + pharmacological therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p>√ = criteria fulfilled; ✗ = criteria not fulfilled; ? = unclear.<br/> BABCP: British Association of Behavioural and Cognitive Psychotherapy; CBT: Cognitive behavioural therapy </p> </div> </div> <p>Fifteen trials compared CBT with non active control therapies (<a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0028" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002 (L)</a>; <a href="./references#CD008712-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002 (M)</a>; <a href="./references#CD008712-bbs2-0030" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002 (N)</a>; <a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>; <a href="./references#CD008712-bbs2-0036" title="ZhangY . Effect of cognitive behavior on coping style in patients with schizophrenia. World Latest Medicine Information [世界最新医学信息文摘]2015;13(72):63. [CSzG: Ref34641] ">NA ‐ Zhang 2015</a>). Twenty‐one trials described active comparison therapies (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>; <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>; <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>; <a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>), the most common being psychoeducation and supportive therapy or counselling. Notably, two trials used particularly well‐defined non CBT interventions. <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> reported outcomes compared with family therapy and <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a> reported outcomes compared with cognitive remediation therapy. </p> </section> </section> <section id="CD008712-sec-0134"> <h5 class="title">4. Outcomes</h5> <section id="CD008712-sec-0135"> <h6 class="title">4.1 Global state outcomes</h6> <p>Relapse data were reported in seven trials (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>). However, different studies used varied criteria for relapse. For example, <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> defined relapse as "the re‐emergence of, or significant deterioration in, positive psychotic symptoms of at least moderate degree persisting for at least 2 weeks", whereas <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> defined relapse as "a rating of at least 5 and a 2‐point increase compared with the previous assessment in at least one of the items of the Positive Syndrome Subscale of the PANSS". </p> <p>Eight trials reported data relating to rehospitalisation (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>). </p> <p>A few trials also used scales to report global state outcomes. Brief descriptions of these scales are below. </p> <p><i>The Global Assessment Scale (GAS)</i> (<a href="./references#CD008712-bbs2-0155" title="EndicottJ , SpitzerR , FleissJ , CohenCJ . The global assessment scale. A procedure to measuring overall severity of psychiatric disturbance. Archives of General Psychiatry1976;33:766‐71. ">Endicott 1976</a>) </p> <p>This scale rates people from zero to 100 on a continuum from psychological or psychiatric sickness to health (high = good). <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> used this scale and reported useable data. </p> <p><i>The Global Assessment of Functioning</i> (GAF) (<a href="./references#CD008712-bbs2-0158" title="GreenbergG A , RosenheckR A . Using the GAF as a national mental health outcome measure in the Department of Veterans Affairs. Psychiatric Services2005;56(4):420‐6. ">Greenberg 2005</a>) </p> <p>GAF is a 90‐point rating scale that assesses psychological, social and occupational functioning. A high score indicates a better outcome. Three trials used this scale (<a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>) and reported useable data. </p> </section> <section id="CD008712-sec-0136"> <h6 class="title">4.2 Mental state outcomes</h6> <p>Seven trials reported important or reliable change in mental health (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>). The definitions of important or reliable change varied between the trials. For example, <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> defined clinically important change as greater than two standard deviations on the Positive and Negative Syndrome Scale (PANSS) global score and a statistically significant Reliable Change Index (RCI), <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a> defined important or reliable change as a clinically significant reduction of positive symptoms, which is a 20% reduction in PANSS positive factor score, and <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> defined important or reliable change as partial or full remission of symptoms without further episode. <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> defined reliable change as greater than 50% improvement and reported outcomes at 18 months from the Comprehensive Psychiatric Rating Scale <i>(</i> CPRS) (CBT 29/46, Befriending 17/44), Montgomery Asberg Depression Rating Scale <i>(</i>MADRS) (CBT 31/46, Befriending 22/44) and the Scale for the Assessment of Negative Symptoms (SANS) (CBT 23/46, Befriending 23/44). For the purpose of this review, the frequency of reliable change was averaged across these three outcome measures. </p> <p>It was common for trialists to report continuous measures of mental state outcomes. Brief descriptions of scales used by the trials to report mental state outcomes are below. </p> <p><i>Brief Psychiatric Rating Scale</i> ‐ BPRS (<a href="./references#CD008712-bbs2-0193" title="OverallJ , GorhamD . The brief psychiattric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>) </p> <p>The BPRS is a brief rating scale used to assess the severity of a range of psychiatric symptoms, including psychotic symptoms. The most commonly used version of the scale has 18 items, which are rated from one if not present to seven with high scores indicating poorer functioning. Each item can be defined on a seven‐point scale varying from 'not present' to 'extremely severe'. <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>, <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> and <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> reported useable data from the BPRS. <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> reported the positive symptoms sub‐scale of the BPRS, but these data were skewed and were not pooled within the meta‐analysis. </p> <p><i>Positive and Negative Syndrome Scale (PANSS)</i> (<a href="./references#CD008712-bbs2-0176" title="KaySR , FiszbeinA , OplerLA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13(2):261‐76. ">Kay 1987</a>) </p> <p>This scale is designed to assess the positive symptoms (i.e. delusions, conceptual disorganisation, hallucinations, hyperactivity, grandiosity, suspiciousness/persecution and hostility), negative symptoms (i.e. blunted affect, emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in abstract thinking, lack of spontaneity and flow of conversation, stereotyped thinking), and general psychopathology (i.e. somatic concern, anxiety, depression, guilt, tension, mannerisms and posture, motor retardation, unco‐operativeness, unusual thought content, disorientation, attentional problems, lack of judgement and insight, disturbance of volition, poor impulse control, preoccupation and active social avoidance). This scale was used by <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>, <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>, <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>, <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>, <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>, <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>, <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>, <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>, <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>, <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>, <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>, <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>, and a Chinese version was used by <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> and <a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a>. <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> reported the positive symptoms sub‐scale of the PANSS, but these data were skewed and were not pooled within the meta‐analysis. </p> <p><i>Comprehensive Psychiatric Rating Scale ‐ CPRS</i> (<a href="./references#CD008712-bbs2-0129" title="AsbergM , MontgomeryS , PerrisC , ShallingD , SedvallG . A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavicia1978;271:5‐27. ">Asberg 1978</a>) </p> <p>The Comprehensive Psychiatric Rating Scale is a general psychiatric rating scale. <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> used this scale and reported useable data. </p> <p><i>Psychotic Symptom Rating Scale ‐ PSYRATS</i> (<a href="./references#CD008712-bbs2-0160" title="HaddockG , McCarronJ , TarrierN , FaragherEB . Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine1999;29(4):879‐89. ">Haddock 1999b</a>) </p> <p>This scale is used to assess dimensions of hallucinations and delusions. PSYRATS consists of two scales designed to rate auditory hallucinations and delusions. The items are rated on a five‐point ordinal scale (zero to four).The auditory hallucinations are on an 11‐item scale. Items include frequency, duration, severity and intensity of distress, controllability, loudness, location, beliefs about origin of voices. This scale was used by <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>, <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>, <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>, <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>, and <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>. The delusions sub‐scale is a six‐item scale that assesses dimensions of delusions. The items include preoccupation, distress, duration, conviction, intensity of distress and disruption. <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a> reported useable data from this scale. This scale was also used by <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>, <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>, <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>, and <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> used this scale but reported skewed data. </p> <p><i>Scale for the Assessment of Positive Symptoms</i> (SAPS) (<a href="./references#CD008712-bbs2-0128" title="AndreasenNC . Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, 1984. ">Andreasen 1984</a>) </p> <p>SAPS is a rating scale to measure positive symptoms in schizophrenia. The scale is split into four domains, and within each domain separate symptoms are rated from zero (absent) to five (severe). Higher score indicates worse outcome. </p> <p><i>Scale for the Assessment of Negative Symptoms (SANS)</i> (<a href="./references#CD008712-bbs2-0128" title="AndreasenNC . Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, 1984. ">Andreasen 1984</a>) </p> <p>The SANS is designed to assess the negative symptoms of schizophrenia. This six‐point scale gives a global rating of the following negative symptoms: alogia, affective blunting, avolition‐apathy, anhedonia‐asociality and attention impairment. Higher scores indicate more symptoms. <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> and <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a> reported useable data from this scale. <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> and <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> used this scale but reported skewed data. </p> <p><i>Symptom Checklist 90 (SCL ‐ 90)</i> (<a href="./references#CD008712-bbs2-0150" title="DerogatisLR . SCL‐90‐R: Symptom Checklist‐90‐R. SCL‐90‐R: Symptom Checklist‐90‐R: Administration, Scoring, and Pprocedures Manual. NCS Pearson, 1975. ">Derogatis 1975</a>) </p> <p>SCL ‐ 90 is a relatively brief self‐report psychometric instrument (questionnaire). It consists of 90 items, yielding nine scores along primary symptom dimensions and three scores among global distress indices. The primary symptom dimensions that are assessed are somatisation, obsessive‐compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of "additional items" which helps clinicians assess other aspect of the clients symptoms. <a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a> used this scale and reported useable data. </p> <p><i>Beck Depression Inventory (BDI)</i> (<a href="./references#CD008712-bbs2-0130" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives General Psychiatry1961;4:561‐71. ">Beck 1961</a>) </p> <p>This is a 21‐item, self‐report questionnaire which measures the intensity of depressive symptoms. <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>, <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>, <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> and <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> used this scale but reported skewed data. </p> <p><i>Montgomery Asberg Depression Rating Scale</i> (MADRS) (<a href="./references#CD008712-bbs2-0189" title="MontgomeryS , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;154:382‐9. ">Montgomery 1979</a>) </p> <p>This depression rating scale is designed to be sensitive to change. It was developed using a 65‐item comprehensive psychopathology scale to identify the 17 most commonly occurring symptoms in primary depressive illness. Ratings are on 10 items, with higher score indicating poor outcome. Maximum score is 30. <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> used this scale, but reported skewed data. </p> <p><i>Hamilton Rating Scale for Depression (HAMD)</i> (<a href="./references#CD008712-bbs2-0162" title="HamiltonM . Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology1967;6(4):278‐96. ">Hamilton 1967</a>) </p> <p>The HAMD is 17‐item scale used to assess the severity of depression. Each item was rated on three‐ or five‐point scale. Higher score indicates severe depression. <a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a> used this scale and reported useable data. </p> <p><i>Rosenberg Self‐Esteem Scale (RSES) (</i><a href="./references#CD008712-bbs2-0196" title="RosenbergM . The measurement of self‐esteem. Society and the Adolescent Self Image. Princeton University Press, 1965:297‐307. ">Rosenberg 1965</a>) </p> <p>This is a 10‐item, self‐rated measure of self‐esteem. <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> and <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> used this scale, but <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> reported skewed data. </p> <p><i>Stigma Scale for Mental Illness (SSMI)</i> (<a href="./references#CD008712-bbs2-0177" title="KingM , DinosS , ShawJ , WatsonR , StevensS , PassettiF , et al. The Stigma Scale: development of a standardised measure of the stigma of mental illness. British Journal of Psychiatry2007;190:248‐54. ">King 2007</a>) </p> <p>SSMI is a 28‐item scale to assess the stigma in mental illness. Each item was rated on five‐point scale (from zero to four), with higher score indicating poor self‐esteem. <a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a> used this scale and reported useable data. </p> <p><i>Beck Anxiety Inventory (BAI)</i> (<a href="./references#CD008712-bbs2-0131" title="BeckAT , EpsteinN , BrownG , SteerRA . An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology1988;56(6):893‐7. ">Beck 1988</a>) </p> <p>This is a 21‐item, self‐report questionnaire which measures the intensity of depressive symptoms. <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> and <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> used this scale, but reported skewed data. </p> <p><i>Hamilton Anxiety Rating Scale (HAMA)</i> (<a href="./references#CD008712-bbs2-0161" title="HamiltonM . HAMA Hamilton Anxiety Scale. ECDEU Assessment Manual for Psychopharmacology193‐8. ">Hamilton 1976</a> </p> <p>The HAMA is a 14‐item psychological questionnaire to assess the severity of anxiety. Each item was rated on five‐point scale, with a possible total score varying from zero to 56. Higher score indicates severe anxiety. <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a> used this scale and reported useable data. </p> <p><i>Self‐Rating Anxiety Scale (SARS)</i> (<a href="./references#CD008712-bbs2-0210" title="ZungWW . A rating instrument for anxiety disorders. Psychosomatics1971;12(6):371‐9. [PUBMED: 5172928] ">Zung 1971</a>) </p> <p>SARS is a 20 items self‐report scale to measure the level of anxiety. Four groups of symptoms were rated: central nervous system, motor, cognitive, and automatic symptoms. The overall score ranged from 20 to 80, with higher score indicating more severe anxiety. Useable data from this scale were reported by <a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a>. </p> <p><i>Yale‐Brown Obsessive Compulsive Scale (Y‐BOCS)</i> (<a href="./references#CD008712-bbs2-0157" title="GoodmanW K , PriceL H , RasmussenS A , et al. The Yale‐Brown Obsessive Compulsive Scale: I. development, use, and reliability. Archives of General Psychiatry1989;46(11):1006‐11. ">Goodman 1989</a>) </p> <p>This is a 10‐item, clinician‐rated scale, which measures the severity of symptoms of obsessive‐compulsive disorder. Each item was rated from zero (no symptoms) to four (extreme symptoms). <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a> used this scale and reported useable data. </p> <p><i>Novaco Anger Scale (NAS)</i> (<a href="./references#CD008712-bbs2-0192" title="NovacoRW . The Novaco Anger Scale and Provocation Inventory (NAS‐PI). Los Angeles: Western Psychological Services, 2003. ">Novaco 2003</a>) </p> <p>This is a 48‐item, self‐report questionnaire measuring cognitive, behaviour and arousal aspects of anger. <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> used this scale and reported useable data. </p> <p><i>Novaco Provocation Inventory (NPI)</i> (<a href="./references#CD008712-bbs2-0192" title="NovacoRW . The Novaco Anger Scale and Provocation Inventory (NAS‐PI). Los Angeles: Western Psychological Services, 2003. ">Novaco 2003</a>) </p> <p>This is a 25‐item, self‐report questionnaire measuring triggers or provocations to anger. <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> used this scale but reported skewed data. </p> <p><i>Ward Anger Rating Scale (WARS)</i> (<a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>) </p> <p>Part A consists of 18 dichotomous, weekly ratings regarding verbal and physical behaviours associated with anger and aggression. Part B consists of seven items regarding affective–behavioural attributes related to anger. <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> used this scale but reported skewed data. </p> <p><i>Historical Clinical Risk Management ‐ 20 (HCR ‐ 20) (</i><a href="./references#CD008712-bbs2-0205" title="WebsterCD , DouglasKS , EavesD , HartSD . HCR–20: Assessing Risk for Violence. 2nd Edition. Simon Fraser University, 1997. ">Webster 1997</a><i>)</i> </p> <p>This 20‐item, clinician‐rated scale consists of three sub‐scales (i.e. historical factors; clinical factors; and risk factors in relation to the future) relating to risk of violence. <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> used this scale but reported skewed data. </p> </section> <section id="CD008712-sec-0137"> <h6 class="title">4.3 Adverse effects/events</h6> <p>Mortality was only reported in six trials (<a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>), with <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a> and <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> specifically reporting suicides. </p> <p><a href="./references#CD008712-bbs2-0180" title="KlingbergS , WittorfA , HerrlichJ , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259:S149‐54. ">Klingberg 2009</a> reported rates for 'No adverse effects'. Twenty trials provided information on participants who left the study early (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a> and <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>). </p> </section> <section id="CD008712-sec-0138"> <h6 class="title">4.4 Functioning outcomes</h6> <p>These important outcomes were not reported in binary form (able to look after self, able to hold employment). Scales were employed by a few trials for social and cognitive functioning plus life skills. </p> <p><i>Social Functioning Scale (SFS)</i> (<a href="./references#CD008712-bbs2-0136" title="BirchwoodM , SmithJ , CochraneR , WettonC , CopestakeS . The social functioning scale: the development and validation of a new scale of social adjustment for use in family intervention programmes with schizophenic patients. British Journal of Psychiatry1990;157:853‐9. ">Birchwood 1990</a>) </p> <p>This scale measures social role and behavioural functioning across seven basic areas of community functioning: social engagement, interpersonal behaviour, prosocial activities, recreation, independence, employment. <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> used this scale and reported useable data. </p> <p><i>Personal and Social Performance scale (PSP)</i><a href="./references#CD008712-bbs2-0190" title="MorosiniPL , MaglianoL , BrambillaL , UgoliniS , PioliR . Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatrica Scandinavica2000;101(4):323‐9. ">Morosini 2000</a> </p> <p>The PSP is a scale to measure social and individual performance, which includes four domains socially useful activities, personal and social relationships, self‐care, disturbing and aggressive behaviours. The overall score ranged from one to 100, with higher scores represent better personal and social functioning. <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> used this scale and reported useable data. </p> <p><i>Maryland Assessment of Social Competence (MASC)</i> (<a href="./references#CD008712-bbs2-0135" title="BellackA S , BrownC H , Thomas‐LohrmanS . Psychometric characteristics of role‐play assessments of social skill in schizophrenia. Behavior Therapy2006;37(4):339‐52. ">Bellack 2006</a>) </p> <p>MASC is a structural behavioural assessment that was used as to measure the functional capacity domain of social competence through conversation. <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a> used this scale and reported useable data. </p> <p><i>Social and Occupational Functioning Assessment Scale (SOFAS) (</i><a href="./references#CD008712-bbs2-0141" title="BrambillaS , PioliR . Development, reliability and acceptability of a new version of the DSM‐IV social and occupational functioning assessment scale (SOFAS) to assess routine social funtioning. Acta Psychiatrica Scandinavica2000;101:323‐9. ">Brambilla 2000</a><i>)</i> </p> <p>This is a clinician‐rated measure of social and occupational functioning on a continuum from excellent to grossly impaired functioning. <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> and <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> used this scale and reported useable data. </p> <p><i>Schedule for Assessment of Insight (SAI)</i> (<a href="./references#CD008712-bbs2-0145" title="DavidAS . Insight and psychosis. British Journal of Psychiatry1990;156:789‐808. ">David 1990</a>) </p> <p>The SAI measures three separate dimensions of insight: treatment compliance (scale of zero to four), recognition of illness (scale of zero to six), and re‐labelling of psychotic phenomena (scale of zero to four). Higher SAI scores indicate greater insight. <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> and <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> used this scale and reported useable data. </p> <p><i>The Insight Scale</i> (<a href="./references#CD008712-bbs2-0137" title="BirchwoodM , SmithJ , DruryV , HealyJ , MacmillanF , SladeM . A self‐report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatrica Scandinavica1994;89(1):62‐7. ">Birchwood 1994</a>) </p> <p>The Insight Scale is a brief eight‐item scale that determines the level of acceptance of a psychiatric condition. <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> used this scale and reported useable data. </p> <p><i>Beck Cognitive Insight Scale (BCIS)</i> (<a href="./references#CD008712-bbs2-0132" title="BeckAT , BaruchE , BalterJM , SteerRA , WarmanDM . A new instrument for measuring insight: the Beck cognitive insight scale. Schizophrenia Research2004;68(2):319‐30. ">Beck 2004</a>) </p> <p>This is a 15‐item, self‐report measure of self‐reflectiveness and over confidence in the interpretation of experiences. <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> and <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> used this scale but reported skewed data. </p> <p><i>Comprehensive Module Test (CMT) (</i><a href="./references#CD008712-bbs2-0184" title="LibermanR P . Psychosocial treatments for schizophrenia. Psychiatry1994;57(2):104‐14. ">Liberman 1994</a>) </p> <p>The CMT is a assess factual knowledge about skills and the application of skills in vignettes, however, it was adapted to assess mastery of the specific content trained in Cognitive Behavioral Social Skills Training (CBSST) in the study <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> and <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>. The total score ranged from 0 to 33 with higher score indicating better CBSST skill acquisition. </p> </section> <section id="CD008712-sec-0139"> <h6 class="title">4.5 Quality of life outcomes</h6> <p>Again, few trials reported on quality of life outcomes. Brief description of scales used to report quality of life outcomes are below. </p> <p><i>Life Satisfaction Index (LSI)</i> (<a href="./references#CD008712-bbs2-0204" title="WallaceKA , WheelerAJ . Reliability generalization of the life satisfaction index. Educational and Psychological Measurement2002;62:674–684. ">Wallace 2002</a>) </p> <p>The LSI measures the overall life satisfaction, which incorporates several domain on well‐being, with higher score indicating more life satisfaction. <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> used this scale and reported useable data. </p> <p><i>European Quality of Life Questionnaire</i> (<a href="./references#CD008712-bbs2-0142" title="BrazierJ , JonesN , KindP . Testing the validity of the EuroQol and comparing it with the SF–36 health survey questionnaire. Quality of Life Research1993;2:169–80. ">Brazier 1993</a>). </p> <p>This is also known as the EuroQoL or the EQ‐5D. This is a self‐rated measure of five dimensions of health‐related quality of life (mobility, self‐care, usual activities, pain/discomfort, anxiety/depression). <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> used this scale and reported useable data. </p> <p><i>The Quality of Life Scale (QLS)</i> (<a href="./references#CD008712-bbs2-0164" title="HeinrichsDW , HanlonTE , CarpenterW TJr . The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin1984;10(3):388‐98. ">Heinrichs 1984a</a>) </p> <p>The QLS is used to assess deficit symptoms, and is a 21‐item based, semi‐structured interview scale. <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> used this scale and reported useable data. </p> <p><i>Modular System for Quality of Life (MSQoL)</i> (<a href="./references#CD008712-bbs2-0195" title='PukropR , MollerHJ , SteinmeyerEM . Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life". European Archives of Psychiatry and Clinical Neuroscience2000;250(3):120‐32. '>Pukrop 2000</a>) </p> <p>The MSQoL is a 47‐item based scale that consists of six domains: physical health, vitality, psychosocial relationships, material resources, affect, and leisure time. <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> used this scale and reported useable data. </p> <p><b>4.6 Engagement with services</b> </p> <p>A few attitudes to medication outcomes were reported. Descriptions of the scales used to report these are below. </p> <p><i>Attitude to Medication Questionnaire</i> (AMQ)<i>(</i><a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>) </p> <p>The AMQ is a 14‐item based scale, with total score ranges from zero to 28. Higher scores indicating more positive attitudes. <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> used this scale and reported useable data. </p> <p><i>Drug Attitude Inventory (DAI) (</i><a href="./references#CD008712-bbs2-0168" title="HoganTP , AwadAG , EastwoodR . A self‐report scale predictive of drugcompliance in schizophrenics: reliability and discriminative validity. Psychological Medicine1983;13(1):177‐83. ">Hogan 1983</a>) </p> <p>The DAI reflects the participants' subjective response to neuroleptics and attitude toward medication, with total score ranges from zero to 30. <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> used this scale and reported useable data. </p> </section> </section> </section> <section id="CD008712-sec-0140"> <h4 class="title">Excluded studies</h4> <p>We excluded 69 studies (81 reports) from this review.</p> <section id="CD008712-sec-0141"> <h5 class="title">1. Issues relating to methods</h5> <p>We excluded 19 studies because they were not randomised controlled trials (RCTs) (<a href="./references#CD008712-bbs2-0038" title="ArlowPB , MoranME , BermanzohnPC , StrongerR , SirisSG . Cognitive‐behavioural treatment of panic attacks in chronic schizophrenia. Journal of Psychotherapy Practice and Research1997;6:145‐50. ">Arlow 1997</a>; <a href="./references#CD008712-bbs2-0042" title="BechdolfA , VeithV , SchwarzerD , SchormannM , StammE , JanssenB , et al. Cognitive‐behavioral therapy in the pre‐psychotic phase: an exploratory study. Psychiatry Research2005;136(2‐3):251‐5. ">Bechdolf 2005b</a>; <a href="./references#CD008712-bbs2-0044" title="BouchaudS , VallieresA , RoyM , MaziadeM . Cognitive restructuring in the treatment of psychotic symptoms in schizophrenia: a critical analysis. Behavior Therapy1996;27:257‐77. ">Bouchaud 1996</a>; <a href="./references#CD008712-bbs2-0048" title="BuchananA . A two year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine1992;22(3):787‐97. ">Buchanan 1992</a>; <a href="./references#CD008712-bbs2-0050" title="ChadwickP , BirchwoodM . The omnipotence of voices: a cognitive approach to auditory hallucinations. British Journal of Psychiatry1994;164:190‐201. ChadwickP , LoweC . A cognitive approach to measuring and modifying delusions. Behavioural Research Therapy1994;32(3):355‐67. ">Chadwick 1994</a>; <a href="./references#CD008712-bbs2-0058" title="GaretyPA , KuiperL , FowlerD , ChamberlinF , DunnG . Cognitive behavioural therapy for drug‐resistant psychosis. British Journal of Medical Psychology1994;67:259‐71. ">Garety 1994</a>; <a href="./references#CD008712-bbs2-0065" title="HartmanLM , CashmanFE . Cognitive‐behavioral and psychopharmacological treatment of delusional symptoms: a preliminary report. Behavioural Psychotherapy1983;11:50‐61. ">Hartman 1983</a>; <a href="./references#CD008712-bbs2-0069" title="HodelB , BrennerHD . Cognitive therapy with schizophrenic patients: conceptual basis, present state, future directions. Acta Psychiatrica Scandinavica1994;90S:108‐15. ">Hodel 1994</a>; <a href="./references#CD008712-bbs2-0070" title="HogartyGE , AndersonCM , ReissDF , KornblithSJ , GreenwaldDP , UlrichRF , et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: II. Two year effects of a controlled study on relapse and adjustment. Archives of General Psychiatry1991;48:340‐7. ">Hogarty 1991</a>; <a href="./references#CD008712-bbs2-0073" title="JacksonH , McGorryP , EdwardsJ , HulbertC , HenryL , FranceyS , et al. Cognitively oriented psychotherapy for early psychosis (COPE): priminary results. British Journal of Psychiatry1998;172(Suppl 33):93‐100. ">Jackson 1998</a>; <a href="./references#CD008712-bbs2-0075" title="KempR , DavidA . Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy1996;24:331‐50. ">Kemp 1996b</a>; <a href="./references#CD008712-bbs2-0076" title="KingdonD , TurkingtonD . The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Journal of Nervous and Mental Disease1991;179(4):207‐11. ">Kingdon 1991</a>; <a href="./references#CD008712-bbs2-0077" title="KuipersE . The management of difficult to treat patients with schizophrenia, using non‐drug therapies. British Journal of Psychiatry1996;169:41‐51. ">Kuipers 1996</a>; <a href="./references#CD008712-bbs2-0083" title="MayPR . A step forward in research on psychotherapy of schizophrenia. Schizophrenia Bulletin1984;10:604‐7. ">May 1984</a>; <a href="./references#CD008712-bbs2-0088" title="PerrisC . A cognitive‐behavioral treatment program for patients with a schizophrenic disorder. New Directions for Mental Health Services1992;53:21‐32. ">Perris 1992</a>; <a href="./references#CD008712-bbs2-0093" title="ShonK , ParkS . Medication and symptom management education program for the rehabilitation of psychiatric patients in Korea: the effects of promoting schedule on self‐efficacy theory. Yonsei Medical Journal2002;43(5):579‐89. ">Shon 2002</a>; <a href="./references#CD008712-bbs2-0094" title="SpauldingWD . Design prerequisites for research on cognitive therapy for schizophrenia. Schizophrenia Bulletin1992;18:139‐42. ">Spaulding 1992</a>; <a href="./references#CD008712-bbs2-0105" title="XieH , LiR . Cognitive therapy to medication compliance in first‐episode schizophrenia patients [认知治疗对首发精神分裂症患者服药依从性的影响]. Attend to Practice and Research [护理实践与研究]2010;7(22):17‐8. ">Xie 2010</a>). </p> </section> <section id="CD008712-sec-0142"> <h5 class="title">2. Issues relating to participants</h5> <p>Two studies reported outcome on individuals at‐risk of psychosis (<a href="./references#CD008712-bbs2-0084" title="McGorryP , YungA , PhillipsL , YuenH , FranceyS , CosgraveE , et al. Randomised controlled trial of interventions designed to reduce the risk of progression to first‐episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry2002;59:921‐8. ">McGorry 2002</a>; <a href="./references#CD008712-bbs2-0085" title="MorrisonAP , BentallRP , FrenchP , WalfordL , Kilcommons A, KnightA , et al. Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high‐risk individuals. British Journal of Psychiatry2002;181(43):78‐84. ">Morrison 2002</a>), and were therefore excluded as they do not apply directly to people with a diagnosis of schizophrenia. </p> </section> <section id="CD008712-sec-0143"> <h5 class="title">3. Issues relating to comparison</h5> <p>A large number of papers reported CBT compared with standard care (<a href="./references#CD008712-bbs2-0040" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. ">Barrowclough 2001</a>; <a href="./references#CD008712-bbs2-0041" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive‐behavioural therapy for schizophrenia. Randomised controlled trial. British Journal of Psychiatry2006;189:527‐32. ">Barrowclough 2006</a>; <a href="./references#CD008712-bbs2-0046" title="BradshawW . Integrating cognitive‐behavioral psychotherapy for persons with schizophrenia into a psychiatric rehabilitation program: results of a three year trial. Community Mental Health Journal2000;36(5):491‐500 . ">Bradshaw 2000</a>; <a href="./references#CD008712-bbs2-0049" title="CastleD , NathanP , KingserP , HalprinS , DrummandP , JeffreysL . Treating social anxiety in schizophrenia: a group based cognitive behaviour therapy approach. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, Pennsylvania, USA. 2002. ">Castle 2002</a>; <a href="./references#CD008712-bbs2-0052" title="DanielsL . A group cognitive‐behavioural and process‐oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167‐76. ">Daniels 1998</a>; <a href="./references#CD008712-bbs2-0055" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;42(2):69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44(1):40‐7. ">England 2007</a>; <a href="./references#CD008712-bbs2-0059" title="GaretyP , FowlerD , KuipersE , FreemanD , DunnG , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis: II. Predictors of outcome. British Journal of Psychiatry1994;171:420‐6. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised control trial of cognitive behavioural therapy for psychosis III: Follow‐up and economic evaluation at 18 months. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis: I. Effects of the treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Garety 1998</a>; <a href="./references#CD008712-bbs2-0061" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162(3):520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68(5):730‐7  . ">Granholm 2005</a>; <a href="./references#CD008712-bbs2-0063" title="GumleyA , O'GradyM , McNayL , RilleyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a twelve month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD008712-bbs2-0074" title="JacksonC . Promoting personal recovery from psychosis: a randomised control trial in first episode schizophrenia. National Research Register2001. ">Jackson 2001</a>; <a href="./references#CD008712-bbs2-0078" title="KuipersE , HollowayF , Rabe‐HeskethS , TennakoonL . An RCT of early intervention in psychosis: Croydon outreach and assertive support team (COAST). Social Psychiatry and Psychiatric Epidemiology2004;39(5):358‐63. ">Kuipers 2004</a>; <a href="./references#CD008712-bbs2-0081" title="LysakerPH , DavisLW , BrysonGJ , BellMD . Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participants with schizophrenia spectrum disorders. Schizophrenia Research2009;107:186‐91  . ">Lysaker 2009</a>; <a href="./references#CD008712-bbs2-0089" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>; <a href="./references#CD008712-bbs2-0091" title="SellwoodW , BarrowcloughC , TarrierN , QuinnJ , MainwaringJ , LewisS . Needs‐based cognitive‐behavioural family intervention for carers of patients suffering from schizophrenia: 12‐month follow‐up. Acta Psychiatrica Scandinavica2001;104(5):346‐55. SellwoodW , WittkowskiA , TarrierN , BarrowcloughC . Needs‐based cognitive‐behavioural family intervention for patients suffering from schizophrenia: 5‐year follow‐up of a randomized controlled effectiveness trial. Acta Psychiatrica Scandinavica2007;116(6):447‐52. ">Sellwood 2001</a>; <a href="./references#CD008712-bbs2-0095" title="StartupM , JacksonM . A controlled trial of cognitive behaviour therapy for schizophrenia and related disorders. Wales Office of Research and Development for Health and Social Care2003. [Grant number: RC012] Wales Office of Research and Development for Heatlh and Social Care. A controlled trial of cognitive behaviour therapy for schizophrenia and related disorders. dialspace.dial.pipex.com/word/ (accessed prior to 01 June 2017). ">Startup 1998</a>; <a href="./references#CD008712-bbs2-0096" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disorders2006;194(10):740‐5. ">Startup 2006</a>; <a href="./references#CD008712-bbs2-0098" title="TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Turkington 2002</a>; <a href="./references#CD008712-bbs2-0099" title="TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. ">Turkington 2006</a>; <a href="./references#CD008712-bbs2-0104" title="WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2003</a>), and were therefore excluded from this review as they do not involve an adjunctive comparison therapy. </p> </section> <section id="CD008712-sec-0144"> <h5 class="title">4. Issues relating to intervention</h5> <p>Several studies reported CBT interventions as part of a broader treatment package where it was not possible to identify the effect of the CBT elements (<a href="./references#CD008712-bbs2-0054" title="EdwardsJ , WongL , BernettP , HarriganSM , McGorryPD , WadeD , et al. Enduring positive symptoms in first episode psychosis: a randomised controlled trial of clozapine and CBT. International Congress on Schizophrenia Research2003;60:321. ">Edwards 2003</a>; <a href="./references#CD008712-bbs2-0056" title="EvinsAE , MaysVK , RigottiNA , TisdaleT , CatherC , GoffD . A pilot trial of bupropion added to cognitive behavioural therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research2001;3:397‐403. ">Evins 2001</a>; <a href="./references#CD008712-bbs2-0064" title="HaldunS , MehmetS , PerhanG , IlktenC , BestiU . Optimal treatment of schizophrenia. 12th World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. ">Haldun 2002</a>; <a href="./references#CD008712-bbs2-0066" title="HaywardP , ChanN , KempR , YouleS , DavidA . Medication self‐management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health1995;4:511‐7. ">Hayward 1995</a>; <a href="./references#CD008712-bbs2-0068" title="HerzMI , LambertiJS , MintzJ , ScottR , O'DellSP , McCartanL , et al. A program for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry2000;57(3):277‐83. ">Herz 2000</a>). In particular, <a href="./references#CD008712-bbs2-0037" title="AnzaiN , YonedaS , KumagaiN , NakamuraY , IkebuchiE , LibermanR . Training persons with schizophrenia in illness self‐management: a randomised controlled trial in Japan. Psychiatric Services2002;53(5):545‐7. ">Anzai 2002</a> reported comparisons of different types of services (community re‐entry model versus occupational rehabilitation) in which CBT had greater or lesser involvement. </p> <p>Several studies employed therapeutic strategies that did not meet our criteria for CBT (<a href="./references#CD008712-bbs2-0039" title="BachP , HayesSC . The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. Journal of Consulting and Clinical Psychology2002;70(5):1129‐39. ">Bach 2002</a>; <a href="./references#CD008712-bbs2-0043" title="BellucciDM , GalbermanK , HaslamN . Computer assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill. Schizophrenia Research2002;59:225‐32. ">Bellucci 2002</a>; <a href="./references#CD008712-bbs2-0045" title="BradshawW . Coping‐skills, training versus a problem‐solving approach with schizophrenic patients. Hospital and Community Psychiatry1993;44(5):491‐500. ">Bradshaw 1993</a>; <a href="./references#CD008712-bbs2-0051" title="ClagthornJL , JohnstoneEE , CookTH , ItschnerL . Group therapy and maintenance treatment of schizophrenics. Archives of General Psychiatry1974;31:361‐5. ">Claghorn 1974</a>; <a href="./references#CD008712-bbs2-0053" title="DrakeRE , BeboutRR , RoachJP . A research evaluation of social network case management for homeless persons with dual disorders. Social Network Research1993;1:83‐98. ">Drake 1993</a>; <a href="./references#CD008712-bbs2-0057" title="FritzeJ , ForthnerB , SchmittB , ThalerU . Cognitive training adjunctive to pharmacotherapy in schizophrenia and depression: a pilot study on the lateralization hypothesis of schizophrenia and depression and on cognitive therapy as adjunctive to pharmacotherapy. Neuropsychobiology1988;19:45‐50. ">Fritze 1988</a>; <a href="./references#CD008712-bbs2-0060" title="GaudianoBA , HerbertJD . Acute treatment of inpatients with psychotic symptoms using acceptance and commitment therapy: pilot results. Behaviour Research and Therapy2006;44(3):415‐37. ">Gaudiano 2006</a>; <a href="./references#CD008712-bbs2-0067" title="HaywardP , DavidAS , GreenN , Rabe‐HeskethS , HaworthE , ThompsonN , et al. Promoting therapeutic alliance in clozapine users: an exploratory randomized controlled trial. Clinical Schizophrenia and Related Psychoses2009;3(3):127‐32. ">Hayward 2009</a>; <a href="./references#CD008712-bbs2-0071" title="HogartyG , CornblithS , GreenwaldD , DiBarryA , CooleyS , UlrichR , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family. I. Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. HogartyG , GreenwaldD , UlrichR , CornblithS , DiBarryA , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family. II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. ">Hogarty 1997</a>; <a href="./references#CD008712-bbs2-0072" title="HogartyGE , FlesherS , UlrichR , CarterM , GreenwaldD , Pogue‐GeileM , et al. Cognitive enhancement therapy for schizophrenia: effects of a 2‐year randomized trial on cognition and behavior. Archives of General Psychiatry2004;61(9):866‐76. ">Hogarty 2004</a>; <a href="./references#CD008712-bbs2-0082" title="MacPhersonR , JerromB , HughesA . A controlled study of education about drug treatment of schizophrenia. British Journal of Psychiatry1996;168:709‐17. ">MacPherson 1996</a>; <a href="./references#CD008712-bbs2-0087" title="OlbrichR , MussgayL . Reducton of schizophrenic deficits by cognitive training: an evaluative study. European Archives of Psychiatry and Neurological Sciences1990;239:366‐9. ">Olbrich 1990</a>; <a href="./references#CD008712-bbs2-0090" title="RoderV , BrennerHD , MullerD , LachlerM , ZornP , ReischT , et al. Development of specific social skills training programmes for schizophrenia patients: results of a multi‐centre study. Acta Psychiatrica Scandinavica2002;105:363‐71. ">Roder 2002</a>; <a href="./references#CD008712-bbs2-0097" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , SharpeL , BeckettR , HarwoodS , BakerA , YusopoffL . A trial of two cognitive behavioural methods of treating drug resistant residual psychotic symptoms in schizophrenic patients: II. Treatment specific changes in coping and problem solving skills. Social Psychiatry and Psychiatric Epidemiology1993;28:5‐10. ">Tarrier 1993</a>; <a href="./references#CD008712-bbs2-0100" title="Van DerGaagM , KernRS , Van DenBoschRJ , LibermanRP . A controlled trial of cognitive remediation in schizophrenia. Schizophrenia Bulletin2003;28:167‐76. ">Van Der Gaag 2003</a>; <a href="./references#CD008712-bbs2-0101" title="VelliganDI , PrihodaTJ , RitchJL , MaplesM , Bow‐ThomasCC , DassoriA . A randomized single blind pilot study of compensatory strategies in schizophrenia out‐patients. Schizophrenia Bulletin2002;28(2):283‐92. ">Velligan 2002</a>; <a href="./references#CD008712-bbs2-0103" title="WykesT . The effectiveness of cognitive remediation therapy (CRT) for patients with schizophrenia. National Research Register2002. ">Wykes 2002</a>). Notably, <a href="./references#CD008712-bbs2-0097" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , SharpeL , BeckettR , HarwoodS , BakerA , YusopoffL . A trial of two cognitive behavioural methods of treating drug resistant residual psychotic symptoms in schizophrenic patients: II. Treatment specific changes in coping and problem solving skills. Social Psychiatry and Psychiatric Epidemiology1993;28:5‐10. ">Tarrier 1993</a> employed coping strategy enhancement which, although a commonly used component of CBT, would not in itself meet our criteria for CBT. The same applied to acceptance and commitment therapy (<a href="./references#CD008712-bbs2-0039" title="BachP , HayesSC . The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. Journal of Consulting and Clinical Psychology2002;70(5):1129‐39. ">Bach 2002</a>; <a href="./references#CD008712-bbs2-0060" title="GaudianoBA , HerbertJD . Acute treatment of inpatients with psychotic symptoms using acceptance and commitment therapy: pilot results. Behaviour Research and Therapy2006;44(3):415‐37. ">Gaudiano 2006</a>), which, like CBT, has a focus on cognitions. However, it aims to help patients respond differently to their thoughts rather than directly challenge or test out their validity. Patients are encouraged to accept and experience their internal events non‐judgmentally. Accordingly, this treatment would not meet our criteria for CBT. Personal therapy (<a href="./references#CD008712-bbs2-0071" title="HogartyG , CornblithS , GreenwaldD , DiBarryA , CooleyS , UlrichR , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family. I. Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. HogartyG , GreenwaldD , UlrichR , CornblithS , DiBarryA , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family. II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. ">Hogarty 1997</a>), like CBT, aims to prevent relapse and promote personal and social adjustment. However, personal therapy differs from CBT in that it consists of psychoeducation awareness of early signs, supportive therapy techniques, social skills training, the teaching of coping strategies, without an explicit focus on beliefs and cognitive restructuring. Accordingly, this treatment would not meet our criteria for CBT. <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> investigated a group‐based CBT intervention, but which did not meet our criteria. <a href="./references#CD008712-bbs2-0062" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114:328‐36. ">Grawe 2006</a> reported a integrated treatment involving CBTand skill training, which we did not consider eligible. </p> <p>Seven papers (<a href="./references#CD008712-bbs2-0043" title="BellucciDM , GalbermanK , HaslamN . Computer assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill. Schizophrenia Research2002;59:225‐32. ">Bellucci 2002</a>; <a href="./references#CD008712-bbs2-0057" title="FritzeJ , ForthnerB , SchmittB , ThalerU . Cognitive training adjunctive to pharmacotherapy in schizophrenia and depression: a pilot study on the lateralization hypothesis of schizophrenia and depression and on cognitive therapy as adjunctive to pharmacotherapy. Neuropsychobiology1988;19:45‐50. ">Fritze 1988</a>; <a href="./references#CD008712-bbs2-0072" title="HogartyGE , FlesherS , UlrichR , CarterM , GreenwaldD , Pogue‐GeileM , et al. Cognitive enhancement therapy for schizophrenia: effects of a 2‐year randomized trial on cognition and behavior. Archives of General Psychiatry2004;61(9):866‐76. ">Hogarty 2004</a>; <a href="./references#CD008712-bbs2-0087" title="OlbrichR , MussgayL . Reducton of schizophrenic deficits by cognitive training: an evaluative study. European Archives of Psychiatry and Neurological Sciences1990;239:366‐9. ">Olbrich 1990</a>; <a href="./references#CD008712-bbs2-0100" title="Van DerGaagM , KernRS , Van DenBoschRJ , LibermanRP . A controlled trial of cognitive remediation in schizophrenia. Schizophrenia Bulletin2003;28:167‐76. ">Van Der Gaag 2003</a>; <a href="./references#CD008712-bbs2-0101" title="VelliganDI , PrihodaTJ , RitchJL , MaplesM , Bow‐ThomasCC , DassoriA . A randomized single blind pilot study of compensatory strategies in schizophrenia out‐patients. Schizophrenia Bulletin2002;28(2):283‐92. ">Velligan 2002</a>; <a href="./references#CD008712-bbs2-0103" title="WykesT . The effectiveness of cognitive remediation therapy (CRT) for patients with schizophrenia. National Research Register2002. ">Wykes 2002</a>) reported the use of therapeutic strategies designed to overcome intellectual and memory deficits associated with schizophrenia rather than psychotic symptoms, beliefs or cognitive distortions. </p> </section> <section id="CD008712-sec-0145"> <h5 class="title">5. Issues relating to outcome data</h5> <p>A paper by <a href="./references#CD008712-bbs2-0102" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermanK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149:1549‐55. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28:241‐5. ">Wirshing 1992</a> was excluded because the author did not report data in each group separately . </p> </section> </section> </section> <section id="CD008712-sec-0146"> <h3 class="title">Risk of bias in included studies</h3> <p>For graphical representation please see <a href="#CD008712-fig-0004">Figure 4</a> and <a href="#CD008712-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD008712-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD008712-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <div class="figure" id="CD008712-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD008712-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD008712-sec-0147"> <h4 class="title">Allocation</h4> <p>All of the 33 included trials reported some form of randomisation. Twenty‐five reported adequate sequence generation, whist the remaining trial provided insufficient information to rate this particular bias. </p> <p>Allocation was concealed in 17 studies, with the remaining studies not providing enough information to rate this bias. </p> </section> <section id="CD008712-sec-0148"> <h4 class="title">Blinding</h4> <p>With respect to blinding of participants and personnel (performance bias) three trials (<a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>) reported attempts at blinding. As noted previously, it is extremely difficult to blind participants and personnel in interventions that require active engagement and participation. Accordingly, the success of these trials to blinding for performance bias remains unclear. </p> <p>Twenty‐five trials attempted to reduce any detection bias by employing raters who were naive to allocation (<a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>; <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>; <a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>). One trial (<a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>) reported that "Data recorded by trained project staff who were not blind with respect to the group of allocation". The remaining trials did not provide sufficient information and were rated as "unclear risk". </p> </section> <section id="CD008712-sec-0149"> <h4 class="title">Incomplete outcome data</h4> <p>Seven studies were rated as high risk regarding incomplete data (<a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>; <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a>; <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>;<a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>; <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>). In the study <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>, overall, 35% of participants were lost to follow‐up; 28% from the compliance therapy group and 43% from the control group. Of the 200 participants randomised in the trial by <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>, 32 participants left the study early and 48 participants were excluded from the final analysis due to invalid data. Thirty three out of seventy seven participants dropped out from the study by <a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a>, and ninty‐two participants (61.7%) left the study early in <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>. </p> </section> <section id="CD008712-sec-0150"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> failed to report a large number, but not all, of their outcomes by individual groups and data were aggregated in a manner which rendered data unsuitable for meta‐analysis. We were unable to use the Psychiatric Assessment Scale (PAS) used by <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a> as the data were only reported in graphical form. The measure of compliance reported in <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> was not peer‐reviewed and therefore could not be included. <a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a> did not report the PANSS and IBS (Irrational Beliefs Scale) scores. <a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> and <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a> measured the mental state by the PANSS scale, however only reported data on a modified version of the positive symptoms scale and the total score of PANSS; as well, the other sub‐scale scores (such as negative symptoms and general psychopathology) were not reported. <a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a> reported many continuous outcomes without standard deviations (SDs) and therefore it was not possible to use these data. </p> </section> <section id="CD008712-sec-0151"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> is one of the few trials to report outcome data with regard to problem behaviours. However, a potential source of bias in these data may result from the inclusion of a mixed sample of in‐patients and out‐patients, with a greater opportunity to observe and record aggressive behaviour in the in‐patient sample. <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> contained only six participants in each of the two arms of the trial. Such a small trial could not guarantee that randomisation would be adequate to control for idiosyncratic participant characteristics. <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> was rated as high risk of other bias due to the imbalanced baseline characteristics. </p> </section> </section> <section id="CD008712-sec-0152"> <h3 class="title" id="CD008712-sec-0152">Effects of interventions</h3> <p>See: <a href="./full#CD008712-tbl-0001"><b>Summary of findings for the main comparison</b> CBT compared to ALL OTHER PSYCHOLOGICAL THERAPIES for schizophrenia</a> </p> <section id="CD008712-sec-0153"> <h4 class="title">Comparison 1: Cognitive behavioural therapy (CBT) versus all other PSYCHOSOCIAL THERAPIES</h4> <section id="CD008712-sec-0154"> <h5 class="title">1. Global state</h5> <p>Four outcomes were reported as indicators of global state; relapse, rehospitalisation, Global Assessment of Functioning (GAF) Scale, and Global Assessment Scale (GAS). </p> <section id="CD008712-sec-0155"> <h6 class="title">1.1.Global state: 1. Relapse</h6> <p>Seven trials reported data on relapse. (<a href="./references#CD008712-fig-0007" title="">Analysis 1.1</a>) </p> <section id="CD008712-sec-0156"> <p><b>1.1.1 Short term</b></p> <p><a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a> reported relapse at short‐term follow‐up. No clear difference between CBT and a non active psychosocial therapy was observed in the short term (risk ratio (RR) 0.72, 95% confidence interval (CI) 0.05 to 11.02; participants = 62; studies = 1). </p> </section> <section id="CD008712-sec-0157"> <p><b>1.1.2 Medium term</b></p> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> and <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a> reported relapse at medium‐term follow‐up. No clear difference between CBT and other psychosocial therapies was observed (RR 1.01, 95% CI 0.56 to 1.81; participants = 150; studies = 2). </p> </section> <section id="CD008712-sec-0158"> <p><b>1.1.3 Long term</b></p> <p>Five studies (<a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>) reported relapse at long‐term follow‐up . No clear difference between CBT and other psychosocial therapies was observed (RR 1.05, 95% CI 0.85 to 1.29; participants = 375; studies = 5; low‐quality evidence). </p> </section> </section> <section id="CD008712-sec-0159"> <h6 class="title">1.2 Global state: 2. Average endpoint score (various scales, high = good)</h6> <p>Four trials reported global state data as endpoint scores from the GAS and the GAF scales. (<a href="./references#CD008712-fig-0008" title="">Analysis 1.2</a>). </p> <section id="CD008712-sec-0160"> <p><b>1.2.1 GAS ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> reported medium‐term data. No clear differences between CBT and an active other psychosocial therapy was observed (mean difference (MD) ‐0.60, 95% CI ‐4.93 to 3.73; participants = 38; studies = 1). </p> </section> <section id="CD008712-sec-0161"> <p><b>1.2.2 GAS ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> also reported long‐term data. No clear differences between CBT and an active other psychosocial therapy was observed (MD ‐0.50, 95% CI ‐7.63 to 6.63; participants = 30; studies = 1). </p> </section> <section id="CD008712-sec-0162"> <p><b>1.2.3 GAF ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> and <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> reported short‐term data. When compared with inactive psychosocial therapies, a positive effect favouring CBT was observed (MD 9.02, 95% CI 4.29 to 13.75; participants = 147; studies = 2). </p> </section> <section id="CD008712-sec-0163"> <p><b>1.2.4 GAF ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>, <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> and <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> reported long‐term data from the GAF. No effect was observed with long‐term data (MD 5.42, 95% CI ‐0.37 to 11.20; participants = 175; studies = 3; I<sup>2</sup> = 69%). These long‐term data have moderate levels of heterogeneity (Chi<sup>2</sup> = 6.54; df = 2; P = 0.04; I<sup>2</sup> = 69%). The outlier, was the only trial detecting a positive effect for CBT (<a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>). When data from this trial were removed, from the meta‐analysis, homogeneity was restored and the result remained the same. </p> </section> </section> <section id="CD008712-sec-0164"> <h6 class="title">1.3 Global state: 3. Rehospitalisation</h6> <p>Eight trials reported data for rehospitalisation. (<a href="./references#CD008712-fig-0009" title="">Analysis 1.3</a>). </p> <section id="CD008712-sec-0165"> <p><b>1.3.1 Short term</b></p> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> reported rehospitalisation at short‐term follow‐up. No difference between CBT and an active other psychosocial therapy was observed (RR 0.44, 95% CI 0.13 to 1.56; participants = 65; studies = 1). </p> </section> <section id="CD008712-sec-0166"> <p><b>1.3.2 Medium term</b></p> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>, <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> and <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> reported rehospitalisation at medium‐term follow‐up. No difference between CBT and active other psychosocial therapies was observed (RR 0.86, 95% CI 0.57 to 1.29; participants = 344; studies = 3). </p> </section> <section id="CD008712-sec-0167"> <p><b>1.3.3 Long term</b></p> <p>Eight studies (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>; <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>) reported rehospitalisation at long‐term follow‐up. No clear difference between CBT and other psychosocial therapies was observed (RR 0.96, 95% CI 0.82 to 1.14; participants = 943; studies = 8, low‐quality evidence). </p> </section> </section> </section> <section id="CD008712-sec-0168"> <h5 class="title">Mental state</h5> <p>Four outcomes were reported as indicators of general mental state: clinically important change ‐ no improvement (defined by each study, see <a href="./references#CD008712-sec-0447" title="">Characteristics of included studies</a>), average endpoint total scores from British Psychiatric Rating Scale (BPRS), Positive and Negative Symptom Scale (PANSS), and the Comprehensive Psychiatric Rating Scale (CPRS). </p> <section id="CD008712-sec-0169"> <h6 class="title">1.4 Mental state: 1. General ‐ clinically important change (no improvement)</h6> <section id="CD008712-sec-0170"> <p><b>1.4.1 Short term</b></p> <p>The two trials reporting useable data for no improvement in the short term used only active therapies as their control (psychoeducation (<a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>), and supportive counselling (<a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>)). A positive effect was observed for CBT (RR 0.75, 95% CI 0.58 to 0.99; participants = 87; studies = 2; <a href="./references#CD008712-fig-0010" title="">Analysis 1.4</a>). </p> </section> <section id="CD008712-sec-0171"> <p><b>1.4.2 Medium term</b></p> <p>Medium‐term data were reported by three trials, where both active and non active therapies were used. No difference between CBT and other psychosocial therapies was observed (RR 0.84, 95% CI 0.58 to 1.23; participants = 195; studies = 3; I<sup>2</sup> = 86%; <a href="./references#CD008712-fig-0010" title="">Analysis 1.4</a>). This subgroup also had important levels of heterogeneity. The source of heterogeneity could not be identified, so we used a random‐effects model for analyses of these data. </p> </section> <section id="CD008712-sec-0172"> <p><b>1.4.3 Long term</b></p> <p>Long‐term data were reported by four trials where both active and non active therapies were used as control interventions. (n = 249). Again, no clear difference between CBT and other psychological therapies was observed (RR 0.82, 95% CI 0.67 to 1.01; participants = 249; studies = 4; low‐quality evidence; <a href="./references#CD008712-fig-0010" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD008712-sec-0173"> <h6 class="title">1.5 Mental state: 2. General (average endpoint total score various scales, high = poor) </h6> <p>Seven trials reported on general mental state by measuring endpoint total scores using the BPRS, the PANSS, and the (CPRS. (<a href="./references#CD008712-fig-0011" title="">Analysis 1.5</a>) </p> <section id="CD008712-sec-0174"> <p><b>1.5.1 BPRS ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>, <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> and <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> reported short‐term data. No difference between CBT and other psychosocial therapies (active and non active) was observed (MD 0.23, 95% CI ‐2.83 to 3.29; participants = 162; studies = 3). </p> </section> <section id="CD008712-sec-0175"> <p><b>1.5.2 BPRS ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> compared CBT with an active therapy (supportive counselling) found a positive effect for CBT in the medium term (MD ‐7.60, 95% CI ‐14.30 to ‐0.90; participants = 37; studies = 1). </p> </section> <section id="CD008712-sec-0176"> <p><b>1.5.3 PANSS ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>, <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>, <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>, <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>, <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>, and <a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a> reported short‐term data. CBT was compared with both active and non active psychosocial therapies in these trials. A positive effect for CBT was observed (MD ‐5.38, 95% CI ‐7.31 to ‐3.44; participants = 568; studies = 6; I<sup>2</sup> = 94%), The short‐term result had an important level of heterogeneity (Heterogeneity: Chi<sup>2</sup> = 77.22; df = 5; P &lt; 0.00001; I<sup>2</sup> = 94%). This heterogeneity appears to be induced by a very small study (<a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>), after removing this trial from the meta‐analysis, homogeneity was restored and the result remains the same. </p> </section> <section id="CD008712-sec-0177"> <p><b>1.5.4 PANSS ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>, <a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>, and <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> reported medium‐term data. CBT was compared with active psychosocial therapies in these trials. A positive effect for CBT was observed (MD ‐4.90, 95% CI ‐7.93 to ‐1.87; participants = 270; studies = 3) </p> </section> <section id="CD008712-sec-0178"> <p><b>1.5.5 PANSS ‐ long term</b></p> <p>Nine trials comparing CBT with both active and non active psychosocial therapies reported long‐term data. A positive effect was found for CBT (MD ‐3.22, 95% CI ‐5.42 to ‐1.01; participants = 596; studies = 9). </p> </section> <section id="CD008712-sec-0179"> <p><b>1.5.6 CPRS ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> reported medium‐term data using the CPRS. No clear difference between CBT and a non active psychosocial therapy was observed (MD ‐4.30, 95% CI ‐9.26 to 0.66; participants = 90; studies = 1) </p> </section> <section id="CD008712-sec-0180"> <p><b>1.5.7 CPRS long term</b></p> <p><a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> also reported long‐term data using the CPRS. No clear difference between CBT and a non active psychosocial therapy was observed (MD ‐4.60, 95% CI ‐11.22 to 2.02; participants = 59; studies = 1). </p> </section> </section> <section id="CD008712-sec-0181"> <h6 class="title">1.6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS sub scale, high = poor) </h6> <p>Twelve trials reported average endpoint scores from positive symptom sub‐scale of the PANSS (<a href="./references#CD008712-fig-0012" title="">Analysis 1.6</a>). </p> <section id="CD008712-sec-0182"> <p><b>1.6.1 Short term</b></p> <p>Ten trials comparing CBT with both active and non active psychosocial therapies reported short‐term data. No clear difference was observed (MD ‐0.57, 95% CI ‐1.19 to 0.05; participants = 883; studies = 10). </p> </section> <section id="CD008712-sec-0183"> <p><b>1.6.2. Medium term</b></p> <p>Six trials comparing CBT with both active and non active psychosocial therapies reported medium‐term data. A positive effect for CBT was observed (MD ‐1.20, 95% CI ‐2.04 to ‐0.36; participants = 497; studies = 6) </p> </section> <section id="CD008712-sec-0184"> <p><b>1.6.3 Long term</b></p> <p>Nine trials comparing CBT with both active and non active psychosocial therapies reported long‐term data. A positive effect for CBT was observed (MD ‐1.22, 95% CI ‐1.96 to ‐0.49; participants = 602; studies = 9). </p> </section> </section> <section id="CD008712-sec-0185"> <h6 class="title">1.7 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score various scales, high = poor) ‐ skewed data </h6> <p><a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> reported data showing an advantage for CBT in the short‐term improvement of positive symptoms. However, these data were skewed, and we did not include in analyses, but presented as 'Other data'. (<a href="./references#CD008712-fig-0013" title="">Analysis 1.7</a>). </p> </section> <section id="CD008712-sec-0186"> <h6 class="title">1.8 Mental state: 3c. Specific ‐ positive symptoms (average endpoint score BPRS, high = poor) ‐ short term </h6> <p><a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> reported short‐term endpoint scores from the positive symptom sub‐scale of the BPRS . No clear difference between the two treatment groups was observed (MD ‐0.10, 95% CI ‐0.45 to 0.25; participants = 68; studies = 1). </p> </section> <section id="CD008712-sec-0187"> <h6 class="title">1.9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PANSS, high = poor) </h6> <p>Five trials (<a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a>; <a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>) reported on hallucinations using the PANSS sub scale . (<a href="./references#CD008712-fig-0015" title="">Analysis 1.9</a>). </p> <section id="CD008712-sec-0188"> <p><b>1.9.1 Short term</b></p> <p>One study (<a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>) reported short‐term data, no difference between CBT and an active psychosocial therapy was observed (MD ‐0.90, 95% CI ‐4.36 to 2.56; participants = 0; studies = 1). </p> </section> <section id="CD008712-sec-0189"> <p><b>1.9 2 Medium term</b></p> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> also reported medium‐term data, again, no difference between CBT and an active psychosocial therapy was observed. (MD ‐0.10, 95% CI ‐3.83 to 3.63; participants = 0; studies = 1). </p> </section> <section id="CD008712-sec-0190"> <p><b>1.9.3 Long term</b></p> <p>Two trials (<a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>) reported long‐term data, and there was no clear difference between CBT and other psychosocial therapies (MD ‐2.10, 95% CI ‐5.53 to 1.33; participants = 0; studies = 2). </p> </section> </section> <section id="CD008712-sec-0191"> <h6 class="title">1.10 Mental sate: 4b. Specific ‐ hallucinations (average endpoint score Psychotic Symptom Rating Scale <i>(</i>PSYRATS), high = poor) ‐ skewed data </h6> <p>Data reported by other trials for this outcome were skewed and are presented as 'Other data', no clear differences were observed at the individual trial level (<a href="./references#CD008712-fig-0016" title="">Analysis 1.10</a>). </p> </section> <section id="CD008712-sec-0192"> <h6 class="title">1.11 Mental state: 5a. Specific ‐ delusions (average endpoint score PSYRATS, high = poor) ‐ long term </h6> <p>Five trials reported endpoint scores from the delusions sub scale of the PSYRATS, but data were useable from one trial only. <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a> show no clear difference between CBT and a non active psychosocial therapies at long term (MD ‐1.04, 95% CI ‐3.27 to 1.19; participants = 0; studies = 1; <a href="./references#CD008712-fig-0017" title="">Analysis 1.11</a>). </p> </section> <section id="CD008712-sec-0193"> <h6 class="title">1.12 Mental sate: 5b. Specific ‐ delusions (average endpoint score PSYRATS, high = poor) ‐ skewed data </h6> <p>Four trials reported skewed data for this outcome. No clear differences between CBT and other psychosocial therapies in the short term (four RCTs), medium term (two RCTs) or long term (three RCTs) were observed at the individual trial level. (<a href="./references#CD008712-fig-0018" title="">Analysis 1.12</a>). </p> </section> <section id="CD008712-sec-0194"> <h6 class="title">1.13 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS, high = poor) </h6> <p>Eleven trials reported endpoint scores using the Negative Symptom sub scale of the PANSS. (<a href="./references#CD008712-fig-0019" title="">Analysis 1.13</a>). </p> <section id="CD008712-sec-0195"> <p><b>1.13.1 Short term</b></p> <p>No clear difference between CBT and other psychosocial therapies was observed in the short term (MD ‐0.07, 95% CI ‐0.76 to 0.61; participants = 581; studies = 7) </p> </section> <section id="CD008712-sec-0196"> <p><b>1.13.2 Medium term</b></p> <p>No clear difference between CBT and other psychosocial therapies was observed in the medium term (MD ‐0.52, 95% CI ‐1.42 to 0.39; participants = 359; studies = 4) </p> </section> <section id="CD008712-sec-0197"> <p><b>1.13.3 Long term</b></p> <p>No clear difference between CBT and other psychosocial therapies was observed in the long term (MD ‐0.84, 95% CI ‐1.67 to 0.00; participants = 548; studies = 8). </p> </section> </section> <section id="CD008712-sec-0198"> <h6 class="title">1.14 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score PANSS, high = poor) ‐ skewed data </h6> <p><a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> also measured negative symptoms by using PANSS sub scale, and found a positive effect for CBT; however, we did not include this very small trial in the meta‐analysis due to skewed data. </p> </section> <section id="CD008712-sec-0199"> <h6 class="title">1.15 Mental state: 6c. Specific ‐ negative symptoms ‐ average endpoint score (Scale for the Assessment of Negative Symptoms (SANS), high = poor) </h6> <p>Four trials (<a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>) reported endpoint scores on the SANS. Two studies reported useable data. (<a href="./references#CD008712-fig-0021" title="">Analysis 1.15</a>) </p> <section id="CD008712-sec-0200"> <p><b>1.15.1 Short term</b></p> <p>No clear difference between CBT and an active psychosocial therapy was observed for this outcome in the short term (MD ‐0.36, 95% CI ‐3.25 to 2.53; participants = 45; studies = 1). </p> </section> <section id="CD008712-sec-0201"> <p><b>1.15.2 Medium term</b></p> <p>No clear difference between CBT and an active psychosocial therapy was observed for this outcome in the medium term (MD ‐6.60, 95% CI ‐19.01 to 5.81; participants = 37; studies = 1). </p> </section> <section id="CD008712-sec-0202"> <p><b>1.15.3 Long term</b></p> <p>No clear difference between CBT and an active psychosocial therapy was observed for this outcome in the long term (MD 0.49, 95% CI ‐2.19 to 3.17; participants = 44; studies = 1). </p> </section> </section> <section id="CD008712-sec-0203"> <h6 class="title">1.16 Mental state: 6d. Specific ‐ negative symptoms (average endpoint score SANS, high = poor) ‐ skewed data </h6> <p>Skewed data on negative symptoms were reported by two studies (<a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>) and are presented as 'Other data' (<a href="./references#CD008712-fig-0022" title="">Analysis 1.16</a>). </p> </section> <section id="CD008712-sec-0204"> <h6 class="title">1.17 Mental state: 6e. Specific ‐ negative symptoms (average endpoint score BPRS sub scale, high = poor) ‐ short term </h6> <p><a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> reported short‐term data for this outcome; no difference between treatment groups was observed (MD 0.10, 95% CI ‐0.31 to 0.51; participants = 68; studies = 1; <a href="./references#CD008712-fig-0023" title="">Analysis 1.17</a>). </p> </section> <section id="CD008712-sec-0205"> <h6 class="title">1.18 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS sub scale, high = poor) </h6> <p>Eight trials reported endpoint scores from the general psychopathology sub scale of the PANSS. (<a href="./references#CD008712-fig-0024" title="">Analysis 1.18</a> </p> <section id="CD008712-sec-0206"> <p><b>1.18.1 Short term</b></p> <p>Six trials compared CBT with active and non active psychosocial therapies. A positive effect for CBT was observed at short term (MD ‐3.38, 95% CI ‐4.62 to ‐2.13; participants = 400; studies = 6). This short‐term effect had an important level of heterogeneity (Chi² = 88.55; df = 5; P &lt;0.00001; I<sup>2</sup> = 94%). This heterogeneity appears to be induced by a very small study (<a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>). After removing this trial from the meta‐analysis, the result changed to no clear difference between treatment groups. </p> </section> <section id="CD008712-sec-0207"> <p><b>1.18.2 Medium term</b></p> <p>Three trials compared CBT with active and non active psychosocial therapies. No clear difference was observed at medium term (MD ‐0.94, 95% CI ‐2.75 to 0.88; participants = 194; studies = 3). </p> </section> <section id="CD008712-sec-0208"> <p><b>1.18.3 Long term</b></p> <p>Seven trials compared CBT with active and non active psychosocial therapies. No clear difference was observed at long term (MD ‐0.94, 95% CI ‐2.28 to 0.40; participants = 379; studies = 7). </p> </section> </section> <section id="CD008712-sec-0209"> <h6 class="title">1.19 Mental state: 7b. Specific ‐ affective symptoms (average endpoint score Symptom Checklist (SCL)90, total, high = poor) ‐ long term </h6> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> reported long‐term endpoint scores from SCL90. A positive effect, favouring the control groups (active psychosocial therapies of family intervention and occupational therapy) was observed (MD 8.26, 95% CI 1.77 to 14.74; participants = 134; studies = 1). (<a href="./references#CD008712-fig-0025" title="">Analysis 1.19</a>). </p> </section> <section id="CD008712-sec-0210"> <h6 class="title">1.20 Mental state: 8a. Specific ‐ depression (average endpoint score BDI, high = poor) ‐ skewed data </h6> <p>Three trials reported outcomes using the Beck Depression Scale (BDI). CBT was compared with enhanced supportive therapy (<a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>), and group goal‐focused supportive contact (<a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>). However, as data were skewed we did not pool them in the meta‐analysis but presented as 'Other data'. No clear difference between CBTand other therapies was observed in the individual studies. (<a href="./references#CD008712-fig-0026" title="">Analysis 1.20</a>). </p> </section> <section id="CD008712-sec-0211"> <h6 class="title">1.21. Mental state: 8b. Specific ‐ depression (average endpoint score Montgomery‐Asberg Depression Rating Scale (MADRS), high = poor) </h6> <p><a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> measured depressive symptomatology using the MADRS and compared CBT with a non active control therapy. We could not use these data in analyses as they were skewed and we presented as 'Other data'. (<a href="./references#CD008712-fig-0027" title="">Analysis 1.21</a>). </p> </section> <section id="CD008712-sec-0212"> <h6 class="title">1.22 Mental state: 8c. Specific ‐ depression (average endpoint score Hamilton Rating Scale for Depression (HAMD), high = poor) ‐ short term </h6> <p>One trial, compared CBT with an active control, and reported endpoint scores from the HAMD an effect favouring CBT that was observed in the short term (1 RCT, N = 95, MD ‐3.92, CI ‐4.96 to ‐2.88; <a href="./references#CD008712-fig-0028" title="">Analysis 1.22</a>). </p> </section> <section id="CD008712-sec-0213"> <h6 class="title">1.23 Mental state: 9a. Specific ‐ self‐esteem (average endpoint score Rosenberg Self‐Esteem Scale <i>(</i>RSES), high = poor) </h6> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> presented data for self‐esteem using the RSES. (<a href="./references#CD008712-fig-0029" title="">Analysis 1.23</a>). </p> <section id="CD008712-sec-0214"> <p><b>1.23.1 Short term</b></p> <p>No clear difference between CBT and an active psychosocial therapy was observed at short term (MD 1.60, 95% CI ‐0.93 to 4.13; participants = 65; studies = 1). </p> </section> <section id="CD008712-sec-0215"> <p><b>1.23.2 Medium term</b></p> <p>No clear difference between CBT and an active psychosocial therapy was observed at medium term (MD 0.80, 95% CI ‐2.17 to 3.77; participants = 65; studies = 1). </p> </section> <section id="CD008712-sec-0216"> <p><b>1.23.3 Long term</b></p> <p>No clear difference between CBT and an active psychosocial therapy was observed at long term (MD 1.70, 95% CI ‐1.79 to 5.19; participants = 65; studies = 1). </p> </section> </section> <section id="CD008712-sec-0217"> <h6 class="title">1.24. Mental state: 9b. Specific ‐ self‐esteem (average endpoint score RSES, high = poor) ‐ skewed data </h6> <p><a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> also presented self‐esteem data from RSES, but these were skewed and are presented as 'Other data' (<a href="./references#CD008712-fig-0030" title="">Analysis 1.24</a>). </p> </section> <section id="CD008712-sec-0218"> <h6 class="title">1.25. Mental health: 10. Specific ‐ self‐stigma (average endpoint score Stigma Scale for Mental Illness (SSMI), high = poor) ‐ short term </h6> <p>One study reported endpoint scores from the SSMI. An effect favouring CBT was observed in the short term (MD ‐8.64, CI ‐11.86 to ‐5.42; participants = 95; studies = 1; <a href="./references#CD008712-fig-0031" title="">Analysis 1.25</a>). </p> </section> <section id="CD008712-sec-0219"> <h6 class="title">1.26. Mental state: 11a. Specific ‐ anxiety (average endpoint score Beck Anxiety Inventory (BAI), high = poor) ‐ skewed data </h6> <p>Two studies reported skewed data from the BAI for this outcome, and are presented as 'Other data' (<a href="./references#CD008712-fig-0032" title="">Analysis 1.26</a>). </p> </section> <section id="CD008712-sec-0220"> <h6 class="title">1.27 Mental state: 11b. Specific ‐ anxiety (average endpoint score Hamilton Anxiety Scale (HAMA), high = poor) ‐ short term </h6> <p>One trial compared CBT with an active psychosocial therapy and measured anxiety using the HAMA. A positive effect was observed for CBT at short tem (MD ‐5.78, 95% CI ‐8.79 to ‐2.77; participants = 65; studies = 1; <a href="./references#CD008712-fig-0033" title="">Analysis 1.27</a>) </p> </section> <section id="CD008712-sec-0221"> <h6 class="title">1.28 Mental state: 11c. Specific ‐ anxiety (average endpoint score Self Rating Anxiety Scale (SRAS), high = poor) ‐ long term </h6> <p><a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a> measured anxiety using the SRAS, a positive effect for CBT was observed at long term (MD ‐2.89, 95% CI ‐4.53 to ‐1.25; participants = 95; studies = 1; <a href="./references#CD008712-fig-0034" title="">Analysis 1.28</a>). </p> </section> <section id="CD008712-sec-0222"> <h6 class="title">1.29 Mental state: 12a. Specific ‐ clinically important change ‐ Obsessive Compulsive Disorder </h6> <p><a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a> observed a positive effect for CBT at short term (RR 0.29, 95% CI 0.12 to 0.68; participants = 65; studies = 1). (<a href="./references#CD008712-fig-0035" title="">Analysis 1.29</a>). </p> </section> <section id="CD008712-sec-0223"> <h6 class="title">1.30 Mental state: 12a. Specific ‐ Obessive Compulsive Disorder (average endpoint score Yale‐Brown Obsessive Compulsive Scale <i>(</i>Y‐BOCS), high = poor) ‐ short term </h6> <p><a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a> also presented average endpoint scores for Obsessive Compulsive Disorder using the Y‐BOCS. A positive effect for CBT was observed (MD ‐13.55, 95% CI ‐15.43 to ‐11.67; participants = 65; studies = 1; <a href="./references#CD008712-fig-0036" title="">Analysis 1.30</a> ). </p> </section> <section id="CD008712-sec-0224"> <h6 class="title">1.31 Mental state: 13. Specific ‐ anger/aggression (Novaco Anger Scale (NAS), high = poor) </h6> <p><a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a> presented endpoint scores for anger/aggression using the NAS. (<a href="./references#CD008712-fig-0037" title="">Analysis 1.31</a>). </p> <section id="CD008712-sec-0225"> <p><b>1.31.1 Short term</b></p> <p>No clear differences between CBT and an active psychosocial therapy was observed at short term (MD 2.10, 95% CI ‐5.70 to 9.90; participants = 77; studies = 1). </p> </section> <section id="CD008712-sec-0226"> <p><b>1.31.2 Long term</b></p> <p>No clear differences between CBT and an active psychosocial therapy was observed at long term (MD ‐1.05, 95% CI ‐9.56 to 7.46; participants = 77; studies = 1). </p> </section> </section> <section id="CD008712-sec-0227"> <h6 class="title">1.32 Mental state: 14. Specific ‐ problem behaviours (endpoint scores various scales, high = poor) ‐ skewed data </h6> <p>Skewed data for this outcome were reported from the NPI, the Ward Anger Rating Scale (WARS), and the Historical Clinical Risk Management–20 scale They are presented as 'Other data'. (<a href="./references#CD008712-fig-0038" title="">Analysis 1.32</a>). </p> </section> <section id="CD008712-sec-0228"> <h6 class="title">1.33 Mental state: 15. Specific ‐ thought disturbances (average endpoint score PANSS sub scale, high = poor) ‐ skewed data </h6> <p>Skewed data for this outcome are presented as 'Other data' (<a href="./references#CD008712-fig-0039" title="">Analysis 1.33</a>). </p> </section> </section> <section id="CD008712-sec-0229"> <h5 class="title">Adverse Effects</h5> <p>Adverse effect reporting was limited with trials providing useable data for only two outcomes. </p> <section id="CD008712-sec-0230"> <h6 class="title">1.34 Adverse effect/event (s): 1. Number of events</h6> <p><a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a> and <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a> reported incidence of adverse events. <a href="./references#CD008712-fig-0040" title="">Analysis 1.34</a> </p> <section id="CD008712-sec-0231"> <p><b>1.34.1 Short term</b></p> <p>Participants in the CBT group experienced fewer adverse events in the short term (RR 1.36, 95% CI 1.04 to 1.79; participants = 120; studies = 1). </p> </section> <section id="CD008712-sec-0232"> <p><b>1.34.2 Long term</b></p> <p>There was no clear difference between CBT and active psychosocial therapies in the long term (RR 0.95, 95% CI 0.87 to 1.03; participants = 198; studies = 1). </p> <p>As short ‐and long‐term outcomes were derived from separate studies it was not possible to separate the effect of trial methodology from true longitudinal differences. </p> </section> </section> <section id="CD008712-sec-0233"> <h6 class="title">1.35 Adverse effect/event (s): 2. Death ‐ any cause</h6> <p>Six studies reported 14 deaths, with <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a> and <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> specifically reporting suicides. Others reported natural or accidental deaths (<a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a>; <a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>; <a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a>). There were nine deaths in the CBT intervention groups and five deaths in other psychosocial therapies groups, with no clear difference observed between the two treatments (RR 1.57, 95% CI 0.62 to 3.98; participants = 627; studies = 6, low‐quality evidence) (<a href="./references#CD008712-fig-0041" title="">Analysis 1.35</a>). </p> </section> </section> <section id="CD008712-sec-0234"> <h5 class="title">Functioning</h5> <p>Studies reported data for social functioning, cognitive functioning and life skills.</p> <section id="CD008712-sec-0235"> <h6 class="title">1.36 Functioning: 1a. Social functioning (average endpoint scores various scales, high = good) </h6> <p>Two studies reported average endpoint scores from the Social Functioning Scale (SFS) and Social and Occupational Functioning Assessment Scale (SOFAS). (<a href="./references#CD008712-fig-0042" title="">Analysis 1.36</a>). </p> <section id="CD008712-sec-0236"> <p><b>1.36 1. SFS ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> reported data from the SFS and observed no clear difference between CBT and an active psychosocial therapy in the short term (MD 5.40, 95% CI ‐5.18 to 15.98; participants = 65; studies = 1). </p> </section> <section id="CD008712-sec-0237"> <p><b>1.36 2. SFS ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> reported data from the SFS and observed no clear difference between CBTand an active psychosocial therapy in the medium term for this outcome (MD 7.20, 95% CI ‐3.46 to 17.86; participants = 65; studies = 1). </p> </section> <section id="CD008712-sec-0238"> <p><b>1.36 .3 SFS ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> reported data from the SFS and observed no clear difference between CBT and an active psychosocial therapy in the long term for this outcome (MD 8.80, 95% CI ‐4.07 to 21.67; participants = 65; studies = 1; very low‐quality evidence). </p> </section> <section id="CD008712-sec-0239"> <p><b>1.36.4 Personal and Social Performance Scale (PSP) ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> reported average endpoint scores from SOFAS. There was no observable difference between CBT and an active psychosocial therapy in the short term (MD 3.28, 95% CI ‐0.50 to 7.06; participants = 165; studies = 1). </p> </section> <section id="CD008712-sec-0240"> <p><b>1.36.5 PSPS ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> reported average endpoint scores from SOFAS. A positive effect for CBT was observed in the medium term (MD 6.72, 95% CI 2.18 to 11.26; participants = 162; studies = 1). </p> </section> <section id="CD008712-sec-0241"> <p><b>1.36.6 ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> reported average endpoint scores from SOFAS. A positive effect for CBT was observed in the long term (MD 9.35, 95% CI 4.66 to 14.04; participants = 168; studies = 1). </p> </section> </section> <section id="CD008712-sec-0242"> <h6 class="title">1.37 Functioning: 1b. Social functioning (average endpoint score Social and Occupational Functioning Assessment Scale (SOFAS), high = poor) </h6> <p>Three studies reported social functioning data using SOFAS (<a href="./references#CD008712-fig-0043" title="">Analysis 1.37</a>. </p> <section id="CD008712-sec-0243"> <p><b>1.37.1 short term</b></p> <p><a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> observed no clear difference between CBT and a non active psychosocial therapy at short term (MD 5.09, 95% CI ‐1.21 to 11.39; participants = 62; studies = 1) . </p> </section> <section id="CD008712-sec-0244"> <p><b>1.37.2 long term</b></p> <p><a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> and <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> also found no observable difference between CBT and other psychosocial therapies for this outcome (MD 1.32, 95% CI ‐4.90 to 7.54; participants = 103; studies = 2). </p> </section> </section> <section id="CD008712-sec-0245"> <h6 class="title">1.38 Functioning: 2a. Cognitive ‐ insight (average endpoint scores various scales, high = good) </h6> <p>Two trials (<a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a>; <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>) reported data from the Schedule for Assessing Insight (SAI) and <a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> reported data using the Insight Scale (IS) (<a href="./references#CD008712-fig-0044" title="">Analysis 1.38</a>) </p> <section id="CD008712-sec-0246"> <p><b>1.38.1 SAI ‐ short term</b></p> <p>No difference between CBT and an active psychosocial therapy was observed in the short term (MD 0.91, 95% CI ‐0.27 to 2.09; participants = 165; studies = 1). </p> </section> <section id="CD008712-sec-0247"> <p><b>1.38.2 SAI ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> observed a positive effect for CBT in the medium term (MD 1.27, 95% CI 0.09 to 2.45; participants = 162; studies = 1). </p> </section> <section id="CD008712-sec-0248"> <p><b>1.38.3 SAI ‐ long term</b></p> <p>No difference between CBT and other psychosocial therapies was observed in the long term (MD 1.00, 95% CI ‐0.01 to 2.00; participants = 218; studies = 2). </p> </section> <section id="CD008712-sec-0249"> <p><b>1.38.4 IS ‐ short term</b></p> <p>No difference between CBT and an active psychosocial therapy was observed on the IS scale (MD ‐0.60, 95% CI ‐2.17 to 0.97; participants = 68; studies = 1). </p> </section> </section> <section id="CD008712-sec-0250"> <h6 class="title">1.39 Functioning: 2b. Cognitive ‐ insight (average endpoint scores Beck Cognitive Insight Scale (BCIS), average endpoint score SAI, high = good) ‐ skewed data </h6> <p>One trial (<a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>) reported skewed data from the BCIS and another trial (<a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>) reported skewed data from the SAI These data are presented as 'Other data' (<a href="./references#CD008712-fig-0045" title="">Analysis 1.39</a>). </p> </section> <section id="CD008712-sec-0251"> <h6 class="title">1.40 Functioning 3. Life skills ‐ skills acquisition (average endpoint score Comprehensive Module Test (CMT), high = good) ‐ skewed data </h6> <p>Two trials (<a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a>; <a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a>) reported data on skills acquisition using CMT These data are skewed and are presented as 'Other data' (<a href="./references#CD008712-fig-0046" title="">Analysis 1.40</a>). </p> </section> </section> <section id="CD008712-sec-0252"> <h5 class="title">Quality of life</h5> <p>Three trials measured quality of life (general) using the Life Satisfaction Index <i>(</i>LSI), European Quality of Life Questionnaire (EuroQoL) and the Quality of Life Scale (QoL) scales. (<a href="./references#CD008712-fig-0047" title="">Analysis 1.41</a>). </p> <section id="CD008712-sec-0253"> <h6 class="title">1.41 Quality of life: 1a. General (average endpoint scores, various scales, high = good) </h6> <section id="CD008712-sec-0254"> <p><b>1.41.1 LSI ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> did not observe any difference between CBT and an other active psychosocial therapy for this outcome in the short term (MD 0.30, 95% CI ‐1.75 to 2.35; participants = 60; studies = 1). </p> </section> <section id="CD008712-sec-0255"> <p><b>1.41.2 LSI ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> did not observe any difference between CBT and an other active psychosocial therapy for this outcome in the medium term (MD 0.60, 95% CI ‐1.59 to 2.79; participants = 58; studies = 1). </p> </section> <section id="CD008712-sec-0256"> <p><b>1.41.3 LSI ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> did not observe any difference between CBT and an other active psychosocial therapy for this outcome in the long term (MD 1.70, 95% CI ‐0.50 to 3.90; participants = 51; studies = 1). </p> </section> <section id="CD008712-sec-0257"> <p><b>1.41.4 EuroQoL ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> reported on changes in general quality of life using average endpoint scores from the EuroQOL. There was no clear differences in EuroQOL scores between CBT and an other active psychosocial therapy in the long term (MD ‐1.86, 95% CI ‐19.20 to 15.48; participants = 37; studies = 1). </p> </section> <section id="CD008712-sec-0258"> <p><b>1.41.5 The QoL scale ‐ long term</b></p> <p><a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> reported on changes in general quality of life using average endpoint scores using the QoL scale. There was no clear difference between CBT and a non active psychosocial therapy for this outcome (MD ‐3.40, 95% CI ‐16.25 to 9.45; participants = 50; studies = 1). </p> </section> <section id="CD008712-sec-0259"> <p><b>1.41.6 <i>Modular System for Quality of Life (</i>MSQoL) ‐ short term</b></p> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> reported changes in general quality of life using average endpoint scores from the MSQoL scale, no differences were observed at short term (MD ‐1.80, 95% CI ‐13.77 to 10.17; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0260"> <p><b>1.41.7 MSQoL ‐ medium term</b></p> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> reported changes in general quality of life using average endpoint scores from the MSQoL scale, no differences were observed at medium term (MD ‐4.50, 95% CI ‐15.66 to 6.66; participants = 64; studies = 1; very low quality) </p> </section> </section> <section id="CD008712-sec-0261"> <h6 class="title">1.42 Quality of life: 2a. Specific (average endpoint score MSQoL, high = good) ‐ short term </h6> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> reported short‐term data for specific aspects of quality of life, using the MSQoL. (<a href="./references#CD008712-fig-0048" title="">Analysis 1.42</a>). </p> <section id="CD008712-sec-0262"> <p><b>1.42.1 physical health</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy for this outcome (MD 2.20, 95% CI ‐7.81 to 12.21; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0263"> <p><b>1.42.2. vitality</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy for this outcome (MD 0.30, 95% CI ‐9.80 to 10.40; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0264"> <p><b>1.42.3 psychosocial</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy for this outcome (MD 0.60, 95% CI ‐10.25 to 11.45; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0265"> <p><b>1.42.4 material</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy for this outcome (MD 3.70, 95% CI ‐6.79 to 14.19; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0266"> <p><b>1.42.5 spare time</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy for this outcome (MD 0.70, 95% CI ‐12.73 to 14.13; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0267"> <p><b>1.42.6 affective</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy for this outcome (MD ‐5.90, 95% CI ‐15.81 to 4.01; participants = 63; studies = 1). </p> </section> </section> <section id="CD008712-sec-0268"> <h6 class="title">1.43 Quality of life: 2a. Specific (average endpoint score MSQoL, high = good) ‐ short term </h6> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> reported medium‐term data for specific aspects of quality of life, again using the MSQoL. (<a href="./references#CD008712-fig-0049" title="">Analysis 1.43</a>). </p> <section id="CD008712-sec-0269"> <p><b>1.43.1 physical health</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy (MD ‐5.00, 95% CI ‐15.93 to 5.93; participants = 64; studies = 1). </p> </section> <section id="CD008712-sec-0270"> <p><b>1.43.2. vitality</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy (MD ‐7.20, 95% CI ‐17.22 to 2.82; participants = 64; studies = 1). </p> </section> <section id="CD008712-sec-0271"> <p><b>1.43.3 psychosocial</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy (MD ‐7.10, 95% CI ‐16.42 to 2.22; participants = 64; studies = 1). </p> </section> <section id="CD008712-sec-0272"> <p><b>1.43.4 material</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy (MD ‐3.40, 95% CI ‐17.05 to 10.25; participants = 64; studies = 1). </p> </section> <section id="CD008712-sec-0273"> <p><b>1.43.5 spare time</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy (MD 5.70, 95% CI ‐4.71 to 16.11; participants = 64; studies = 1). </p> </section> <section id="CD008712-sec-0274"> <p><b>1.43.6 affective</b></p> <p>No clear difference was observed between CBT and an active psychosocial therapy (MD ‐6.20, 95% CI ‐15.76 to 3.36; participants = 64; studies = 1). </p> </section> </section> <section id="CD008712-sec-0275"> <h6 class="title">1.44 Satisfaction with treatment: 1. Leaving the study early</h6> <p>Twenty‐six trials reported data on participants leaving the trial early and a clear difference, favouring CBT was observed (RR 0.86, 95% CI 0.75 to 0.99; participants = 2392; studies = 26; low‐quality evidence; <a href="./references#CD008712-fig-0050" title="">Analysis 1.44</a> and <a href="#CD008712-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD008712-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 CBT versus ALL OTHER PSYCHOLOGICAL THERAPIES, outcome: 1.50 Satisfaction with treatment: 2. Leaving the study early." data-id="CD008712-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CBT versus ALL OTHER PSYCHOLOGICAL THERAPIES, outcome: 1.50 Satisfaction with treatment: 2. Leaving the study early. </p> </div> </div> </div> </section> <section id="CD008712-sec-0276"> <h6 class="title">1.45 Engagement with services: 1. Compliance (favourable) with medication ‐ long term</h6> <p>Three trials observed no clear effect for CBT compared to other psychosocial therapies (active and inactive) for this outcome (RR 1.01, 95% CI 0.93 to 1.11; participants = 354; studies = 3; <a href="./references#CD008712-fig-0051" title="">Analysis 1.45</a>). </p> </section> <section id="CD008712-sec-0277"> <h6 class="title">1.46 Engagement with services: 2. Attitude to medication (average endpoint score various scales, high = good) </h6> <p>Attitude to medication was measured by two trials; <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> used the Attitue to Medication Questionnaire and <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> used the DAI. (<a href="./references#CD008712-fig-0052" title="">Analysis 1.46</a>). </p> <section id="CD008712-sec-0278"> <p><b>1.46.1 Attitude to Medication Questionnaire ‐ short term</b></p> <p>One trial compared CBT with a non active psychosocial therapy and a positive effect was observed for CBT (MD 4.50, 95% CI 2.17 to 6.83; participants = 74; studies = 1). </p> </section> <section id="CD008712-sec-0279"> <p><b>1.46.2 DAI ‐ short term</b></p> <p>One trial compared CBT with a non active psychosocial therapy and a positive effect was observed for CBT (MD 5.70, 95% CI 2.05 to 9.35; participants = 63; studies = 1). </p> </section> <section id="CD008712-sec-0280"> <p><b>1.46.3 DAI ‐ long term</b></p> <p>One trial compared CBT with a non active psychosocial therapy and no effect was observed (MD ‐2.10, 95% CI ‐6.11 to 1.91; participants = 50; studies = 1). </p> </section> </section> </section> </section> <section id="CD008712-sec-0281"> <h4 class="title">2. SUBGROUP 2: Cognitive behavioural therapy (CBT) versus ACTIVE PSYCHOSOCIAL THERAPIES</h4> <p>We performed subgroup analyses for outcomes where both inactive and non active therapies were used as control interventions. We then tested these outcomes for subgroup differences. </p> <section id="CD008712-sec-0282"> <h5 class="title">2.1 Global state: 1. Relapse</h5> <p>There was no clear difference between CBT and active psychosocial therapies at both medium (RR 0.97, 95% CI 0.54 to 1.78; participants = 88; studies = 1) and long term (RR 1.02, 95% CI 0.58 to 1.78; participants = 120; studies = 3) follow‐up. </p> </section> <section id="CD008712-sec-0283"> <h5 class="title">2.2 Global state: 2. Rehospitalistaion</h5> <p>There was no clear difference between CBT and active psychosocial therapies at long‐term follow‐up (RR 0.87, 95% CI 0.71 to 1.06; participants = 527; studies = 4). </p> </section> <section id="CD008712-sec-0284"> <h5 class="title">2.3 Mental state: 1. General ‐ clinically important change (no improvement)</h5> <p>No difference between CBT and active psychosocial therapies was observed at medium (RR 1.02, 95% CI 0.91 to 1.14; participants = 133; studies = 2) or long term (RR 0.96, 95% CI 0.77 to 1.21; participants = 158; studies = 3). </p> </section> <section id="CD008712-sec-0285"> <h5 class="title">2.4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) </h5> <p>There was no clear difference between CBT and active psychosocial therapies at short term (MD ‐0.25, 95% CI ‐1.09 to 0.60; participants = 499; studies = 6), but a positive effect was observed for CBT at medium term (MD ‐1.29, 95% CI ‐2.21 to ‐0.36; participants = 439; studies = 5), and long term (MD ‐2.10, 95% CI ‐3.15 to ‐1.05; participants = 371; studies = 5) follow‐up. </p> </section> <section id="CD008712-sec-0286"> <h5 class="title">2.5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score Positive Symptoms Rating Scale (PSRS), high = poor) </h5> <p>There was no clear difference between CBT and active psychosocial therapy at long term (MD 0.00, 95% CI ‐4.76 to 4.76; participants = 0; studies = 1). </p> </section> <section id="CD008712-sec-0287"> <h5 class="title">2.6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>There was no clear difference between CBT and active psychosocial therapy at short (MD ‐0.08, 95% CI ‐1.04 to 0.89; participants = 346; studies = 4) or medium term (MD ‐0.80, 95% CI ‐1.92 to 0.31; participants = 301; studies = 3), but a clear effect favouring CBT at long term .(MD ‐1.34, 95% CI ‐2.57 to ‐0.11; participants = 317; studies = 4). </p> </section> <section id="CD008712-sec-0288"> <h5 class="title">2.7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>At short term there was a clear difference, favouring CBT, between CBT and active psychosocial therapies (MD ‐4.90, 95% CI ‐6.69 to ‐3.11; participants = 165; studies = 3; I<sup>2</sup> = 97%); there was high heterogeneity for this outcome, when the outlier <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> was removed, homogeneity was restored and the result changed to show no effect; medium term (MD ‐1.68, 95% CI ‐4.04 to 0.69; participants = 136; studies = 2); and at long term (MD ‐1.61, 95% CI ‐3.65 to 0.44; participants = 148; studies = 3) results also showed no difference between these treatment groups. </p> </section> <section id="CD008712-sec-0289"> <h5 class="title">2.8 Adverse effect/event(s) ‐ death</h5> <p>There was no clear difference between CBT and active psychosocial therapies for the outcome of death (RR 0.94, 95% CI 0.19 to 4.56; participants = 302; studies = 3). </p> </section> <section id="CD008712-sec-0290"> <h5 class="title">2.9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good)</h5> <p>There was no clear difference between CBT and active psychosocial therapy at long term (MD 1.36, 95% CI ‐9.59 to 12.31; participants = 41; studies = 1). </p> </section> <section id="CD008712-sec-0291"> <h5 class="title">2.10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good) </h5> <p>There was a favourable effect for CBT compared to active psychosocial therapy for this outcome at long term ((MD 1.55, 95% CI 0.38 to 2.72; participants = 168; studies = 1). </p> </section> <section id="CD008712-sec-0292"> <h5 class="title">2.11 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason</h5> <p>There was no clear difference between numbers of participants leaving the study early from the CBT groups compared to numbers leaving early from the active psychosocial therapy groups ((RR 0.85, 95% CI 0.72 to 1.01; participants = 1779; studies = 19). </p> </section> <section id="CD008712-sec-0293"> <h5 class="title">2.12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term </h5> <p>There was no clear difference between CBT and active psychosocial therapy at long term (RR 1.11, 95% CI 0.99 to 1.24; participants = 198; studies = 1). </p> </section> </section> <section id="CD008712-sec-0294"> <h4 class="title">3. SUBGROUP 3: Cognitive behavioural therapy (CBT) versus NON ACTIVE PSYCHOSOCIAL THERAPIES </h4> <section id="CD008712-sec-0295"> <h5 class="title">3.1 Global state: 1. Relapse</h5> <p>There was no clear difference between CBT and non active psychosocial therapies for relapse at medium (RR 1.44, 95% CI 0.14 to 15.10; participants = 62; studies = 1) or long term (RR 1.05, 95% CI 0.85 to 1.31; participants = 255; studies = 2) follow‐up. </p> </section> <section id="CD008712-sec-0296"> <h5 class="title">3.2 Global state: 2. Rehospitalistaion</h5> <p>There was no clear difference between CBT and non active psychosocial therapies at long‐term follow‐up (RR 1.14, 95% CI 0.86 to 1.52; participants = 416; studies = 4). </p> </section> <section id="CD008712-sec-0297"> <h5 class="title">3.3 Mental state: 1. General ‐ clinically important change (no improvement)</h5> <p>There was a clear effect, favouring CBT compared to non active psychosocial therapies at medium (RR 0.53, 95% CI 0.33 to 0.86; participants = 62; studies = 1) and long term (RR 0.60, 95% CI 0.39 to 0.94; participants = 90; studies = 1). </p> </section> <section id="CD008712-sec-0298"> <h5 class="title">3.4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) </h5> <p>There was a clear difference between CBT and non active psychosocial therapies at short term (MD ‐0.93, 95% CI ‐1.84 to ‐0.03; participants = 384; studies = 4), but no effect was observed for CBT at medium term (MD ‐0.80, 95% CI ‐2.82 to 1.22; participants = 58; studies = 1) or long term (MD ‐0.36, 95% CI ‐1.40 to 0.68; participants = 231; studies = 4) follow‐up. </p> </section> <section id="CD008712-sec-0299"> <h5 class="title">3.5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor) </h5> <p>There was no clear difference between CBT and non active psychosocial therapy at long term (MD ‐4.36, 95% CI ‐9.30 to 0.58; participants = 0; studies = 1). </p> </section> <section id="CD008712-sec-0300"> <h5 class="title">3.6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>There was no clear difference between CBT and non active psychosocial therapy at short term (MD ‐0.07, 95% CI ‐1.06 to 0.91; participants = 235; studies = 3), medium term (MD 0.04, 95% CI ‐1.52 to 1.60; participants = 58; studies = 1) and long term (MD ‐0.40, 95% CI ‐1.54 to 0.74; participants = 231; studies = 4). </p> </section> <section id="CD008712-sec-0301"> <h5 class="title">3.7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>At short term there was a clear difference, favouring CBT, between CBT and non active psychosocial therapies (MD ‐1.95, 95% CI ‐3.68 to ‐0.22; participants = 235; studies = 3). There was no effect observed at medium term (MD 0.12, 95% CI ‐2.71 to 2.95; participants = 58; studies = 1), and long term (MD ‐0.44, 95% CI ‐2.21 to 1.34; participants = 231; studies = 4) follow‐up. </p> </section> <section id="CD008712-sec-0302"> <h5 class="title">3.8 Adverse effect/event(s) ‐ death</h5> <p>There was no clear difference between CBT and non active psychosocial therapies for the outcome of death (RR 2.06, 95% CI 0.63 to 6.75; participants = 325; studies = 3). </p> </section> <section id="CD008712-sec-0303"> <h5 class="title">3.9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good)</h5> <p>There was no clear difference between CBT and non active psychosocial therapy at long term (MD 1.30, 95% CI ‐6.26 to 8.86; participants = 62; studies = 1). </p> </section> <section id="CD008712-sec-0304"> <h5 class="title">3.10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good) </h5> <p>There no effect observed between CBT and non active psychosocial therapy for this outcome at long term (MD ‐0.50, 95% CI ‐2.43 to 1.43; participants = 50; studies = 1). </p> </section> <section id="CD008712-sec-0305"> <h5 class="title">3.11 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason</h5> <p>There was no clear difference between numbers of participants leaving the study early from the CBT groups compared to numbers leaving early from the non active psychosocial therapy groups (RR 0.88, 95% CI 0.68 to 1.15; participants = 613; studies = 7) </p> </section> <section id="CD008712-sec-0306"> <h5 class="title">3.12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term </h5> <p>There was no clear difference between CBT and non active psychosocial therapy at long term (RR 0.89, 95% CI 0.78 to 1.03; participants = 156; studies = 2). </p> </section> </section> <section id="CD008712-sec-0307"> <h4 class="title">4. SUBGROUP DIFFERENCE TESTS</h4> <p>We tested for subgroup differences between active and non active psychosocial therapies. Overall, there was no evidence that CBT had different effects when compared with active or non active therapies.The only outcomes where there was some evidence are presented below. </p> <section id="CD008712-sec-0308"> <h5 class="title">4.4 ‐ 4.5 Mental state: General ‐ clinically important change</h5> <p>At medium term there was no evidence of a difference between CBT and an active therapy, but there was a favourable effect for CBT when compared with non active therapies (<a href="./references#CD008712-fig-0080" title="">Analysis 4.4</a>); this difference in effect was significant: Test for subgroup differences: Chi² = 6.60, df = 1 (P = 0.01), I² = 84.8% This effect remained at long term (<a href="./references#CD008712-fig-0081" title="">Analysis 4.5</a>): Test for subgroup differences: Chi² = 3.39, df = 1 (P = 0.07), I² = 70.5%. </p> </section> <section id="CD008712-sec-0309"> <h5 class="title">4.8 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>Long‐term results from the PANSS sub scale for positive symptoms showed a favourable effect CBT when compared with active therapies but no difference when compared with non active therapies (<a href="./references#CD008712-fig-0084" title="">Analysis 4.8</a>), this difference in effect was significant: Test for subgroup differences: Chi² = 5.36, df = 1 (P = 0.02), I² = 81.4%. </p> </section> <section id="CD008712-sec-0310"> <h5 class="title">4.13 Mental state: 6a. Specific ‐ affective symptoms (average endpoint score PANSS sub scale, high = poor) ‐ long term </h5> <p>Short‐term data showed a difference between subgroups Test for subgroup differences: Chi² = 5.39, df = 1 (P = 0.02), I² = 81.5%, but the data for active comparison were highly skewed, when the outlier is removed, there are no subgroup differences for this outcome. Test for subgroup differences: Chi² = 1.97, df = 1 (P = 0.16), I² = 49.2%. (<a href="./references#CD008712-fig-0089" title="">Analysis 4.13</a>). </p> </section> </section> <section id="CD008712-sec-0311"> <h4 class="title">Sensitivity analysis</h4> <section id="CD008712-sec-0312"> <h5 class="title">1. Implication of randomisation</h5> <p>As we did not include any study that implied randomisation, we were unable to carry out a sensitivity analyses. </p> </section> <section id="CD008712-sec-0313"> <h5 class="title">2. Blinding</h5> <p>As no study clearly stated that the outcome assessor was non‐blinded, we did not perform sensitivity analysis for this domain. </p> </section> <section id="CD008712-sec-0314"> <h5 class="title">3. Well‐defined CBT versus less‐well‐defined CBT</h5> <p>No clear difference in results were found when trials with less‐well‐defined CBT were excluded from the meta‐analyses of the primary outcomes <i>(</i><a href="./references#CD008712-fig-0097" title="">Analysis 5.1</a>; <a href="./references#CD008712-fig-0098" title="">Analysis 5.2</a>; <a href="./references#CD008712-fig-0099" title="">Analysis 5.3</a>; <a href="./references#CD008712-fig-0100" title="">Analysis 5.4</a><i>).</i> </p> </section> <section id="CD008712-sec-0315"> <h5 class="title">4. Therapist experience</h5> <p>No clear difference in results were found when trials with 'less experienced' therapists were excluded from the meta‐analyses of the primary outcome<i>(</i><a href="./references#CD008712-fig-0101" title="">Analysis 6.1</a>; <a href="./references#CD008712-fig-0102" title="">Analysis 6.2</a>). </p> </section> <section id="CD008712-sec-0316"> <h5 class="title">5. Assumptions for lost binary data</h5> <p>We made assumptions for lost binary data (see <a href="#CD008712-sec-0086">Dealing with missing data</a>). Sensitivity analysis showed that there was no substantial difference between results using our assumption and results from completers only (<a href="./references#CD008712-fig-0103" title="">Analysis 7.1</a>; <a href="./references#CD008712-fig-0104" title="">Analysis 7.2</a>; <a href="./references#CD008712-fig-0105" title="">Analysis 7.3</a>; <a href="./references#CD008712-fig-0106" title="">Analysis 7.4</a>). </p> </section> <section id="CD008712-sec-0317"> <h5 class="title">6. Risk of bias</h5> <p>No substantive difference in results were found when trials with a high risk of bias were excluded from meta‐analyses of the primary outcomes (<a href="./references#CD008712-fig-0107" title="">Analysis 8.1</a>; <a href="./references#CD008712-fig-0108" title="">Analysis 8.2</a>; <a href="./references#CD008712-fig-0109" title="">Analysis 8.3</a>; <a href="./references#CD008712-fig-0110" title="">Analysis 8.4</a>; <a href="./references#CD008712-fig-0111" title="">Analysis 8.5</a>). </p> </section> <section id="CD008712-sec-0318"> <h5 class="title">7. Imputed values</h5> <p>We did not carry out a sensitivity analysis for imputed values as no cluster‐randomised trials are included in the review. </p> </section> <section id="CD008712-sec-0319"> <h5 class="title">8. Fixed‐ and random‐effects</h5> <p>No substantive difference in results were found when we combined data using a random‐effects model for the primary outcome <a href="./references#CD008712-fig-0112" title="">Analysis 9.1</a><i>.</i> </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008712-sec-0320" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008712-sec-0320"></div> <section id="CD008712-sec-0321"> <h3 class="title" id="CD008712-sec-0321">Summary of main results</h3> <section id="CD008712-sec-0322"> <h4 class="title">1. Comparison 1. Cognitive behavioural therapy (CBT) versus other psychosocial therapies</h4> <p>The conclusions of this review should be read in conjunction with another Cochrane Review of the efficacy of cognitive behavioural therapy relative to standard care. It should be noted that the outcomes reported for this review compare CBT with other psychosocial therapies that were designed to achieve meaningful symptom reduction. Accordingly, these outcomes are not measures of overall efficacy of CBT for people with schizophrenia, but rather should be interpreted as measures of the relative advantage of CBT specifically compared with other psychosocial interventions. </p> <section id="CD008712-sec-0323"> <h5 class="title">1.1 Global state</h5> <p>No advantage was found for CBT over other psychological therapies with respect to rate of relapse or rehospitalisation. No differential effect of CBT was observed on global state when measured using the Global Assessment Scale (GAS). In contrast, there was a consistent positive effect for CBT when global state was measured using the Globals Assessment of Functioning (GAF); this effect was based on data from two studies and only observed in the short term and may be a chance finding. </p> <p>When CBT was compared specifically active psychosocial therapies, the lack of effect on rate of relapse or rehospitalisation remained, and results were also unchanged when CBT was compared specifically with non active therapies. </p> </section> <section id="CD008712-sec-0324"> <h5 class="title">1.2 Mental state</h5> <p>We found a positive effect for CBT over other psychosocial therapies with respect to important change in general mental state in the short term (based on two studies with a total 87 participants) but no difference was observed in the medium term (based on three studies with a total of 195 participants) or long term (based on four studies with a total of 249 participants). </p> <p>For general mental state measured in terms of endpoints scores on the Brief Psychiatric Rating Scale (BPRS), no effect was found in the short or long term. A small advantage for CBT was found in the medium term, but this was observed in only a single small trial (<a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a>), which compared CBT with an active therapy (supportive counselling). </p> <p>When general mental state was measured using endpoints scores on the Positive and Negative Syndrome Scale (PANSS), a positive effect for CBT in the short, medium and long term was found. This relatively modest advantage of CBT is a reduction in the PANSS total score by an average of five points in the short term reducing to an average of approximately three points in the long term. There were important levels of heterogeneity for this result but the positive effect for CBT was maintained when the outlier, <a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a>, was removed and heterogeneity was reduced to 11%. </p> <p>Much of the CBT‐based interventions for psychosis focus on specific symptoms. With respect to positive symptoms on the PANSS, no clear difference between CBTand other psychosocial therapies was observed in the short term. However, there was a small but reliable effect in favour of CBT of approximately one point reduction in PANSS positive symptom score in the medium term and long term, </p> <p>When more specific measures of mental state such hallucinations were measured no advantage was found for CBT at any duration of treatment outcome. With respect to delusions as measured by the sub‐scale of the PANSS across nine trials, there was also no clear difference between CBT and other therapies in the short, medium‐or long term. Five trials reported outcomes for delusions, four trials reported skewed data with only one trial reported short‐term positive effects for CBT (<a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>). No other studies reported significant effects, although the failure to demonstrate an effect may also reflect the lack of trials reporting this outcome and the preponderance of skewed data. Therefore accordingly there is no systematic evidence of a treatment effect on these outcome measures. </p> <p>No consistent effect was found for the differential impact of CBT on negative symptoms at any treatment duration. </p> <p>With respect to affective symptoms, no positive effect for CBT was observed on the General Psychopathology scale of the PANSS. Symptoms of depression were measured on the Montgomery Asberg Depression Rating Scale (MADRS), Beck Depression Inventory (BDI) and the Hamilton Depression Scale (HAMD). The data for outcomes on the MADRS and BDI were skewed, however a medium‐term advantage for CBT was observed on the MADRS and a short‐term advantage was observed on the HADS. Accordingly, there is inconsistent evidence of a treatment effect for depressive symptoms. </p> <p>Anxiety was measured using the Beck Anxiety scale (BAI), the Hamilton Anxiety scale (HAMA)and the Self Rating Anxiety Scale (SARS) . There was an advantage for CBT in the short term on the HAMA and the SARS but not the BAI. Accordingly, there is inconsistent evidence of a treatment effect for anxiety symptoms. </p> <p>On the basis of data from one trial (<a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a>), no advantage was observed on the Novaco Anger scale (NAS) in the short or long term and no difference was observed on the Novaco Provocation Inventory (NPI) in the short or long term. </p> <p>One study (<a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a>) reported short‐term improvement for CBT on the Stigma Scale for Mental Illness (SSMI). However, when self‐esteem was measured using the Rosenberg Self‐Esteem scale (RSES), no advantage for CBT was observed in the short, medium or long term. </p> <p>With respect to problem behaviours, no advantage was observed for CBT on the Ward Anger Rating Scale (WARS) or the risk management sub scale of the HCR20. </p> <p>These findings provide only weak and inconsistent support for the assertion by <a href="./references#CD008712-bbs2-0138" title="BirchwoodM , TrowerP . The future of cognitive–behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry2006;188:107‐8. ">Birchwood 2006</a> that CBT when correctly applied should effect change in emotional distress and/or problematic behaviours rather than psychotic symptomatology. However, it should be noted that the trials reporting outcomes in this category have not specifically included interventions that have targeted the affective response to psychotic symptomatology and have generally not measured specific belief‐related distress (or has been measured on scales with psychometric propetries that were not compatible with meta‐analytic synthesis). Similarly, it should be noted that these data compare CBT with other psychological therapies, it is possible that the interventions in the control arm may also exert an effect on symptom‐related distress and thus obscure any treatment effect related to CBT per se. </p> </section> <section id="CD008712-sec-0325"> <h5 class="title">1.3 Adverse effect/events</h5> <p>CBT did not show an advantage with respect to avoidance of death by natural causes or suicide, although it should be noted that the overall numbers were small with only six studies reporting deaths. </p> <p>Only two trials reported adverse effect data. One of these trials (<a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a>) found participants in the CBT group experienced less adverse effects in the short term in comparison with supportive therapy, whereas the other study (<a href="./references#CD008712-bbs2-0180" title="KlingbergS , WittorfA , HerrlichJ , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259:S149‐54. ">Klingberg 2009</a>) reported no difference in adverse outcomes between CBT and Cognitive Remediation Training in the long term. </p> <p>Many of the included studies do not report adverse effects of this therapy. If such treatment is potentially to be recommended for wide adoption, routine recording and reporting of adverse effects should be expected within evaluative studies. </p> </section> <section id="CD008712-sec-0326"> <h5 class="title">1.4 Functioning</h5> <p>No advantage for CBT was observed on the Social Functioning Scale (SFS) or the Social and Occupational Functioning Assessment Scale (SOFAS). On the Personal and Social Performance Scale (PSP), a positive effect for CBT was observed in the medium term and long term. </p> <p>On the Schedule for Assessing Insight (SAI), no difference was observed in the short term or long term and no advantage for CBT was reported from skewed data for the Beck Cognitive Insight Scale (BCIS). However, a positive effect for CBT was observed in the medium term from one trial on the SAI. Overall, there is no consistent evidence of an advantage for CBT with regard to promoting insight. </p> <p>No clear difference was observed on the SFS when CBT was compared with an active psychosocial therapy (enhanced supportive therapy (<a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>) at any duration of outcome. Similarly, when CBT was compared with a non active psychosocial therapy (befriending), no advantage was observed using the SOFAS by <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> and <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> in the short or long term. </p> <p>This important outcome is not often measured but there is no indication that the addition of CBT to standard care has any convincing generalised effect. </p> </section> <section id="CD008712-sec-0327"> <h5 class="title">1.5 Quality of life</h5> <p>There is no evidence of an advantage for CBT on general or specific measures of Quality of Life. </p> </section> <section id="CD008712-sec-0328"> <h5 class="title">1.6 Satisfaction with treatment</h5> <p>One trial (<a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a>) reported an advantage for CBT in the short term on the Attitude to Medication Questionnaire (AMQ)and the Drug Attitude Inventory (DAI), although no effect in the long term was reported by <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a>. </p> <p>Twenty‐six studies contributed data to leaving the study early. CBT had a moderate effect for keeping people in the study more than other psychosocial therapies. Whether this is directly due to 'satisfaction with care' is unclear. </p> </section> <section id="CD008712-sec-0329"> <h5 class="title">1.7 Engagement with service</h5> <p>No advantage for CBT was observed in three trials reporting compliance with medication.</p> </section> </section> <section id="CD008712-sec-0330"> <h4 class="title">2. SUBGROUP DIFFERENCES: ACTIVE or NON ACTIVE PSYCHOSOCIAL THERAPIES</h4> <p>When we tested for subgroup differences between active and non active psychosocial therapies, in general there was no evidence that CBT had different effects when compared with active or non active therapies, except in the following analyses. At medium term there was no evidence of a difference between CBT and an active therapy, but there was a favourable effect for CBT when compared with non active therapies (<a href="./references#CD008712-fig-0080" title="">Analysis 4.4</a>), this difference in effect between subgroups was significant (Chi² = 6.60, df = 1 (P = 0.01), I² = 84.8%). In addition, long‐term results from the PANSS sub‐scale showed a favourable effect of CBT when compared with active therapies but no difference when compared with non active therapies (<a href="./references#CD008712-fig-0084" title="">Analysis 4.8</a>), this difference in effect for the subgroups was significant: Chi² = 5.36, df = 1 (P = 0.02), I² = 81.4%. </p> </section> </section> <section id="CD008712-sec-0331"> <h3 class="title" id="CD008712-sec-0331">Overall completeness and applicability of evidence</h3> <section id="CD008712-sec-0332"> <h4 class="title">1. Completeness</h4> <p>There has been an improvement in the reporting of the main outcomes (relapse, hospitalisation, mental state, adverse event) since the last update of this review. At the time of the last update, even the most replete of the outcomes contained less than 300 participants, and this has improved since this update. For rehospitalisation, the current review reports outcomes from eight trials involving 943 participants. </p> <p>Nevertheless, the trials were often small and often undertaken by pioneers of CBT. There is a poverty of measurement of certain outcomes and none on others. For example, there are two trials reporting any adverse event and six trials reporting deaths. </p> </section> <section id="CD008712-sec-0333"> <h4 class="title">2. Applicability</h4> <section id="CD008712-sec-0334"> <h5 class="title">2.1 Participants</h5> <p>The included studies involved people with schizophrenia or psychosis as derived from recognised diagnostic criteria from a wide range of settings, including both in‐patients and out‐patients. The results of this review could thus be said to be valid for people with a diagnosis of a psychotic disorder whose illness has taken a chronic course whether treated on an in‐patient or out‐patient basis. </p> <p>The exclusion criteria were such that this review is of less relevance to people with other psychotic disorders such as bipolar disorder, substance‐induced psychosis, significant physical or sensory difficulties or people with acquired brain injury or co‐existing developmental learning disabilities. It should be noted that people who were described as in the category of "at risk" of psychosis but not yet diagnosed were not included in this review. </p> </section> <section id="CD008712-sec-0335"> <h5 class="title">2.2 Interventions</h5> <p>Eleven trials meet our criteria for ‘well‐defined CBT’. The period of active therapy varied between studies. For example, <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> provided up to eight weeks of individual CBT, whilst <a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a> gave both individual and group cognitive therapy over the course of recovery (which did not exceed nine months) as well as family engagement, aimed at developing familial coping strategies and a structured activity programme (for an average of five hours per week) including cooking, creative therapy and discussion groups. On the other hand, <a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> reported that their intervention consisted of four to six sessions of therapy aimed at increasing medication compliance. </p> <p>The CBT interventions varied in both the target of the therapy and the degree of specificity of the focus of the intervention. For example,<a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> and <a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> used a CBT intervention focused specifically on medication compliance, whereas the CBT intervention described by <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> had a wider focus and targeted auditory hallucinations and delusions, anxiety, depression, relapse prevention and enhancing medication compliance. Most trials targeted positive symptoms of psychosis, some with an explicit focus on auditory hallucinations <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>) and/or delusions <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a>; <a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a>; <a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>). It was less common for the CBT intervention to target negative symptoms of psychosis (<a href="./references#CD008712-bbs2-0180" title="KlingbergS , WittorfA , HerrlichJ , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259:S149‐54. ">Klingberg 2009</a>). Strategies for relapse prevention were a common component in the CBT intervention and a specific focus in some trials (e.g. <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>). Emotional distress <a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a>) and self‐esteem (<a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a>; <a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a>), either in general or specifically related to the experience of psychosis, was a target in some trials that also targeted other symptoms. Finally, <a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a> focused specifically on psychotic symptoms and anger relating to aggression and violence. </p> <p>The present review has adopted a tiered definition of CBT. Cognitive behavioural therapy in clinical practice typically includes a number of components: cognitive restructuring, hypothesis testing, behavioural experiments, psychoeducation, relapse prevention, coping strategy enhancement, problem‐solving strategies, with or without, relaxation training. In this respect, many of the current trials reflect common clinical practice. However, this multi‐component approach is not necessarily helpful in identifying the active components of CBT because the control arms of the trials are often not balanced in terms of component therapies. Trials generally include a range of interventions in the same treatment arm and in many the intervention is described as “CBT” without a clear indication that the active element of therapy involves explicit manipulation of beliefs. In addition, cognitive therapy for psychosis, as reflected in current trials, has become increasingly distanced from its basis in CBT for non‐psychotic mood disorders where the focus is on the emotional and behavioural consequences of dysfunctional thinking patterns and the intervention is clearly designed to address cognitions and beliefs. This point has been identified by <a href="./references#CD008712-bbs2-0138" title="BirchwoodM , TrowerP . The future of cognitive–behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry2006;188:107‐8. ">Birchwood 2006</a> who has noted that CBT for psychosis has often been treated as if it were a 'quasi‐neuroleptic' where the focus of outcome measurement has been on global symptoms with the expectation that CBT should reduce psychotic symptoms directly as opposed to eliciting emotional and behavioural changes. More recent trials of CBT in relation to standard care are more clearly based on theoretical models of psychotic symptoms (e.g. <a href="./references#CD008712-bbs2-0201" title="TrowerP , BirchwoodM , MeadenA , BryneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry 2004;184:312‐20. ">Trower 2004</a>). Such trials have a clear focus on the specificity of the beliefs addressed (e.g. power beliefs about voices) and outcome measures which are sensitive to belief change as the mediator of emotional and behavioural change. </p> <p>Overall, interventions did vary considerably but the findings were consistent. When well‐implemented CBT is given, for long or short periods, with various foci of treatment, there is no convincing difference between CBT and other psychosocial interventions in relation to psychotic symptomatology and broad measures of functioning (<a href="./full#CD008712-tbl-0001">summary of findings Table for the main comparison</a>). However, there are some promising preliminary findings with respect to the effect of CBT on symptoms of depression. At present, it remains unclear, but it is interesting to speculate as to the relative benefits for CBT for psychosis compared with CBT which is specifically focused upon depression in this group of patients. </p> </section> </section> </section> <section id="CD008712-sec-0336"> <h3 class="title" id="CD008712-sec-0336">Quality of the evidence</h3> <p>This is an attempt to quantitatively summarise the effects of cognitive behavioural therapy for schizophrenia. This has not been an easy task and the review authors will be pleased to hear from readers in order to improve this work for future issues of the Cochrane Library. The methodological quality of the included studies is summarised in <a href="#CD008712-fig-0005">Figure 5</a>. There still are too few trials. Studies are too small. Outcomes are often reported in such a way that leaves presentation in a systematic review, difficult or impossible. In addition, rating scales are often used to measure outcomes that are not directly relevant to psychological therapy: i.e. they do not measure belief‐mediated distress or behaviour. </p> <p>There has, however, been a general improvement in methodological rigor of the more recent trials. Several trials had relatively large sample sizes (<a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a>; <a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a>; <a href="./references#CD008712-bbs2-0180" title="KlingbergS , WittorfA , HerrlichJ , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259:S149‐54. ">Klingberg 2009</a>; <a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a>, all exceeded 100 participants). All 33 included studies which report some form of randomisation, with 21 describing adequate sequence generation. Allocation was concealed in 18 studies and 25 of the 36 trials employed raters blinded to the treatment condition. </p> <p>One of the key issues, which is a limiting factor in interpreting current trial data, is the wide variation in the targets of treatment and there is little agreement on how these targets and key outcomes should be operationalised. Studies frequently measure different outcomes or measure the same outcome using different measures. The differences in the psychometric properties of these measures make it difficult to interpret the variability of the outcomes reported in the trials. It would be invaluable to future trials to receive direction regarding a common consensus on the most reliable, valid and clinically‐relevant outcome measures for CBT for psychosis. In the view of the authors this is likely to require the design and validation of new outcome measures both for specific aspects of positive symptoms (e.g. beliefs, preoccupation and conviction), as well as key emotional and behavioural outcomes including anxiety, depression and more specific symptom‐related distress. For example, current state‐of‐the‐art measures of these dimensions are not fully adequate to assess the efficacy of CBT. The Psychotic Symptom Rating Scale<i>(</i>PSYRATS), for example, includes only a single four‐point measure of delusional or voice‐related distress and the Beliefs About Voices Questionnaire includes measures of emotional response to voices which are not clearly delineated from other variables, such as the person's behaviour in relation to the voice. In addition, the ultimate aim of clinical intervention is to improve functioning and trials should include primary outcomes relating to this including, return to work, social functioning and quality of life. It would seem important to also report on some economic outcomes. </p> <p>Finally, a welcome addition to some of the newer trials is the introduction of protocols to assess adherence to CBT methods, though there remains a lack of consensus across trials as to how this is implemented. In addition, a recent government focus in the UK on making psychological therapies more widely available is likely to mean that a broader range of expertise is employed in the delivery of CBT for psychosis. At present, the experience of therapists in trials is not always clearly described and this renders it difficult to undertake a sensitivity analysis of the effect of therapist expertise. </p> </section> <section id="CD008712-sec-0337"> <h3 class="title" id="CD008712-sec-0337">Potential biases in the review process</h3> <p>One of the review authors (AM) is actively engaged in the evaluation of the efficacy of CBT for psychosis. </p> </section> <section id="CD008712-sec-0338"> <h3 class="title" id="CD008712-sec-0338">Agreements and disagreements with other studies or reviews</h3> <p>There are few reviews of CBT that have made comparisons with other psychological therapies. However, in a meta‐analysis of eight trials with 528 patients, <a href="./references#CD008712-bbs2-0194" title="PillingS , BebbingtonP , KuipersE , GaretyP , GeddesJ , MartindaleB , et al. Psychological treatments in schizophrenia : II. Meta‐analyses of randomized controlled trials of social skills training and cognitive remediation. Psychological Medicine2002;32:783‐91. ">Pilling 2002</a> reported that CBT did not show an advantage over other active therapies (i.e. supportive counselling, and a problem‐solving group) although positive effects of CBT were reported relative to standard care. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008712-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study selection from 2014 and 2015 searching" data-id="CD008712-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study selection from 2014 and 2015 searching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Study selection from 2017 searching" data-id="CD008712-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study selection from 2017 searching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Merged study flow diagrams for all searching up to March 2017" data-id="CD008712-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Merged study flow diagrams for all searching up to March 2017</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD008712-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD008712-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 CBT versus ALL OTHER PSYCHOLOGICAL THERAPIES, outcome: 1.50 Satisfaction with treatment: 2. Leaving the study early." data-id="CD008712-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CBT versus ALL OTHER PSYCHOLOGICAL THERAPIES, outcome: 1.50 Satisfaction with treatment: 2. Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 1 Global state: 1. Relapse." data-id="CD008712-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 1 Global state: 1. Relapse.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 2 Global state: 2. Average endpoint total score various scales, high = good)." data-id="CD008712-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 2 Global state: 2. Average endpoint total score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 3 Global state: 3. Rehospitalisation." data-id="CD008712-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 3 Global state: 3. Rehospitalisation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement)." data-id="CD008712-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 5 Mental state: 2. General (average endpoint total score, various scales, high = poor)." data-id="CD008712-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 5 Mental state: 2. General (average endpoint total score, various scales, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0013"> <p> <div class="table" id="CD008712-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>PANSS ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Levine 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reporetd as favouring CBT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Levine 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>SAPS ‐ medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Pinto 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as favouring CBT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Pinto 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>BPRS ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>BPRS ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 7 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score various subscales, high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0013">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 8 Mental state: 3c. Specific ‐ positive symptoms (average endpoint BPRS subscale, high = poor) ‐ short term." data-id="CD008712-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 8 Mental state: 3c. Specific ‐ positive symptoms (average endpoint BPRS subscale, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor)." data-id="CD008712-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0016"> <p> <div class="table" id="CD008712-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Cather 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Cather 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Lewis 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Lewis 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 10 Mental state: 4b. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0016">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 11 Mental state: 5a. Specific ‐ delusions (average endpoint score PSYRATS subscale, high = poor) ‐ long term." data-id="CD008712-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 11 Mental state: 5a. Specific ‐ delusions (average endpoint score PSYRATS subscale, high = poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0018"> <p> <div class="table" id="CD008712-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Cather 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Cather 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as favouring CBT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Lewis 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Lewis 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 12 Mental state: 5b. Specific ‐ delusions (average endpoint score PSYRATS subscale, high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0018">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 13 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 13 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0020"> <p> <div class="table" id="CD008712-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Levine 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported favouring CBT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Levine 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 14 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term, skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0020">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 15 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score SANS, high = poor)." data-id="CD008712-fig-0021" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 15 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score SANS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0022"> <p> <div class="table" id="CD008712-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Jackson 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as favouring CBT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 16 Mental state: 6d. Specific ‐ negative symptoms (average endpoint score SANS, high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0022">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 17 Mental state: 6e. Specific ‐ negative symptoms (average endpoint score BPRS subscale, high = poor) ‐ short term." data-id="CD008712-fig-0023" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 17 Mental state: 6e. Specific ‐ negative symptoms (average endpoint score BPRS subscale, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 18 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0024" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 18 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 19 Mental state: 7b. Specific ‐ affective symptoms (average endpoint score SCL90, high=poor) ‐ long term." data-id="CD008712-fig-0025" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 19 Mental state: 7b. Specific ‐ affective symptoms (average endpoint score SCL90, high=poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0026"> <p> <div class="table" id="CD008712-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Garety 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report whether there is a significant statistical difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Garety 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 20 Mental state: 8a. Specific ‐ depression (average endpoint score BDI, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0026">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0027"> <p> <div class="table" id="CD008712-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as favouring CBT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Sensky 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 21 Mental state: 8b. Specific ‐ depression (average endpoint score MADRS, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0027">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 22 Mental state: 8c. Specific ‐ depression (average endpoint score HAMD, high = poor) ‐ short term." data-id="CD008712-fig-0028" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 22 Mental state: 8c. Specific ‐ depression (average endpoint score HAMD, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 23 Mental state: 9a. Specific ‐ self esteem (average endpoint score RSES, high = good)." data-id="CD008712-fig-0029" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 23 Mental state: 9a. Specific ‐ self esteem (average endpoint score RSES, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0030"> <p> <div class="table" id="CD008712-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Lecomte 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Lecomte 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 24 Mental state: 9b. Specific ‐ self esteem (average endpoint score RSES, high = good) ‐ short term, skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0030">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 25 Mental state: 10. Specific ‐ self stigma (average endpoint score SSMI, high = poor) ‐ short term." data-id="CD008712-fig-0031" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 25 Mental state: 10. Specific ‐ self stigma (average endpoint score SSMI, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0032"> <p> <div class="table" id="CD008712-tblf-0009"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Garety 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report whether there is a significant statistical difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Garety 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 26 Mental state: 11a. Specific ‐ anxiety (average endpoint score BAI, high = poor) ‐ long term, skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0032">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 27 Mental state: 11b. Specific ‐ anxiety (average endpoint score HAMA, high = poor) ‐ short term." data-id="CD008712-fig-0033" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 27 Mental state: 11b. Specific ‐ anxiety (average endpoint score HAMA, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 28 Mental state: 11c. Specific ‐ anxiety (average endpoint score SARS, high = poor) ‐ short term." data-id="CD008712-fig-0034" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 28 Mental state: 11c. Specific ‐ anxiety (average endpoint score SARS, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 29 Mental state: 12b. Specific ‐ clinically important change ‐ Obessive Compulsive Disorder (no improvement)." data-id="CD008712-fig-0035" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 29 Mental state: 12b. Specific ‐ clinically important change ‐ Obessive Compulsive Disorder (no improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 30 Mental state: 12a. Specific ‐ Obsessive Compulsive Disorder (average endpoint score Y‐BOCS, high = poor) ‐ short term." data-id="CD008712-fig-0036" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 30 Mental state: 12a. Specific ‐ Obsessive Compulsive Disorder (average endpoint score Y‐BOCS, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 31 Mental state: 13. Specific ‐ anger/aggression (average endpoint score NAS, high = poor)." data-id="CD008712-fig-0037" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 31 Mental state: 13. Specific ‐ anger/aggression (average endpoint score NAS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0038"> <p> <div class="table" id="CD008712-tblf-0010"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Novaco Provocation Inventory ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Novaco Provocation Inventory ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Ward Anger Rating Scale ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Ward Anger Rating Scale ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>HCR‐20 risk management ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Haddock 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 32 Mental state: 14. Specific ‐ problem behaviours (average endpoint score various scales, high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0038">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0039"> <p> <div class="table" id="CD008712-tblf-0011"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Levine 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Levine 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 33 Mental state: 15. Specific ‐ thought disturbances (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0039">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 34 Adverse effect/event(s): 1. Number of events." data-id="CD008712-fig-0040" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 34 Adverse effect/event(s): 1. Number of events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 35 Adverse effect/event(s): 2. Death ‐ any cause." data-id="CD008712-fig-0041" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 35 Adverse effect/event(s): 2. Death ‐ any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 36 Functioning: 1a. Social functioning (average endpoint score various scales, high = good)." data-id="CD008712-fig-0042" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 36 Functioning: 1a. Social functioning (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 37 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good)." data-id="CD008712-fig-0043" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 37 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 38 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good)." data-id="CD008712-fig-0044" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 38 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0045"> <p> <div class="table" id="CD008712-tblf-0012"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Kemp 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Kemp 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as no difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Kemp 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA ‐ Kemp 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 39 Functioning: 2b. Cognitive functioning ‐ insight (average endpoint score BCIS / SAI, high = good) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0045">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0046"> <p> <div class="table" id="CD008712-tblf-0013"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as in favour of CBT group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ Granholm 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 40 Functioning: 3. Life skills ‐ skills acquisition ‐ (average endpoint score CMT, high = good) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0046">Navigate to figure in review</a></div> </div> <div class="figure" id="CD008712-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 41 Quality of life: 1a. General (average endpoint score various scales, high = good)." data-id="CD008712-fig-0047" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 41 Quality of life: 1a. General (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 42 Quality of life: 2a. Specific (average endpoint score MSQOL, high = good) ‐ short term." data-id="CD008712-fig-0048" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 42 Quality of life: 2a. Specific (average endpoint score MSQOL, high = good) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 43 Quality of life: 2b. Specific (average endpoint score MSQOL, high = good) ‐ medium term." data-id="CD008712-fig-0049" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 43 Quality of life: 2b. Specific (average endpoint score MSQOL, high = good) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-44.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 44 Satisfaction with treatment: 1. Leaving the study early." data-id="CD008712-fig-0050" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 44 Satisfaction with treatment: 1. Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 45 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term." data-id="CD008712-fig-0051" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 45 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-001-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-001-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 46 Engagement with services: 2. Attitude to medication (average endpoint score, various scales, high = good)." data-id="CD008712-fig-0052" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1 CBT versus OTHER PSYCHOSOCIAL THERAPIES, Outcome 46 Engagement with services: 2. Attitude to medication (average endpoint score, various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-001-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 1 Global state: 1. Relapse." data-id="CD008712-fig-0053" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 1 Global state: 1. Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 2 Global state: 2. Rehospitalisation." data-id="CD008712-fig-0054" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 2 Global state: 2. Rehospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement)." data-id="CD008712-fig-0055" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor)." data-id="CD008712-fig-0056" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor)." data-id="CD008712-fig-0057" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0058" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0059" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 8 Adverse effect/event(s): 2. Death ‐ any cause." data-id="CD008712-fig-0060" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 8 Adverse effect/event(s): 2. Death ‐ any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good)." data-id="CD008712-fig-0061" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good)." data-id="CD008712-fig-0062" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 11 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason." data-id="CD008712-fig-0063" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 11 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term." data-id="CD008712-fig-0064" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 1 Global state: 1. Relapse." data-id="CD008712-fig-0065" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 1 Global state: 1. Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 2 Global state: 2. Rehospitalisation." data-id="CD008712-fig-0066" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 2 Global state: 2. Rehospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement)." data-id="CD008712-fig-0067" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor)." data-id="CD008712-fig-0068" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor)." data-id="CD008712-fig-0069" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0070" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD008712-fig-0071" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 8 Adverse effect/event(s): 2. Death ‐ any cause." data-id="CD008712-fig-0072" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 8 Adverse effect/event(s): 2. Death ‐ any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good)." data-id="CD008712-fig-0073" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good)." data-id="CD008712-fig-0074" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 11 Satisfaction with treatment: 1. Leaving the study early." data-id="CD008712-fig-0075" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 11 Satisfaction with treatment: 1. Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term." data-id="CD008712-fig-0076" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES, Outcome 12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 1 Global state: 1. Relapse ‐ medium term." data-id="CD008712-fig-0077" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 1 Global state: 1. Relapse ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 2 Global state: 1. Relapse ‐ long term." data-id="CD008712-fig-0078" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 2 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 3 Global state: 2. Rehospitalisation ‐ long term." data-id="CD008712-fig-0079" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 3 Global state: 2. Rehospitalisation ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 4 Mental state: General ‐ clinically important change (no improvement) ‐ medium term." data-id="CD008712-fig-0080" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 4 Mental state: General ‐ clinically important change (no improvement) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 5 Mental state: General ‐ clinically important change (no improvement) ‐ long term." data-id="CD008712-fig-0081" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 5 Mental state: General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ short term." data-id="CD008712-fig-0082" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 7 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ medium term term." data-id="CD008712-fig-0083" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 7 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ medium term term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 8 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ long term." data-id="CD008712-fig-0084" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 8 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor) ‐ long term." data-id="CD008712-fig-0085" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 10 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term." data-id="CD008712-fig-0086" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 10 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 11 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ medium term." data-id="CD008712-fig-0087" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 11 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 12 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ long term." data-id="CD008712-fig-0088" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 12 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 13 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term." data-id="CD008712-fig-0089" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 13 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 14 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ medium term." data-id="CD008712-fig-0090" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 14 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 15 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ long term." data-id="CD008712-fig-0091" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 15 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 16 Adverse effects: 1b. Adverse effect/event(s) ‐ death." data-id="CD008712-fig-0092" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 16 Adverse effects: 1b. Adverse effect/event(s) ‐ death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 17 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good) ‐ long term." data-id="CD008712-fig-0093" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 17 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 18 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score SAI, high = good) ‐ long term." data-id="CD008712-fig-0094" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 18 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score SAI, high = good) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 19 Satisfaction with treatment: 1. Leaving the study early." data-id="CD008712-fig-0095" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 19 Satisfaction with treatment: 1. Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-004-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-004-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 20 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term." data-id="CD008712-fig-0096" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.20</div> <div class="figure-caption"> <p>Comparison 4 SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS, Outcome 20 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-004-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 1 Global state: 1. Relapse ‐ long term." data-id="CD008712-fig-0097" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 1 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term." data-id="CD008712-fig-0098" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term." data-id="CD008712-fig-0099" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term." data-id="CD008712-fig-0100" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (UNCLEAR EXPERIENCED THERAPISTS), Outcome 1 Global state: 1. Relapse ‐ long term." data-id="CD008712-fig-0101" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (UNCLEAR EXPERIENCED THERAPISTS), Outcome 1 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (UNCLEAR EXPERIENCED THERAPISTS), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term." data-id="CD008712-fig-0102" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (UNCLEAR EXPERIENCED THERAPISTS), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 1 Global state: 1. Relapse ‐ medium term." data-id="CD008712-fig-0103" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 1 Global state: 1. Relapse ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 2 Global state: 1. Relapse ‐ long term." data-id="CD008712-fig-0104" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 2 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term." data-id="CD008712-fig-0105" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term." data-id="CD008712-fig-0106" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 1 Global state: 1. Relapse ‐ medium term." data-id="CD008712-fig-0107" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 1 Global state: 1. Relapse ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 2 Global state: 1. Relapse ‐ long term." data-id="CD008712-fig-0108" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 2 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term." data-id="CD008712-fig-0109" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term." data-id="CD008712-fig-0110" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 5 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term." data-id="CD008712-fig-0111" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS), Outcome 5 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008712-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/urn:x-wiley:14651858:media:CD008712:CD008712-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_t/tCD008712-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RANDOM EFFECT MODEL), Outcome 1 Global state: 1. Relapse (random effect model)." data-id="CD008712-fig-0112" src="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RANDOM EFFECT MODEL), Outcome 1 Global state: 1. Relapse (random effect model). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/media/CDSR/CD008712/image_n/nCD008712-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD008712-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Suggested design of study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: randomised, fully explicit description of methods of randomisation and allocation concealment.<br/> Blinding: single, tested.<br/> Setting: community rather than hospital.<br/> Duration: 12 weeks treatment, and then follow‐up to at least 52 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: schizophrenia (ICD).<br/> N = 300.*<br/> Age: adults.<br/> Sex: both. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Cognitive behaviour therapy + standard care. N = 150.</p> <p>Content:</p> <p> <ol id="CD008712-list-0008"> <li> <p>a discrete psychological intervention, which is in addition to, and separate from, other therapeutic interventions (for example, behavioural family therapy) and </p> </li> <li> <p>recipients establish links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour and </p> </li> <li> <p>the re‐evaluation of their perceptions, beliefs or reasoning relating to the target symptoms; this may include the re‐evaluation of specific "inferential" beliefs or more global "evaluative" beliefs. </p> </li> </ol> </p> <p>Delivered by: experienced therapists.</p> <p>2. Other psychosocial therapy + standard care . N = 150.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General: time to all‐cause treatment failure marked by its discontinuation, relapse/rehospitalisation, general impression of clinician (CGI), career/other, compliance with treatment.<br/> Mental state: BPRS and PANSS.<br/> Global state: CGI (Clinical Global Impression).<br/> Quality of life. QOL (Quality of Life Questionnaire).<br/> Social functioning: return to everyday living for 80% of time.*<br/> Economic outcomes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* Powered to be able to identify a difference of ˜ 20% between groups for primary outcome with adequate degree of certainty. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>BPRS: Brief Psychiatric Rating Scale; ICD: International Classification of Diseases; PANSS: Positive and Negative Syndrome Scale </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Suggested design of study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008712-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">CBT compared to ALL OTHER PSYCHOLOGICAL THERAPIES for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CBT compared to OTHER PSYCOSOCIAL THERAPIES for people with schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia </p> <p><b>Setting:</b> inpatients and outpatients<br/> <b>Intervention:</b> CBT+ standard care<br/> <b>Comparison:</b> Other psychological therapies + standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with ALL OTHER PSYCHOLOGICAL THERAPIES</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with CBT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: relapse<br/> follow‐up: range 8 weeks to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.85 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>375<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>463 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>486 per 1,000<br/> (393 to 597) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: rehospitalisation*<br/> follow‐up: range 70 days to 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.82 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>943<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Data for pre‐defined outcome 'clinically important change' not reported.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1,000<br/> (307 to 427) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mental state: General ‐ clinically important change (no improvement)<br/> follow‐up: range 12 months to 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.82<br/> (0.67 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>249<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>636 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>522 per 1,000<br/> (426 to 643) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effect/event: death ‐ any cause<br/> follow‐up: range 70 days to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.57<br/> (0.62 to 3.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>627<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1,000<br/> (10 to 64) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning ‐ average scores (Social Functioning Scale, high = good)<br/> follow‐up: mean 12 months * </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functioning ‐ average scores (Social Functioning Scale, high = good, long term) was 128.5 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 8.80 higher<br/> (4.07 lower to 21.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2, 5, 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data for pre‐defined outcome 'clinically important change' not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: average scores (MSQOL, high = good, medium term)<br/> follow‐up: mean 6 months * </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life: average scores (MSQOL, high = good, medium‐term) was 60.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.50 lower<br/> (15.66 lower to 6.66 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2,6 ,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data for pre‐defined outcome 'clinically important change' not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Satisfaction with treatment ‐ leaving the study early for any reason</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.75 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2392<br/> (26 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>247 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>217 per 1,000<br/> (192 to 256) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>MD:</b> mean difference; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level due to risk of bias: some studies had unclear or high risk of bias with blinding of participants and outcome assessments, as well as attrition issues. </p> <p><sup>2</sup> Downgraded by one level due to imprecision: small sample size and wide confidence interval. </p> <p><sup>3</sup> Downgraded by one level due to risk of bias: majority of the included studies had unclear risk of blinding of participants and outcome assessments. </p> <p><sup>4</sup> Downgraded by one level due to imprecision: small event rate and wide confidence interval around effect estimate. </p> <p><sup>5</sup> Downgraded by one level due to risk of bias: high risk of detection bias due to unblinded assessment. </p> <p><sup>6</sup> Downgraded by one level due to indirectness: scores from scale were employed as a surrogate index of the intended outcome. </p> <p><sup>7</sup> Downgraded by one level due to risk of bias: high risk of allocation concealment bias, and unclear risk around blinding. </p> <p><sup>8</sup> Downgraded by one level due to imprecision: small sample size and wide confidence interval which included appreciable benefit and no effect. </p> <p><sup>9</sup> Downgraded one level due to indirectness: leaving the study early used to predict satisfaction with treatment </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">CBT compared to ALL OTHER PSYCHOLOGICAL THERAPIES for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008712-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Outcome categories</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These relate to meaningful changes in symptomatology and general clinical condition, recovery and well‐being. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mental state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These refer to presence or absence of symptoms of psychosis as well as continuous measures relating to characteristics of psychotic symptoms (e.g. preoccupation; conviction; frequency; duration; intensity, loudness; perceived interference with daily living) and insight. Measures of general affect are also considered (e.g. anxiety, depression, shame, hopelessness, anger; self‐esteem) and symptom‐related affect measures (e.g. voice‐related distress; delusional distress).The presence or frequency of problematic behaviours are included (such as suicide attempts; deliberate self‐harm; violence to others, etc) and functional and adaptive behaviours (e.g. increased coping strategies) . </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All health interventions have the capacity for unintended and unwanted side effects. To‐date there has been a paucity of studies that have attempted to identify adverse effects of psychological therapies. Such outcomes might include dependency, increased distress, increased family dysfunction and disengagement from mental health services. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Service utilisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of service utilisation and functional outcomes may convey important information regarding health economic benefits, as well as provide indirect markers of personal independence. Such outcomes might include number of acute hospital or inpatient days, number of acute hospital admissions or equivalent (e.g. home treatment/crisis team intervention; respite admissions), changes in legal status under mental health legislation (<a href="./references#CD008712-bbs2-0149" title="Department of Health. Mental Health Act. www.legislation.gov.uk/ukpga/1983/20/contents (accessed prior to 02 June 2017). ">Department of Health 1983</a>), changes in level of care (including accommodation type and intensity of service (Assertive Outreach Team versus Community Mental Health Team)). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Functional outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include changes in employment, occupational and educational status, level of received social security benefits or social welfare, perceived quality of life and level of social functioning. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacological treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes would include alterations in the degree of compliance with the prescribed medication regimen, as well as alterations to the prescribed medication including changes in type of medication and prescribed dosage. Unwanted side effects will also be assessed. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Economic outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes would include both the direct costs of CBT (e.g. costs relating to the provision of therapy) and the indirect costs of CBT (e.g. reduction in medication, reduction in relapse, etc). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CBT: Cognitive behavioural therapy</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Outcome categories</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008712-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">More detailed description of interventions in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Cognitive Behavioural Therapy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Control therapy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>No other active therapies</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Experienced therapists</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Well‐defined CBT</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><sub>Comments</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Active</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Nonactive</b> </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0001" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110(1):21‐8. [CSzG: Ref11268] BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144‐50. [CSzG: Ref19694] BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112(3):172‐9. [CSzG: Ref18491] Munk‐JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSzG: Ref18577] ">A ‐ Bechdolf 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT administered by trained psychiatrist or psychologist.</sup> </p> <p><sup>CBT strategies included: formulation, guided recovery, symptom monitoring, exposure/focusing strategies for managing voices, hypothesis/reality testing, re‐framing attributions, rational responding, coping strategy enhancement, distraction techniques, role play, anxiety management, depression and self‐esteem work, medication compliance/motivational interviewing, schema work, relapse prevention and keeping well strategies.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Psychoeducation</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0002" title="BuchkremerG , KlingbergS , HolleR , Schulze MonkingH , HornungW . Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: Results of a two year follow‐up. Acta Psychiatrica Scandinavica1997;96(6):483‐91. [CSzG: Ref602] KlingbergS , BuchkremerG , HolleR , MonkingH , HornungW . Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients ‐ results of 2‐year follow‐up. European Archives of Psychiatry and Clinical Neuroscience1999;249:66‐72. [CSzG: Ref5104] ">A ‐ Buchkremer 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT included Key Working and Psychoeducation.</sup> </p> <p><sup>CBT not provided as a discrete psychological intervention and it is not explicit whether the recipients of the therapy established links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour·</sup> </p> <p><sup>Insufficient information provided regarding the experience of the therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Psychoeducation regarding medication and structured free time activity</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0003" title="CatherC , PennD , OttoMW , YovelI , MueserKT , GoffDC . A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research2005;74(23):201‐9. [CSzG: Ref12184] ">A ‐ Cather 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>No indication other active therapies In the CBT arm of the trial.</sup> </p> <p><sup>Treatment was delivered by nine therapists with an average of 7.8 years (SD = 4.77) of experience conducting CBT.</sup> </p> <p><sup>Well‐defined CBT: cognitive restructuring, goal setting and coping skills enhancement.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Psychoeducation</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0023" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. British Journal of Psychiatry2000;177:8‐14. [CSzG: Ref4107] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. [CSzG: Ref1476] DruryV , BrichwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. [CSzG: Ref1477] ">NA ‐ Drury 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT included family engagement sessions + structured activity + self‐care skills.</sup> </p> <p><sup>Insufficient information provided regarding the experience of the therapists.</sup> </p> <p><sup>CBT involved challenging and testing key beliefs.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Recreation support, leisure and social activities</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. British Journal of Psychiatry2003;182:303‐11. [CSzG: Ref9545] ">A ‐ Durham 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The CBT was delivered by five clinical nurse specialists with extensive professional experience of severe mental disorder. All had completed a recognised post‐registration training on standard CBT. All were registered as therapists with the British Association of Behavioural and Cognitive Psychotherapy (BABCP).</sup> </p> <p><sup>CBT included: initial emphasis on engagement, education and building a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; development of a normalising rationale for the patient’s psychotic experiences; exploration and enhancement of current coping strategies; acquisition of additional coping strategies for hallucinations and delusions; and focus on accompanying affective symptomatology using relaxation training, personal effectiveness training and problem‐solving as appropriate.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive Psychotherapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0022" title="DavisLW , RingerJM , StrasburgerAM , LysakerPH . Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatric Rehabilitation Journal2008;32:55‐8. [CSzG: Ref16644] ">NA ‐ Davis 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: The weekly 1‐hour CBT group therapy intervention includes presentation of didactic material, exercises designed to apply didactic material to participants' experiences at work and work feedback. The weekly 30‐45 minute individual CBT sessions offer personalised application of group material.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>supportive group</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0005" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . Cognitive‐behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry2008;192(6):412‐23. [CSzG: Ref16445] ">A ‐ Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Clinical psychologists employed full time on the trial, provided CBT for 96 individuals (72% of the total).</sup> </p> <p><sup>A further 37 participants were seen by a mix of doctoral clinical psychologists and nurses who had received specialist training in CBT.</sup> </p> <p><sup>A CBT adherence protocol was used.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Family Intervention</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0006" title="GranholmE , HoldenJ , LinkP . Randomized clinical trial of cognitive behavioral social skills training (cbsst) for older people with schizophrenia: Replication and role of defeatist attitudes. Schizophrenia Bulletin2011;37:304. [CSzG: Ref22776] ">A ‐ Granholm 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Group based intervention included thought Challenging, Social Skills Training, and Problem‐Solving Training. Cognitive therapy was combined with role‐play practice of communication skills and problem‐solving training.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Goal‐Focused Supportive Contact</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82(6):1173‐85. [CSzG: Ref29118] ">A ‐ Granholm 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Group based intervention included thought Challenging, Social Skills Training, and Problem‐Solving Training. Cognitive therapy was combined with role‐play practice of communication skills and problem‐solving training.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Goal‐Focused Supportive Contact</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0008" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34(5):254‐8. [CSzG: Ref8475] ">A ‐ Haddock 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT was provided by clinical psychologists with expertise in CBT for psychosis.</sup> </p> <p><sup>CBT involved formulation, guided discovery, symptom monitoring, exposure/focusing, hypothesis/ reality testing reframing attributions and coping strategy enhancement.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive counselling and Psychoeducation</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0024" title="HaddockG , BarrowcloughC , ShawJJ , DunnG , NovacoRW , TarrierN . Cognitive‐behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. British Journal of Psychiatry2009;194(2):152‐7. [CSzG: Ref18298] ">NA ‐ Haddock 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Therapists processed BABCP minimum standards for practice of CBT and were experienced at applying CBT to psychosis. </sup> </p> <p><sup>A CBT adherence protocol was used.</sup> </p> <p><sup>A therapy manual for each treatment was developed and audio tapes of sessions were assessed by supervisors using the Cognitive Therapy Scale for Psychosis.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Social activities therapy</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0025" title="AllottK , Alvarez‐JimenezM , KillackeyEJ , BendallS , McGorryPD , JacksonHJ . Patient predictors of symptom and functional outcome following cognitive behaviour therapy or befriending in first‐episode psychosis. Schizophrenia Research2011;132(2‐3):125‐30. [CSzG: Ref23404] AllottKA , Alvarez‐JimenezM , BendallS , KillackeyEJ , McGorryPD , JacksonHJ . Predictors of functional outcome following CBT in first‐episode psychosis. Schizophrenia Bulletin2011;37:258. [CSzG: Ref22824] BendallS , AllottK , JovevM , MaroisM , KillackeyE , GleesonJ , et al. Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive Psychotherapy2015;43:314‐27. [CSzG: Ref29748] BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. [CSzG: Ref18494] JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. [CSzG: Ref16107] ">NA ‐ Jackson 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Authors reports that CBT was adapted from Kingdon and Turkington (1994), however, insufficient detail is given with regard to specific procedures.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Befriending</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0009" title="JiangY , WangH , WangJ . Effect of cognitive behavioral therapy in patients with chronic schizophrenia to obsessive‐compulsive symptoms. Sichuan Mental Health [四川精神卫生]2010;23:227‐9. [CSzG: Ref24094] ">A ‐ Jiang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT involves remediation of the participants' false cognition; remediation of the harmful behaviour; relaxation training; promote the participants getting involved in recreational activities.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Health education</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0026" title="KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: a randomised controlled trial. BMJ1996;312:345‐9. [CSzG: Ref1308] KempR , KirovG , EverittB , HaywardP , DavidA . Randomised controlled trial of compliance therapy. British Journal of Psychiatry1998;172:413‐9. [CSzG: Ref3499] ">NA ‐ Kemp 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>No indication of other active therapy in the CBT arm of the trial.</sup> </p> <p><sup>The therapists were trained in cognitive‐behavioural psychotherapy. Regular supervision was undertaken to ensure consistency with regard to the delivery of the intervention.</sup> </p> <p><sup>Compliance therapy did not make explicit to links between beliefs and affective states, rather beliefs about medication and illness were identified and explored.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Non‐specific counselling</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0010" title="CanteroMD , DuqueA , ValienteC , FuentenebroF , VillavicencioP , MehlS , et al. Social cognitive biases as moderators and mediators of successful cognitive behavioural therapy in schizophrenia – results of the positive study. Schizophrenia Research2012;136(April):1088‐5. KlingbergS , HerrlichJ , WiedemannG , WolwerW , MeisnerC , EngelC , et al. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. Journal of Nervous and Mental Disease2012;200:569‐76. [CSzG: Ref24444] KlingbergS , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(Suppl 2):S149‐54. [CSzG: Ref20607] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical tones study. Schizophrenia Bulletin2011;37(Suppl 2):98‐110. [CSzG: Ref23239] KlingbergS , WolwerW , EngelC , WittorfA , HerrlichJ , MeisnerC , et al. The role of cognitive behavioral therapy and cognitive remediation for the treatment of negative symptoms. European Archives of Psychiatry and Clinical Neuroscience2011;261:S36. [CSzG: Ref23741] ">A ‐ Klingberg 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT involved case formulation, goal setting, homework assignments, role play. Focus on initiative and planning, social activity, emotional participation and expression and speech activity.</sup> </p> <p><sup>CBT strategies designed specifically to reduce negative symptoms.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Cognitive Remediation therapy </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0011" title="BeauchampMC , LecomteT , LecomteC , LeclercC , CorbiereM . Personality traits in early psychosis: relationship with symptom and coping treatment outcomes. Early Intervention in Psychiatry2011;5(1):33‐40. [CSzG: Ref22697] LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease2008;196:866‐75. [CSzG: Ref17174] LecomteT , LeclercC , WykesT , SpidelA . Group CBT for early psychosis ‐ are there still benefits 1 year later?. Early Intervention in Psychiatry2010;4(Suppl 1):150. [CSzG: Ref23485] ">A ‐ Lecomte 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: The manual is built in 4 parts: (1) stress: how it affects me; (2) testing hypotheses and looking for alternatives, (3) drugs, alcohol, and how I feel; and (4) coping and competence.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Group social skill training</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. [CSzG: Ref7252] ">A ‐ Levine 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Therapists were previously trained in inducing "cognitive dissonance in person with paranoia".</sup> </p> <p><sup>CBT involved identifying relationships between beliefs and behaviours and generating alternative explanations.</sup> </p> <p><sup>Insufficient information provided about the experience of the therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0027" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. [CSzG: Ref8736] TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. [CSzG: Ref10096] ">NA ‐ Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>All therapists were eligible for accreditation as cognitive behaviour therapists by the BABCP.</sup> </p> <p><sup>CBT involved identifying relationships between beliefs and behaviours and generating alternative explanations.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0013" title="LiZJ , GuoZH , WangN , XuZY , QuY , WangXQ , et al. Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychological Medicine2015;45(9):1893‐905. ">A ‐ Li 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The trial protocol for using CBT to treat schizophrenia was compiled in Chinese and based on the principles and practice developed by Kingdon &amp; Turkington (2004).</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive Therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0016" title="MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on coping style for patients with schizophrenia [认知行为治疗对精神分裂症患者应对方式的影响]. Chinese Journal of Clinical Psychology [中国临床心理学杂志]2013;21(3):455‐7. [CSzG: Ref28418] MaY , LiZ , XuZ , GuoZ , QuY , WangX , et al. Effects of cognitive behavioral therapy on quality of life in patients with schizophrenia: a single blind randomized controlled study [认知行为治疗改善精神分裂症患者生活质量的随机单盲对照试验]. Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]2012;26(11):801‐7. [CSzG: Ref27002] ">A ‐ Ma 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The CBT therapy referred to Kingdon D et. al's (Kingdon 2005) CBT handbook. The CBT mainly involves therapies for hallucination, delusion, negative symptoms or emotional symptoms, medication compliance and prevention of relapse.Trainee CBT therapists conducted the CBT.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>supportive therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0032" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. [CSzG: Ref9883] ">NA ‐ O'Donnell 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>No indication of other active therapy in the CBT arm of the trial.</sup> </p> <p><sup>insufficient details provided regarding the qualifications of the therapist.</sup> </p> <p><sup>Compliance therapy did not make explicit to links between beliefs and affective states, rather beliefs about medication and illness were identified and explored.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Non‐specific counselling </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0017" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. [CSzG: Ref18213] ">A ‐ Penn 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The therapists included a clinical psychologist, a psychiatrist, a social work graduate student, and doctoral students in clinical psychology with the equivalent of at least a Master's degree in psychology.</sup> </p> <p><sup>Adherence measured by rating of audio taped sessions.</sup> </p> <p><sup>CBT emphasised coping skills enhancement rather than cognitive restructuring.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Enhanced supportive therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0018" title="PintoA , LaPiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioural therapy and clozapine for clients with treatment refactory schizophrena. Psychiatric Services1999;50(7):901‐4. [CSzG: Ref5215] ">A ‐ Pinto 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT arm included individual CBT + social skills training + standard care.</sup> </p> <p><sup>Insufficient details provided regarding the qualifications of the therapists.</sup> </p> <p><sup>CBT emphasised the "disputation of irrational belief relating to delusions and hallucinations as well as reality testing".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0033" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57:165‐72. [CSzG: Ref5259] TurkingtonD , SenskyT , ScottJ , BarnesT , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. [CSzG: Ref15582] ">NA ‐ Sensky 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT conducted by experienced psychiatric nurses, who underwent recognised training in CBT, and were registered as therapists by the United Kingdom Council for Psychotherapies.</sup> </p> <p><sup>The therapy including "developing a normalizing rationale, treating coexisting anxiety or depression, and generating a shared case formulation. Thereafter, specific techniques were used with positive psychotic symptoms. Thereafter, Socratic questioning was used, and for grandiose or systematised delusions, linked underlying beliefs were identified using inference chaining (the downward arrow technique)".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Befriending </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0019" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. outcome. British Journal of Psychiatry1993;162:524‐32. [CSzG: Ref2814] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , Morris , J . Two‐year follow‐up of cognitive behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [CSzG: Ref5396] TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. [CSzG: Ref3681] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [CSzG: Ref3682] ">A ‐ Tarrier 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The therapists were all clinical psychologists.</sup> </p> <p><sup>CBT is described as including coping strategies, problem‐solving and relapse prevention. The description of CBT does not include establishing explicit links between beliefs and affective states.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive counselling</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0034" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. [CSzG: Ref5385] ">NA ‐ Turkington 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The CBT arm does not have any other active therapies.</sup> </p> <p><sup>insufficient details provided regarding the qualifications of the therapists.</sup> </p> <p><sup>CBT is described as "disputation of irrational belief relating to delusions and hallucinations as well as reality testing".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Befriending</sup>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0035" title="ValmaggiaLR , GaagMVD , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. [CSzG: Ref11462] ">NA ‐ Valmaggia 2005</a>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBT was provided by psychologists specialising in CBT and who were experienced in working with patients with schizophrenia.</sup> </p> <p><sup>Treatment fidelity was assessed.</sup> </p> <p><sup>CBT "begins with an engagement phase emphasising collaboration and focuses upon delusional distress. In the second phase a shared case formulation is identified, specific techniques are used for symptom and distress reduction. With auditory hallucinations the aim is to change the beliefs about the origin, power and dangerousness of voices. In delusions, the focus is on challenging the dysfunctional beliefs and learning to make more balanced conclusions. In the last phase of therapy, treatment focuses on relapse prevention strategies".</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive counselling</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0020" title="NCT01915017 . Interventions to improve functional outcome and persistent symptoms in schizophrenia. Clinicaltrials.gov/show/NCT01915017 (first received 26 July 2013). [CSzG: Ref27937] VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. [CSzG: Ref29077] ">A ‐ Velligan 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>CBTp is a talk therapy designed to treat persistent symptoms of psychosis and the accompanying distress. A 9‐month treatment manual was developed based upon Kingdon and Turkington and included simple handouts and homework assignments based on the work of Granhom et al. The focus of the sessions was on patient identified problems, particularly those that interfered with daily functioning or were distressing, normalizing symptoms, and using CBT techniques to develop alternative explanatory models of event.</sup> </p> <p><sup>The CBT was delivered by experienced therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Cognitive adaptation training</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0021" title="WittorfA , JakobiUE , BannertKK , BechdolfA , MullerBW , SartoryG , et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?. Journal of Nervous and Mental Disease2010;198:478‐85. [CSzG: Ref21349] WittorfA , KlingbergS . The therapeutic alliance in CBT for pychoses: course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. [CSzG: Ref23759] ">A ‐ Wittorf 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>In collaboration with the patient an individual treatment plan including behaviour analyses is established and treatment goals are retrieved. This process of a ease formulation should be completed until session 9. Afterward, specific cognitive disputing strategies such as work on delusions (e.g. debating persecutory delusions; testing beliefs), hallucinations (e.g. use of a voice diary; work on reattribution with the patient's explanation of voice hearing, and test it out), and cognitive schemata (e.g. linking defectiveness schema to the content of the voices; confronting the patient with evidence that discredits the schema) are the central part of the CBT.</sup> </p> <p><sup>The CBT was conducted by 7 specifically trained female clinical psychologists. A mixture of trainees and experienced therapists.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0031" title="LiY , LiZ , XinL , HouL , ZhaoY , HouC . The efficacy of special cognitive‐behavior approaches on schizophrenia during acute‐phase [特定认知行为技术对急性期精神分裂症的干预效果]. Hebei Medicine [河北医学]2015;21(06):1018‐20. [CSzG: Ref33920] ">NA ‐ Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>The author did not state who delivered CBT</sup> </p> <p><sup>the content of CBT includes: patients information and baseline condition was comprehensively collected and evaluated to pave the way for establishment of treatment plan. Towards hallucination, reasonable explanation was developed with patients to ease their anxiety; diary was kept for voices they heard; individual coping strategy was established. Similar process was followed to deal with delusion. Therapists generally adopted the process of identifying problem, establish a rational explanation, reinforce correct perception</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard psychological support + pharmacological therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0014" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of effects of community comprehensive rehabilitation on family burden and psychological health of their main caregivers of patients the chronic schizophrenia [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese People's Health [中国民康医学]2015;27(9):1‐4+7. [CSzG: Ref34296] ">A ‐ Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: through analysis of underlying causes and developing problem‐solving models to correct patients negative/problematic behaviour, as well as improving patients understanding of the condition. Re‐build behavioural model that is beneficial to patient cognitive ability, reduces social conflict, improve medication compliance and reduce symptoms.</sup> </p> <p><sup>Delivered by: psychiatrists taking part in the present study's institution.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Family intervention or occupational therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008712-bbs2-0015" title="LiY , XiongA , HouL , ZhaoY , HouC . Effects of behavior treatment for schizophrenia patients during recovery stage [精神分裂症患者恢复期应用行为治疗的作用分析]. Journal of Hainan Medical University [海南医学院学报]2015;21(3):430‐2. [CSzG: Ref31686] ">A ‐ Li 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Content: three stages and each with distinctive therapeutic goals. Therapy programme was developed with clear focus of each stage and homework was allocated. Initially therapeutic relationship was established by investigating patients feeling towards illness stigma and their perception of the illness. During second stage, CBT techniques were employed to correct the misconception and to incept positive thought model and coping strategy. In final stage, previous learning was reinforced and consolidated.</sup> </p> <p><sup>Delivered by: not stated.</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>Supportive therapy + pharmacological therapy</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>√ = criteria fulfilled; ✗ = criteria not fulfilled; ? = unclear.<br/> BABCP: British Association of Behavioural and Cognitive Psychotherapy; CBT: Cognitive behavioural therapy </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">More detailed description of interventions in the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/full#CD008712-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CBT versus OTHER PSYCHOSOCIAL THERAPIES</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.05, 11.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.56, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. Average endpoint total score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 GAS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐4.93, 3.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 GAS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐7.63, 6.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 GAF ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.02 [4.29, 13.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 GAF‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.42 [‐0.37, 11.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 3. Rehospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.13, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.57, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.82, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. General ‐ clinically important change (no improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.58, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.58, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.67, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 2. General (average endpoint total score, various scales, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 BPRS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐2.83, 3.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 BPRS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.60 [‐14.30, ‐0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 PANSS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>568</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.38 [‐7.31, ‐3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 PANSS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐7.93, ‐1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 PANSS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.22 [‐5.42, ‐1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 CPRS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.30 [‐9.26, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 CPRS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.60 [‐11.22, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.57 [‐1.19, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐2.04, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>602</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐1.96, ‐0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score various subscales, high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 PANSS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 SAPS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 BPRS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 BPRS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mental state: 3c. Specific ‐ positive symptoms (average endpoint BPRS subscale, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.45, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐4.36, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.1 [‐3.83, 3.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐5.53, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 4b. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mental state: 5a. Specific ‐ delusions (average endpoint score PSYRATS subscale, high = poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐3.27, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 5b. Specific ‐ delusions (average endpoint score PSYRATS subscale, high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.76, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.42, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.84 [‐1.67, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term, skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score SANS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐3.25, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.60 [‐19.01, 5.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [‐2.19, 3.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Mental state: 6d. Specific ‐ negative symptoms (average endpoint score SANS, high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Mental state: 6e. Specific ‐ negative symptoms (average endpoint score BPRS subscale, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.31, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.38 [‐4.62, ‐2.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐2.75, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐2.28, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mental state: 7b. Specific ‐ affective symptoms (average endpoint score SCL90, high=poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.26 [1.77, 14.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Mental state: 8a. Specific ‐ depression (average endpoint score BDI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Mental state: 8b. Specific ‐ depression (average endpoint score MADRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Mental state: 8c. Specific ‐ depression (average endpoint score HAMD, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.92 [‐4.96, ‐2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Mental state: 9a. Specific ‐ self esteem (average endpoint score RSES, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [‐0.93, 4.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐2.17, 3.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐1.79, 5.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Mental state: 9b. Specific ‐ self esteem (average endpoint score RSES, high = good) ‐ short term, skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Mental state: 10. Specific ‐ self stigma (average endpoint score SSMI, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Mental state: 11a. Specific ‐ anxiety (average endpoint score BAI, high = poor) ‐ long term, skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Mental state: 11b. Specific ‐ anxiety (average endpoint score HAMA, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.78 [‐8.79, ‐2.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Mental state: 11c. Specific ‐ anxiety (average endpoint score SARS, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.89 [‐4.53, ‐1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Mental state: 12b. Specific ‐ clinically important change ‐ Obessive Compulsive Disorder (no improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Mental state: 12a. Specific ‐ Obsessive Compulsive Disorder (average endpoint score Y‐BOCS, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.55 [‐15.43, ‐11.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Mental state: 13. Specific ‐ anger/aggression (average endpoint score NAS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [‐5.70, 9.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.05 [‐9.56, 7.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Mental state: 14. Specific ‐ problem behaviours (average endpoint score various scales, high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 Novaco Provocation Inventory ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.2 Novaco Provocation Inventory ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.3 Ward Anger Rating Scale ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.4 Ward Anger Rating Scale ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.5 HCR‐20 risk management ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Mental state: 15. Specific ‐ thought disturbances (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Adverse effect/event(s): 1. Number of events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [1.04, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.87, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Adverse effect/event(s): 2. Death ‐ any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.62, 3.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Functioning: 1a. Social functioning (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 Social Functioning Scale ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.40 [‐5.18, 15.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.2 Social Functioning Scale ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.20 [‐3.46, 17.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.3 Social Functioning Scale ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.80 [‐4.07, 21.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.4 Personal and Social Performance Scale ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.28 [‐0.50, 7.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.5 Personal and Social Performance Scale ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.72 [2.18, 11.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.6 Personal and Social Performance Scale ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.35 [4.66, 14.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.7 Maryland Assessment of Social Competence ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.05, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.09 [‐1.21, 11.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [‐4.90, 7.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 Schedule for Assessment of Insight ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [‐0.27, 2.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.2 Schedule for Assessment of Insight ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.09, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.3 Schedule for Assessment of Insight ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐0.01, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.4 The Insight Scale ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐2.17, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Functioning: 2b. Cognitive functioning ‐ insight (average endpoint score BCIS / SAI, high = good) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Functioning: 3. Life skills ‐ skills acquisition ‐ (average endpoint score CMT, high = good) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Quality of life: 1a. General (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐0.52, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.1 LSI ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐1.75, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.2 LSI ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐1.59, 2.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.3 LSI ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐0.50, 3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.4 EuroQOL ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.86 [‐19.20, 15.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.5 The Quality of Life Scale ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐16.25, 9.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.6 MSQoL ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐13.77, 10.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.7 MSQoL ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.50 [‐15.66, 6.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Quality of life: 2a. Specific (average endpoint score MSQOL, high = good) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1 Physcial health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [‐7.81, 12.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.2 Vitality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐9.80, 10.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.3 Psychosocial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐10.25, 11.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.4 Material</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [‐6.79, 14.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.5 Spare time</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐12.73, 14.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.6 Affective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.90 [‐15.81, 4.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Quality of life: 2b. Specific (average endpoint score MSQOL, high = good) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 Physical health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.0 [‐15.93, 5.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.2 Vitality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.20 [‐17.22, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.3 Psychosocial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.10 [‐16.42, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.4 Material</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐17.05, 10.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.5 Spare time</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.70 [‐4.71, 16.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.6 Affective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.20 [‐15.76, 3.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Satisfaction with treatment: 1. Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.75, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.93, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Engagement with services: 2. Attitude to medication (average endpoint score, various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 Attitude to Medication Questionnaire ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.50 [2.17, 6.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.2 Drug Attitude Inventory ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.70 [2.05, 9.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.3 Drug Attitude Inventory ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐6.11, 1.91]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CBT versus OTHER PSYCHOSOCIAL THERAPIES</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.58, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. Rehospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 1. General ‐ clinically important change (no improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.91, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.77, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐1.09, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.29 [‐2.21, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐3.15, ‐1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐4.76, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐1.04, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.92, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.34 [‐2.57, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐6.69, ‐3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.68 [‐4.04, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.61 [‐3.65, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse effect/event(s): 2. Death ‐ any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.19, 4.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [‐9.59, 12.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Schedule for assessment of insight ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.38, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.72, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.99, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUBGROUP 1: CBT versus ACTIVE PSYCHOSOCIAL THERAPIES</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.14, 15.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. Rehospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.86, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 1. General ‐ clinically important change (no improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.33, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.39, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐1.84, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐2.82, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐1.40, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.36 [‐9.30, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐1.06, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐1.52, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.54, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.95 [‐3.68, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐2.71, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐2.21, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse effect/event(s): 2. Death ‐ any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.63, 6.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐6.26, 8.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Schedule for assessment of insight ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐2.43, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Satisfaction with treatment: 1. Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.68, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.78, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SUBGROUP 2: CBT versus NON ACTIVE PSYCHOSOCIAL THERAPIES</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.56, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.14, 15.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.58, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 2. Rehospitalisation ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.82, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.86, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: General ‐ clinically important change (no improvement) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.77, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.91, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.33, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.67, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.77, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.39, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.84, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐1.09, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐1.09, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ medium term term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐2.04, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.29 [‐2.21, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Non Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐2.82, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS, high = poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>602</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐1.96, ‐0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐3.15, ‐1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Non Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐1.40, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mental state: 4a. Specific ‐ hallucinations (average endpoint score PSYRATS, high = poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐5.53, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐4.76, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.36 [‐9.30, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.76, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐1.04, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐1.06, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.42, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.92, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐1.52, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS subscale, high = poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.84 [‐1.67, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.34 [‐2.57, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.54, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.38 [‐4.62, ‐2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐6.69, ‐3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.95 [‐3.68, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐2.75, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.68 [‐4.04, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐2.71, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS subscale, high = poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐2.28, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.61 [‐3.65, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐2.21, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Adverse effects: 1b. Adverse effect/event(s) ‐ death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.62, 3.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.19, 4.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.63, 6.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Functioning: 1b. Social functioning (average endpoint score SOFAS, high = good) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [‐4.90, 7.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [‐9.59, 12.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐6.26, 8.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Functioning: 2a. Cognitive functioning ‐ insight (average endpoint score SAI, high = good) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐0.01, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.38, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐2.43, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Satisfaction with treatment: 1. Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.75, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.72, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.68, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Engagement with services: 1. Compliance with medication ‐ favourable compliance ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.93, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.99, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 Non active</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.78, 1.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SUBGROUP 3. CBT versus OTHER THERAPIES (TEST FOR DIFFERENCE BETWEEN ACTIVE/NON ACTIVE SUBGROUPS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 with less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 without less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.84, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 with less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.58, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 without less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.28, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 with less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.58, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 without less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.29, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 with less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.67, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 without less‐well‐designed CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.44, 1.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (LESS‐WELL‐DESIGNED CBT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (UNCLEAR EXPERIENCED THERAPISTS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 with unclear experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 without unclear experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.82, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 with unclear experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.58, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 without unclear experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.85, 1.18]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (UNCLEAR EXPERIENCED THERAPISTS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 with assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.56, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 without assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.28, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 with assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 without assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.86, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 with assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.58, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 without assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.58, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 with assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.67, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 without assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.66, 1.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (ASSUMPTION FOR MISSING DATA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 with high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.56, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 without high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.14, 15.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 with high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 without high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.81, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 with high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.58, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 without high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.28, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 with high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.58, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 without high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.71, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 with high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.67, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 without high risk of bias studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.57, 1.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RISK OF BIAS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008712-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RANDOM EFFECT MODEL)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse (random effect model) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.05, 11.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.56, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.85, 1.27]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SENSITIVITY ANALYSIS: CBT versus OTHER PSYCHOSOCIAL THERAPIES (RANDOM EFFECT MODEL)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008712.pub3/references#CD008712-tbl-0013">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008712.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD008712-note-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD008712-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008712-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD008712-note-0008">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD008712-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD008712-note-0001">Português</a> </li> <li class="section-language"> <a class="" href="th#CD008712-note-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD008712-note-0017">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD008712-note-0005">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008712\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008712\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008712\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008712\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008712\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008712.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008712.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008712.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008712.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008712.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715262589"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008712.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715262593"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008712.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d82cb6c2ef446',t:'MTc0MDcxNTI2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 